#Other Patient ID	Patient Identifier	Form completion date	Neoplasm Histologic Type Name	Tumor Other Histologic Subtype	Primary Tumor Site	Gleason pattern primary	Gleason pattern secondary	Radical Prostatectomy Gleason Score for Prostate Cancer	Gleason pattern tertiary	Primary Tumor Laterality	Tumor Level	Sex	Tissue Prospective Collection Indicator	Tissue Retrospective Collection Indicator	Birth from Initial Pathologic Diagnosis Date	Prior Cancer Diagnosis Occurence	Neoadjuvant Therapy Type Administered Prior To Resection Text	Year Cancer Initial Diagnosis	Days to bone Scan performed	Bone Scan Result	Ct scan ab pelvis indicator	Days to ct scan ab pelvis	Ct scan ab pelvis results	Diagonstic MRI Result	Days to mri	Mri results	Primary Lymph Node Presentation Assessment Ind-3	Lymph Node(s) Examined Number	Positive Finding Lymph Node Hematoxylin and Eosin Staining Microscopy Count	Surgical Margin Resection Status	Patient's Vital Status	Days to Last Followup	Death from Initial Pathologic Diagnosis Date	Patient Death Reason	Cause of death source	Person Neoplasm Status	Days to PSA	Psa most recent results	Biochemical Recurrence Indicator	Did patient start adjuvant postoperative radiotherapy?	Primary Therapy Outcome Success Type	New Neoplasm Event Post Initial Therapy Indicator	Days to biochemical recurrence first	Diagnosis Age	Neoplasm American Joint Committee on Cancer Clinical Distant Metastasis M Stage	Neoplasm American Joint Committee on Cancer Clinical Regional Lymph Node N Stage	Neoplasm American Joint Committee on Cancer Clinical Primary Tumor T Stage	Neoplasm American Joint Committee on Cancer Clinical Group Stage	Last Alive Less Initial Pathologic Diagnosis Date Calculated Day Value	Disease code	Ethnicity Category	Lymphomatous Extranodal Site Involvement Indicator	ICD-10 Classification	International Classification of Diseases for Oncology, Third Edition ICD-O-3 Histology Code	International Classification of Diseases for Oncology, Third Edition ICD-O-3 Site Code	Informed consent verified	Initial pathologic diagnosis method	American Joint Committee on Cancer Metastasis Stage Code	Neoplasm Disease Lymph Node Stage American Joint Committee on Cancer Code	American Joint Committee on Cancer Tumor Stage Code	Neoplasm Disease Stage American Joint Committee on Cancer Code	Project code	Race Category	Stage Other	American Joint Committee on Cancer Publication Version Type	Adjuvant Postoperative Targeted Therapy Administered Indicator	Tissue Source Site	Tumor Disease Anatomic Site	Overall Survival Status	Overall Survival (Months)	Disease Free Status	Disease Free (Months)
#Legacy DMP patient identifier (DMPnnnn)	Identifier to uniquely specify a patient.	Form completion date	Text term for the structural pattern of cancer cells used to define a microscopic diagnosis.	Text to describe a tumor's histologic subtype or mixed diagnosis that is different from previously specified options.	Text term to describe the organ sub-division in an individual with cancer.	Gleason pattern primary	Gleason pattern secondary	The score derived from universally embraced prostate cancer grading system developed by Dr. Donald F. Gleason in 1977. The system provides a reproducible description of the glandular architecture of prostate tissue to which a pathologist assigns a score depending primarily on the microscopic patterns of cancerous glands and cell morphology. The system correlates well with behavior at the extremes: Gleason 1+1 tumors are the most well differentiated, slowly growing and rarely spread; Gleason 4+5 tumors are the most poorly differentiated, often widely metastatic at the time of diagnosis. In the commoner intermediate grade tumors, however, behavior is extremely variable.	Gleason pattern tertiary	For tumors in paired organs, designates the side on which the cancer originates.	Tumor level.	Sex	Text indicator for the time frame of tissue procurement, indicating that the tissue was procured in parallel to the project.	Text indicator for the time frame of tissue procurement, indicating that the tissue was obtained and stored prior to the initiation of the project.	Time interval from a person's date of birth to the date of initial pathologic diagnosis, represented as a calculated number of days.	Text term to describe the patient's history of prior cancer diagnosis and the spatial location of any previous cancer occurrence.	Text term to describe the patient's history of neoadjuvant treatment and the kind of treament given prior to resection of the tumor.	Numeric value to represent the year of an individual's initial pathologic diagnosis of cancer.	Days to bone Scan performed	Bone scan result.	Diagnostic ct abd pelvis performed	Days to diagnostic computed tomography performed	Diagnostic ct abd pelvis result	Diagonostic MRI result.	Days to diagnostic mri performed	Diagnostic mri result	the yes/no/unknown indicator whether a lymph node assessment was performed at the primary presentation of disease.	The total number of lymph nodes removed and pathologically assessed for disease.	Numeric value to signify the count of positive lymph nodes identified through hematoxylin and eosin (H&E) staining light microscopy.	Text terms to describe the status of a tissue margin following surgical resection.	The survival state of the person.	Time interval from the date of last followup to the date of initial pathologic diagnosis, represented as a calculated number of days.	Time interval from a person's date of death to the date of initial pathologic diagnosis, represented as a calculated number of days.	Text term to identify the cause of death for a patient.	Source of patient death reason	The state or condition of an individual's neoplasm at a particular point in time.	Days to Prostate-Specific Antigen (PSA) Test	Psa most recent results	Biochemical Recurrence Indicator	A yes/no indicator that asks whether the patient started adjuvant postoperative radiotherapy.	Text term for the measure of success of outcome after primary treatment (surgery and adjuvant therapies).	Yes/No/Unknown indicator to identify whether a patient has had a new tumor event after initial treatment.	Days to first biochemical recurrence	Age at which a condition or disease was first diagnosed.	Extent of the distant metastasis for the cancer based on evidence obtained from clinical assessment parameters determined prior to treatment.	Extent of the regional lymph node involvement for the cancer based on evidence obtained from clinical assessment parameters determined prior to treatment.	Extent of the primary cancer based on evidence obtained from clinical assessment parameters determined prior to treatment.	Stage group determined from clinical information on the tumor (T), regional node (N) and metastases (M) and by grouping cases with similar prognosis for cancer.	Time interval from the last day on which a person is known to be alive to the date of initial pathologic diagnosis, represented as a calculated number of days.	Disease code	The text for reporting information about ethnicity.	Indicator that identifies whether a patient with malignant lymphoma has lymphomatous involvement of an extranodal site.	10th revision of the International Statistical Classification of Diseases and Related Health Problems.	The third edition of the International Classification of Diseases for Oncology, published in 2000, used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms._The study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs.  In pathology, the microscopic process of identifying normal and abnormal morphologic characteristics in tissues, by employing various cytochemical and immunocytochemical stains._A system of numbered categories for representation of data.	The third edition of the International Classification of Diseases for Oncology, published in 2000, used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms._The description of an anatomical region or of a body part._Named locations of, or within, the body._A system of numbered categories for representation of data.	Informed consent verified	Initial pathologic diagnosis method	Code to represent the defined absence or presence of distant spread or metastases (M) to locations via vascular channels or lymphatics beyond the regional lymph nodes, using criteria established by the American Joint Committee on Cancer (AJCC).	The codes that represent the stage of cancer based on the nodes present (N stage) according to criteria based on multiple editions of the AJCC's Cancer Staging Manual.	Code of pathological T (primary tumor) to define the size or contiguous extension of the primary tumor (T), using staging criteria from the American Joint Committee on Cancer (AJCC).	The extent of a cancer, especially whether the disease has spread from the original site to other parts of the body based on AJCC staging criteria.	Project code	The text for reporting information about race.	Stage Other	The version or edition of the American Joint Committee on Cancer Cancer Staging Handbooks, a publication by the group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.	Text term to signify postoperative adjuvant cancer therapies which use drugs to act upon specific molecules, metabolic pathways or processes involved in carcinogenesis, tumor growth, or tumor spread. [Manually-curated]	A Tissue Source Site collects samples (tissue, cell, or blood) and cliincal metadata which are then sent to tha Biospecimen Core Resource.	Text term that describes the anatomic site of the tumor or disease.	Overall patient survival status.	Overall survival in months since initial diagonosis.	Disease free status since initial treatment.	Disease free (months) since initial treatment.
#STRING	STRING	STRING	STRING	STRING	STRING	NUMBER	NUMBER	STRING	NUMBER	STRING	STRING	STRING	STRING	STRING	NUMBER	STRING	STRING	NUMBER	NUMBER	STRING	STRING	NUMBER	STRING	STRING	NUMBER	STRING	STRING	NUMBER	NUMBER	STRING	STRING	NUMBER	NUMBER	STRING	STRING	STRING	STRING	NUMBER	STRING	STRING	STRING	STRING	NUMBER	NUMBER	STRING	STRING	STRING	STRING	NUMBER	STRING	STRING	STRING	STRING	STRING	STRING	STRING	STRING	STRING	STRING	STRING	STRING	STRING	STRING	STRING	STRING	STRING	STRING	STRING	STRING	NUMBER	STRING	NUMBER
#1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
OTHER_PATIENT_ID	PATIENT_ID	FORM_COMPLETION_DATE	HISTOLOGICAL_DIAGNOSIS	HISTOLOGICAL_SUBTYPE	PRIMARY_SITE	GLEASON_PATTERN_PRIMARY	GLEASON_PATTERN_SECONDARY	GLEASON_SCORE	GLEASON_PATTERN_TERTIARY	LATERALITY	TUMOR_LEVEL	SEX	PROSPECTIVE_COLLECTION	RETROSPECTIVE_COLLECTION	DAYS_TO_BIRTH	HISTORY_OTHER_MALIGNANCY	HISTORY_NEOADJUVANT_TRTYN	INITIAL_PATHOLOGIC_DX_YEAR	DAYS_TO_BONE_SCAN_PERFORMED	BONE_SCAN_RESULT	CT_SCAN_AB_PELVIS_INDICATOR	DAYS_TO_CT_SCAN_AB_PELVIS	CT_SCAN_AB_PELVIS_RESULTS	DIAGNOSTIC_MRI_RESULT	DAYS_TO_MRI	MRI_RESULTS	LYMPH_NODES_EXAMINED	LYMPH_NODE_EXAMINED_COUNT	LYMPH_NODES_EXAMINED_HE_COUNT	RESIDUAL_TUMOR	VITAL_STATUS	DAYS_TO_LAST_FOLLOWUP	DAYS_TO_DEATH	PATIENT_DEATH_REASON	CAUSE_OF_DEATH_SOURCE	TUMOR_STATUS	DAYS_TO_PSA	PSA_MOST_RECENT_RESULTS	BIOCHEMICAL_RECURRENCE_INDICATOR	RADIATION_TREATMENT_ADJUVANT	TREATMENT_OUTCOME_FIRST_COURSE	NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT	DAYS_TO_BIOCHEMICAL_RECURRENCE_FIRST	AGE	CLIN_M_STAGE	CLIN_N_STAGE	CLIN_T_STAGE	CLINICAL_STAGE	DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS	DISEASE_CODE	ETHNICITY	EXTRANODAL_INVOLVEMENT	ICD_10	ICD_O_3_HISTOLOGY	ICD_O_3_SITE	INFORMED_CONSENT_VERIFIED	INITIAL_PATHOLOGIC_DIAGNOSIS_METHOD	PATH_M_STAGE	PATH_N_STAGE	PATH_T_STAGE	AJCC_PATHOLOGIC_TUMOR_STAGE	PROJECT_CODE	RACE	STAGE_OTHER	AJCC_STAGING_EDITION	TARGETED_MOLECULAR_THERAPY	TISSUE_SOURCE_SITE	TUMOR_TISSUE_SITE	OS_STATUS	OS_MONTHS	DFS_STATUS	DFS_MONTHS
49197847-CC83-4CE1-8397-D09CEA4C4928	TCGA-2A-A8VL	3/29/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Peripheral Zone	3	3	6	4	Left	Middle|Base	Male	NO	YES	-18658	No	No	2010	21	Normal (no evidence of prostate cancer) [cM0]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	YES	15	0	R0	Alive	621	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	585	0.05	NO	NO	[Not Available]	NO	[Not Available]	51	M0	[Not Applicable]	[Unknown]	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T2b	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	2A	Prostate	LIVING	20.40	DiseaseFree	20.40
91C0D161-2B59-4B7A-8C19-6D26DEA31849	TCGA-2A-A8VO	3/30/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Overlapping / Multiple Zones	3	3	6	4	Bilateral	Apex|Middle|Base	Male	NO	YES	-20958	No	No	2010	22	Normal (no evidence of prostate cancer) [cM0]	YES	11	No Evidence of Extraprostatic Extension	YES	84	Extraprostatic Extension Localized (e.g. seminal vesicles)	NO	[Not Available]	[Not Available]	R1	Alive	1332	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	1332	0.05	NO	NO	[Not Available]	NO	[Not Available]	57	M0	[Not Applicable]	T1c	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	[Not Available]	T3a	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	2A	Prostate	LIVING	55.88	DiseaseFree	55.88
931B549F-B9F2-4E8D-83ED-FF663671883C	TCGA-2A-A8VT	3/29/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Overlapping / Multiple Zones	4	5	9	[Not Available]	Bilateral	Apex|Middle|Base	Male	NO	YES	-17365	No	No	2011	4	Normal (no evidence of prostate cancer) [cM0]	YES	-2	No Evidence of Extraprostatic Extension	YES	4	No Evidence of Extraprostatic Extension	YES	16	2	R1	Alive	995	[Not Applicable]	[Not Available]	[Not Available]	[Discrepancy]	995	0.05	NO	YES	[Discrepancy]	NO	[Not Available]	47	M0	[Not Applicable]	T2c	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N1	T4	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	YES	2A	Prostate	LIVING	45.11	DiseaseFree	45.11
75A7AFB5-66D5-47E3-8A8A-3E3A1E749A96	TCGA-2A-A8VV	3/29/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Peripheral Zone	3	3	6	4	Right	Apex|Middle	Male	NO	YES	-19065	No	No	2010	167	Equivocal	YES	29	No Evidence of Extraprostatic Extension	YES	204	No Evidence of Extraprostatic Extension	YES	16	0	R0	Alive	671	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	560	0.05	NO	NO	[Not Available]	NO	[Not Available]	52	M0	[Not Applicable]	T2b	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T2b	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	2A	Prostate	LIVING	22.04	DiseaseFree	22.04
942F1788-D977-4AC0-A177-659F9D4CD077	TCGA-2A-A8VX	3/29/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Peripheral Zone	4	4	8	[Not Available]	Bilateral	Middle	Male	NO	YES	-25904	No	No	2011	32	Normal (no evidence of prostate cancer) [cM0]	YES	32	Extraprostatic Extension  Localized (e.g. seminal vesicles)	YES	89	Extraprostatic Extension Localized (e.g. seminal vesicles)	YES	16	0	R0	Alive	1033	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	1033	0.05	NO	NO	[Not Available]	NO	[Not Available]	70	M0	[Not Applicable]	T2c	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3b	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	2A	Prostate	LIVING	45.27	DiseaseFree	45.27
F5319FD5-BEAE-4CA8-8F42-45FCA5E6A2D2	TCGA-2A-A8W1	3/29/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Peripheral Zone	4	3	7	[Not Available]	Left	Middle|Base	Male	NO	YES	-19964	No	No	2011	27	Normal (no evidence of prostate cancer) [cM0]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	YES	12	0	R1	Alive	112	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	-122	0.05	NO	[Not Available]	[Not Available]	NO	[Not Available]	54	M0	[Not Applicable]	T1c	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3a	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	2A	Prostate	LIVING	3.68	DiseaseFree	3.68
5A790086-4887-4D2B-9C28-0FDD5DD1F1FB	TCGA-2A-A8W3	3/29/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Peripheral Zone	4	5	9	[Not Available]	Left	Apex|Middle|Base	Male	NO	YES	-25557	No	No	2011	13	Normal (no evidence of prostate cancer) [cM0]	YES	13	No Evidence of Extraprostatic Extension	YES	-14	No Evidence of Extraprostatic Extension	YES	3	0	R0	Alive	771	[Not Applicable]	[Not Available]	[Not Available]	[Discrepancy]	771	0.36	YES	NO	[Not Available]	YES	198	69	M0	[Not Applicable]	T2b	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3a	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	2A	Prostate	LIVING	28.35	Recurred/Progressed	6.5
490E84ED-3C02-4593-990E-ADE5C109DF44	TCGA-2A-AAYF	7/7/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Overlapping / Multiple Zones	3	4	7	[Not Available]	Right	Apex|Middle|Base	Male	NO	YES	-20866	No	No	2011	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	YES	186	Extraprostatic Extension Localized (e.g. seminal vesicles)	NO	[Not Available]	[Not Available]	R0	Alive	972	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	972	0.05	NO	NO	Complete Remission/Response	NO	[Not Available]	57	M0	[Not Applicable]	T1c	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	[Not Available]	T3a	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	2A	Prostate	LIVING	44.81	DiseaseFree	44.81
8C0D361F-EAAB-4768-90F2-B7A610E2BBB1	TCGA-2A-AAYO	7/7/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Overlapping / Multiple Zones	3	3	6	[Not Available]	Bilateral	Apex|Middle	Male	NO	YES	-21183	No	No	2011	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	YES	180	No Evidence of Extraprostatic Extension	NO	[Not Available]	[Not Available]	R0	Alive	922	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	922	0.05	NO	NO	Complete Remission/Response	NO	[Not Available]	57	M0	[Not Applicable]	T1c	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	[Not Available]	T2c	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	2A	Prostate	LIVING	41.79	DiseaseFree	41.79
AA1A3A43-2F9C-456C-BA74-81C29B9801CB	TCGA-2A-AAYU	7/7/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Overlapping / Multiple Zones	3	3	6	4	Left	Apex|Middle|Base	Male	NO	YES	-20582	No	No	2012	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	YES	52	Extraprostatic Extension Localized (e.g. seminal vesicles)	YES	28	0	R1	Alive	615	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	269	0.05	NO	NO	[Discrepancy]	NO	[Not Available]	56	M0	[Not Applicable]	T1c	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3a	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	2A	Prostate	LIVING	20.2	DiseaseFree	20.2
47ABCD03-C6FF-4777-AC26-F880474092FF	TCGA-4L-AA1F	11/14/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Overlapping / Multiple Zones	4	4	8	[Not Available]	Bilateral	Middle	Male	YES	NO	-23665	No	No	2013	0	Abnormal (not related to prostate cancer)	YES	4	Extraprostatic Extension  Localized (e.g. seminal vesicles)	YES	5	Extraprostatic Extension Localized (e.g. seminal vesicles)	YES	4	0	R1	Alive	350	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	350	3.5	NO	NO	Complete Remission/Response	NO	[Not Available]	64	M1a	[Not Applicable]	T2c	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3b	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	YES	4L	Prostate	LIVING	11.5	DiseaseFree	11.5
4f9f1fce-d96e-407b-a873-56129985aece	TCGA-CH-5737	3/16/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Peripheral Zone	4	3	7	[Not Available]	Bilateral	[Not Available]	Male	YES	NO	-26753	No	No	2007	91	Normal (no evidence of prostate cancer) [cM0]	YES	91	No Evidence of Extraprostatic Extension	YES	91	No Evidence of Extraprostatic Extension	YES	8	0	R0	Alive	91	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	[Discrepancy]	14.69	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	73	M0	[Not Applicable]	[Not Available]	[Not Applicable]	0	[Not Available]	NOT HISPANIC OR LATINO	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T2c	[Not Applicable]	[Not Available]	WHITE	[Not Available]	[Not Applicable]	[Not Available]	CH	Prostate	LIVING	2.99	DiseaseFree	2.99
5828401b-0901-4a73-9d0c-1e85d3431475	TCGA-CH-5738	3/16/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	3	3	6	4	Bilateral	[Not Available]	Male	YES	NO	-26329	No	No	2006	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	R0	Alive	212	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	195	0.01	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	72	M0	[Not Applicable]	[Not Available]	[Not Applicable]	0	[Not Available]	NOT HISPANIC OR LATINO	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	[Not Available]	[Discrepancy]	[Not Applicable]	[Not Available]	WHITE	[Not Available]	[Not Applicable]	[Not Available]	CH	Prostate	LIVING	6.96	DiseaseFree	6.96
79601d90-b198-4b94-b60f-4cff329c7a10	TCGA-CH-5739	3/16/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Peripheral Zone	3	4	7	[Not Available]	Left	[Not Available]	Male	YES	NO	-23953	No	No	2006	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	YES	8	0	R0	Alive	671	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	586	0.02	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	65	M0	[Not Applicable]	[Not Available]	[Not Applicable]	0	[Not Available]	NOT HISPANIC OR LATINO	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3a	[Not Applicable]	[Not Available]	WHITE	[Not Available]	[Not Applicable]	[Not Available]	CH	Prostate	LIVING	22.04	DiseaseFree	22.04
cd113dc4-915a-47d2-bce0-9dba915a9d29	TCGA-CH-5740	3/21/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	3	4	7	[Not Available]	Bilateral	[Not Available]	Male	YES	NO	-20880	No	No	2009	31	Normal (no evidence of prostate cancer) [cM0]	NO	[Not Available]	[Not Available]	YES	31	No Evidence of Extraprostatic Extension	YES	4	0	R0	Alive	31	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	[Discrepancy]	1.6	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	57	M0	[Not Applicable]	[Not Available]	[Not Applicable]	0	[Not Available]	NOT HISPANIC OR LATINO	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T2c	[Not Applicable]	[Not Available]	WHITE	[Not Available]	[Not Applicable]	[Not Available]	CH	Prostate	LIVING	1.02	DiseaseFree	1.02
b3bf57d4-e31a-4740-b438-fa826fb79550	TCGA-CH-5741	3/16/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Overlapping / Multiple Zones	4	5	9	[Not Available]	Bilateral	[Not Available]	Male	YES	NO	-20759	No	No	2008	30	Normal (no evidence of prostate cancer) [cM0]	YES	30	No Evidence of Extraprostatic Extension	NO	[Not Available]	[Not Available]	YES	5	1	R1	Alive	395	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	339	0.02	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	56	M0	[Not Applicable]	[Not Available]	[Not Applicable]	0	[Not Available]	NOT HISPANIC OR LATINO	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N1	T3b	[Not Applicable]	[Not Available]	WHITE	[Not Available]	[Not Applicable]	[Not Available]	CH	Prostate	LIVING	12.98	DiseaseFree	12.98
2dee4bd8-b00e-4f8a-bfea-5d8d1a068202	TCGA-CH-5743	3/16/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Peripheral Zone	3	4	7	[Not Available]	Bilateral	[Not Available]	Male	YES	NO	-24321	No	No	2008	29	Normal (no evidence of prostate cancer) [cM0]	YES	29	No Evidence of Extraprostatic Extension	NO	[Not Available]	[Not Available]	YES	1	0	R0	Alive	425	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	394	0.1	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	66	M0	[Not Applicable]	[Not Available]	[Not Applicable]	0	[Not Available]	NOT HISPANIC OR LATINO	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T2c	[Not Applicable]	[Not Available]	WHITE	[Not Available]	[Not Applicable]	[Not Available]	CH	Prostate	LIVING	13.96	Recurred/Progressed	13.96
4e76de8e-cb0d-4b83-8ab4-53bc67a7a9d3	TCGA-CH-5744	3/16/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Peripheral Zone	4	3	7	5	Bilateral	[Not Available]	Male	YES	NO	-23621	No	No	2008	60	Normal (no evidence of prostate cancer) [cM0]	YES	60	No Evidence of Extraprostatic Extension	NO	[Not Available]	[Not Available]	YES	3	0	R0	Alive	60	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	48	9.63	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	64	M0	[Not Applicable]	[Not Available]	[Not Applicable]	0	[Not Available]	NOT HISPANIC OR LATINO	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T2c	[Not Applicable]	[Not Available]	WHITE	[Not Available]	[Not Applicable]	[Not Available]	CH	Prostate	LIVING	1.97	DiseaseFree	1.97
ac67d0df-7dc0-4a1a-8b47-beec9b94de86	TCGA-CH-5745	3/16/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Overlapping / Multiple Zones	3	4	7	[Not Available]	[Not Available]	[Not Available]	Male	YES	NO	-24837	No	No	2008	91	Normal (no evidence of prostate cancer) [cM0]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	YES	5	0	R0	Alive	91	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	84	4.3	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	68	M0	[Not Applicable]	[Not Available]	[Not Applicable]	0	[Not Available]	NOT HISPANIC OR LATINO	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3a	[Not Applicable]	[Not Available]	WHITE	[Not Available]	[Not Applicable]	[Not Available]	CH	Prostate	LIVING	2.99	DiseaseFree	2.99
618272c0-c2ed-4bfb-bb4b-404f0987f822	TCGA-CH-5746	3/16/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	3	4	7	[Not Available]	Bilateral	[Not Available]	Male	YES	NO	-20941	No	No	2007	59	Normal (no evidence of prostate cancer) [cM0]	YES	59	No Evidence of Extraprostatic Extension	NO	[Not Available]	[Not Available]	YES	2	0	R1	Alive	731	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	693	0.1	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	57	M0	[Not Applicable]	[Not Available]	[Not Applicable]	0	[Not Available]	NOT HISPANIC OR LATINO	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T2c	[Not Applicable]	[Not Available]	WHITE	[Not Available]	[Not Applicable]	[Not Available]	CH	Prostate	LIVING	24.01	DiseaseFree	24.01
0af98331-9305-41e9-af55-30390016d65e	TCGA-CH-5748	3/21/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	4	3	7	[Not Available]	Bilateral	[Not Available]	Male	YES	NO	-23649	No	No	2009	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	YES	2	0	R1	Alive	31	[Not Applicable]	[Not Available]	[Not Available]	WITH TUMOR	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	64	[Not Available]	[Not Applicable]	[Not Available]	[Not Applicable]	0	[Not Available]	NOT HISPANIC OR LATINO	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3a	[Not Applicable]	[Not Available]	WHITE	[Not Available]	[Not Applicable]	[Not Available]	CH	Prostate	LIVING	1.02	DiseaseFree	1.02
dc40cf49-b208-4f59-b5f0-cfbdd02970b2	TCGA-CH-5750	3/16/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Peripheral Zone	3	4	7	[Not Available]	Bilateral	[Not Available]	Male	YES	NO	-26389	No	No	2008	31	Normal (no evidence of prostate cancer) [cM0]	YES	31	No Evidence of Extraprostatic Extension	NO	[Not Available]	[Not Available]	YES	7	0	R0	Alive	396	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	337	0.02	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	72	M0	[Not Applicable]	[Not Available]	[Not Applicable]	0	[Not Available]	NOT HISPANIC OR LATINO	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T2c	[Not Applicable]	[Not Available]	WHITE	[Not Available]	[Not Applicable]	[Not Available]	CH	Prostate	LIVING	13.01	DiseaseFree	13.01
721e76d0-4b1d-4e78-adb8-1344b8030062	TCGA-CH-5751	3/16/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Overlapping / Multiple Zones	5	5	10	[Not Available]	Bilateral	[Not Available]	Male	YES	NO	-24957	No	No	2006	92	Equivocal	YES	92	Equivocal	YES	92	Equivocal	YES	3	1	R1	Alive	1065	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	1004	0.01	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	68	M0	[Not Applicable]	[Not Available]	[Not Applicable]	0	[Not Available]	NOT HISPANIC OR LATINO	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N1	T4	[Not Applicable]	[Not Available]	WHITE	[Not Available]	[Not Applicable]	[Not Available]	CH	Prostate	LIVING	34.99	Recurred/Progressed	11.99
d8f56d75-51ab-4a86-a502-c86e1dcd1eff	TCGA-CH-5752	3/16/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Overlapping / Multiple Zones	4	4	8	[Not Available]	Bilateral	[Not Available]	Male	YES	NO	-24290	No	No	2006	30	Normal (no evidence of prostate cancer) [cM0]	YES	30	No Evidence of Extraprostatic Extension	NO	[Not Available]	[Not Available]	YES	9	0	R0	Alive	943	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	868	0.02	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	66	M0	[Not Applicable]	[Not Available]	[Not Applicable]	0	[Not Available]	NOT HISPANIC OR LATINO	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3a	[Not Applicable]	[Not Available]	WHITE	[Not Available]	[Not Applicable]	[Not Available]	CH	Prostate	LIVING	30.98	DiseaseFree	30.98
928c48a0-68ee-4e28-ae83-9832e52850ca	TCGA-CH-5753	3/21/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Overlapping / Multiple Zones	4	5	9	[Not Available]	Bilateral	[Not Available]	Male	YES	NO	-25780	Yes	No	2008	31	Normal (no evidence of prostate cancer) [cM0]	YES	31	No Evidence of Extraprostatic Extension	NO	[Not Available]	[Not Available]	YES	10	3	R0	Alive	31	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	31	4.53	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	70	M0	[Not Applicable]	[Not Available]	[Not Applicable]	0	[Not Available]	NOT HISPANIC OR LATINO	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N1	T3b	[Not Applicable]	[Not Available]	WHITE	[Not Available]	[Not Applicable]	[Not Available]	CH	Prostate	LIVING	1.02	DiseaseFree	1.02
0aad0abd-750a-400d-a34f-491da996d46c	TCGA-CH-5754	3/21/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Peripheral Zone	4	5	9	3	Bilateral	[Not Available]	Male	YES	NO	-23803	No	No	2008	62	Normal (no evidence of prostate cancer) [cM0]	YES	62	No Evidence of Extraprostatic Extension	NO	[Not Available]	[Not Available]	YES	11	3	R1	Alive	62	[Not Applicable]	[Not Available]	[Not Available]	WITH TUMOR	62	37.36	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	65	M0	[Not Applicable]	[Not Available]	[Not Applicable]	0	[Not Available]	NOT HISPANIC OR LATINO	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N1	T3b	[Not Applicable]	[Not Available]	WHITE	[Not Available]	[Not Applicable]	[Not Available]	CH	Prostate	LIVING	2.04	DiseaseFree	2.04
854a481b-71a2-4f23-80aa-e91e9f4069b1	TCGA-CH-5761	3/16/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Peripheral Zone	5	4	9	3	Left	[Not Available]	Male	YES	NO	-22433	No	No	2007	28	Normal (no evidence of prostate cancer) [cM0]	YES	28	Equivocal	YES	28	Equivocal	YES	5	0	R0	Alive	28	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	39	8.49	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	61	M0	[Not Applicable]	[Not Available]	[Not Applicable]	0	[Not Available]	NOT HISPANIC OR LATINO	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3b	[Not Applicable]	[Not Available]	WHITE	[Not Available]	[Not Applicable]	[Not Available]	CH	Prostate	LIVING	0.92	DiseaseFree	0.92
d4ffafdc-ee83-43df-aa3b-7326503c6438	TCGA-CH-5762	3/16/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Peripheral Zone	4	3	7	[Not Available]	Bilateral	[Not Available]	Male	YES	NO	-22068	No	No	2005	92	Normal (no evidence of prostate cancer) [cM0]	YES	92	No Evidence of Extraprostatic Extension	NO	[Not Available]	[Not Available]	YES	7	0	R1	Alive	1339	[Not Applicable]	[Not Available]	[Not Available]	[Discrepancy]	1313	0.01	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	60	M0	[Not Applicable]	[Not Available]	[Not Applicable]	0	[Not Available]	NOT HISPANIC OR LATINO	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3b	[Not Applicable]	[Not Available]	WHITE	[Not Available]	[Not Applicable]	[Not Available]	CH	Prostate	LIVING	43.99	DiseaseFree	43.99
18e79a01-07a2-4cd5-b700-71d41724e041	TCGA-CH-5763	3/16/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Peripheral Zone	3	4	7	[Not Available]	Bilateral	[Not Available]	Male	YES	NO	-24380	Yes	No	2008	0	Normal (no evidence of prostate cancer) [cM0]	YES	0	No Evidence of Extraprostatic Extension	NO	[Not Available]	[Not Available]	YES	5	0	R0	Alive	365	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	360	0.1	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	66	M0	[Not Applicable]	[Not Available]	[Not Applicable]	0	[Not Available]	NOT HISPANIC OR LATINO	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3a	[Not Applicable]	[Not Available]	WHITE	[Not Available]	[Not Applicable]	[Not Available]	CH	Prostate	LIVING	11.99	DiseaseFree	11.99
ed73f136-42e8-4100-b432-d10370d07e8b	TCGA-CH-5764	3/16/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Peripheral Zone	4	3	7	[Not Available]	Bilateral	[Not Available]	Male	YES	NO	-24257	Yes	No	2008	31	Normal (no evidence of prostate cancer) [cM0]	YES	31	No Evidence of Extraprostatic Extension	NO	[Not Available]	[Not Available]	YES	8	0	R0	Alive	31	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	29	13.95	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	66	M0	[Not Applicable]	[Not Available]	[Not Applicable]	0	[Not Available]	NOT HISPANIC OR LATINO	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3b	[Not Applicable]	[Not Available]	WHITE	[Not Available]	[Not Applicable]	[Not Available]	CH	Prostate	LIVING	1.02	DiseaseFree	1.02
716eb429-d7af-4d4f-bd8d-afcff1a323ee	TCGA-CH-5765	3/16/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	3	4	7	[Not Available]	Bilateral	[Not Available]	Male	YES	NO	-20364	No	No	2007	31	Normal (no evidence of prostate cancer) [cM0]	YES	31	No Evidence of Extraprostatic Extension	NO	[Not Available]	[Not Available]	YES	7	0	R0	Alive	700	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	694	0.02	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	55	M0	[Not Applicable]	[Not Available]	[Not Applicable]	0	[Not Available]	NOT HISPANIC OR LATINO	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3a	[Not Applicable]	[Not Available]	WHITE	[Not Available]	[Not Applicable]	[Not Available]	CH	Prostate	LIVING	23	DiseaseFree	23
a5c77ab6-6e98-4a3d-81c8-f3d5fabd31d2	TCGA-CH-5766	3/16/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Peripheral Zone	4	3	7	[Not Available]	Bilateral	[Not Available]	Male	YES	NO	-20392	No	No	2007	31	Normal (no evidence of prostate cancer) [cM0]	YES	31	No Evidence of Extraprostatic Extension	NO	[Not Available]	[Not Available]	YES	4	1	R0	Alive	31	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	39	13.9	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	55	M0	[Not Applicable]	[Not Available]	[Not Applicable]	0	[Not Available]	NOT HISPANIC OR LATINO	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N1	T3a	[Not Applicable]	[Not Available]	WHITE	[Not Available]	[Not Applicable]	[Not Available]	CH	Prostate	LIVING	1.02	DiseaseFree	1.02
8dc53431-44ab-485e-b4e6-c3d06509506d	TCGA-CH-5767	3/16/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Peripheral Zone	4	3	7	[Not Available]	Bilateral	[Not Available]	Male	YES	NO	-24287	No	No	2007	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	YES	19	0	R0	Alive	458	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	377	0.04	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	66	M0	[Not Applicable]	[Not Available]	[Not Applicable]	0	[Not Available]	NOT HISPANIC OR LATINO	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T2c	[Not Applicable]	[Not Available]	WHITE	[Not Available]	[Not Applicable]	[Not Available]	CH	Prostate	LIVING	15.05	DiseaseFree	15.05
f6c61a22-a711-416d-9e65-6a1b957e5b2e	TCGA-CH-5768	3/16/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Overlapping / Multiple Zones	2	4	6	3	Bilateral	[Not Available]	Male	YES	NO	-26480	No	No	2007	30	Normal (no evidence of prostate cancer) [cM0]	YES	30	No Evidence of Extraprostatic Extension	NO	[Not Available]	[Not Available]	YES	16	0	R0	Alive	731	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	634	0.1	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	72	M0	[Not Applicable]	[Not Available]	[Not Applicable]	0	[Not Available]	NOT HISPANIC OR LATINO	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3a	[Not Applicable]	[Not Available]	WHITE	[Not Available]	[Not Applicable]	[Not Available]	CH	Prostate	LIVING	24.01	DiseaseFree	24.01
a7b76662-8380-4f35-9307-99c0acacb904	TCGA-CH-5769	3/16/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	5	4	9	[Not Available]	Bilateral	[Not Available]	Male	YES	NO	-17807	No	No	2007	62	Normal (no evidence of prostate cancer) [cM0]	YES	62	No Evidence of Extraprostatic Extension	NO	[Not Available]	[Not Available]	YES	8	0	R1	Alive	62	[Not Applicable]	[Not Available]	[Not Available]	WITH TUMOR	60	11.16	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	48	M0	[Not Applicable]	[Not Available]	[Not Applicable]	0	[Not Available]	NOT HISPANIC OR LATINO	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3b	[Not Applicable]	[Not Available]	WHITE	[Not Available]	[Not Applicable]	[Not Available]	CH	Prostate	LIVING	2.04	DiseaseFree	2.04
3acd8328-76f7-4f43-9660-394b95748c3d	TCGA-CH-5771	3/16/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	4	3	7	5	Bilateral	[Not Available]	Male	YES	NO	-23101	No	No	2008	31	Normal (no evidence of prostate cancer) [cM0]	YES	31	No Evidence of Extraprostatic Extension	NO	[Not Available]	[Not Available]	YES	2	0	R0	Alive	396	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	396	0.03	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	63	M0	[Not Applicable]	[Not Available]	[Not Applicable]	0	[Not Available]	NOT HISPANIC OR LATINO	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T2c	[Not Applicable]	[Not Available]	WHITE	[Not Available]	[Not Applicable]	[Not Available]	CH	Prostate	LIVING	13.01	DiseaseFree	13.01
ecf9f8be-7830-4626-8617-694c68ef4074	TCGA-CH-5772	3/16/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	4	5	9	3	Bilateral	[Not Available]	Male	YES	NO	-23194	Yes	No	2008	90	Normal (no evidence of prostate cancer) [cM0]	YES	90	No Evidence of Extraprostatic Extension	YES	90	No Evidence of Extraprostatic Extension	YES	6	0	R1	Alive	486	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	424	0.03	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	63	M0	[Not Applicable]	[Not Available]	[Not Applicable]	0	[Not Available]	NOT HISPANIC OR LATINO	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3a	[Not Applicable]	[Not Available]	WHITE	[Not Available]	[Not Applicable]	[Not Available]	CH	Prostate	LIVING	15.97	DiseaseFree	15.97
c039014f-821c-43d6-9d3c-914f9c8d98fa	TCGA-CH-5788	3/16/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	4	3	7	5	Bilateral	Base	Male	YES	NO	-25233	No	No	2007	31	Normal (no evidence of prostate cancer) [cM0]	YES	31	No Evidence of Extraprostatic Extension	NO	[Not Available]	[Not Available]	YES	21	6	R0	Alive	821	[Not Applicable]	[Not Available]	[Not Available]	[Discrepancy]	786	3.58	YES	[Not Available]	[Not Available]	[Not Available]	786	69	M0	[Not Applicable]	[Not Available]	[Not Applicable]	0	[Not Available]	NOT HISPANIC OR LATINO	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N1	T3b	[Not Applicable]	[Not Available]	WHITE	[Not Available]	[Not Applicable]	[Not Available]	CH	Prostate	LIVING	26.97	DiseaseFree	26.97
be5411dc-3caa-4b25-9b94-ce463e8e52b4	TCGA-CH-5789	3/16/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Peripheral Zone	3	4	7	[Not Available]	Bilateral	[Not Available]	Male	YES	NO	-22494	No	No	2006	[Not Available]	[Not Available]	YES	61	No Evidence of Extraprostatic Extension	[Not Available]	[Not Available]	[Not Available]	[Not Available]	4	0	R0	Alive	304	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	229	0.02	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	61	M0	[Not Applicable]	[Not Available]	[Not Applicable]	0	[Not Available]	NOT HISPANIC OR LATINO	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3a	[Not Applicable]	[Not Available]	WHITE	[Not Available]	[Not Applicable]	[Not Available]	CH	Prostate	LIVING	9.99	DiseaseFree	9.99
2b5ef82d-e137-43f6-bfef-b202f20ee187	TCGA-CH-5790	3/16/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	3	4	7	[Not Available]	Bilateral	[Not Available]	Male	YES	NO	-23529	Yes	No	2006	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	YES	5	0	R0	Alive	974	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	914	0.1	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	64	M0	[Not Applicable]	[Not Available]	[Not Applicable]	0	[Not Available]	NOT HISPANIC OR LATINO	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T2c	[Not Applicable]	[Not Available]	WHITE	[Not Available]	[Not Applicable]	[Not Available]	CH	Prostate	LIVING	32	DiseaseFree	32
829bed0c-c40d-44fd-aee8-6c7589db60f9	TCGA-CH-5791	3/16/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Peripheral Zone	3	4	7	[Not Available]	Bilateral	[Not Available]	Male	YES	NO	-26390	Yes	No	2006	61	Normal (no evidence of prostate cancer) [cM0]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	YES	2	0	R1	Alive	1004	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	882	0.18	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	72	M0	[Not Applicable]	[Not Available]	[Not Applicable]	0	[Not Available]	NOT HISPANIC OR LATINO	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3a	[Not Applicable]	[Not Available]	WHITE	[Not Available]	[Not Applicable]	[Not Available]	CH	Prostate	LIVING	32.98	Recurred/Progressed	32
8a5f2d7f-835c-4726-b238-f82d6a7f25bd	TCGA-CH-5792	3/21/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	4	5	9	[Not Available]	Bilateral	[Not Available]	Male	YES	NO	-21002	No	No	2009	91	Normal (no evidence of prostate cancer) [cM0]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	YES	6	0	R1	Alive	91	[Not Applicable]	[Not Available]	[Not Available]	WITH TUMOR	91	11.49	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	57	M0	[Not Applicable]	[Not Available]	[Not Applicable]	0	[Not Available]	NOT HISPANIC OR LATINO	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3a	[Not Applicable]	[Not Available]	WHITE	[Not Available]	[Not Applicable]	[Not Available]	CH	Prostate	LIVING	2.99	DiseaseFree	2.99
a80d3ee7-60dd-49bb-b049-9335afc035f5	TCGA-CH-5794	3/16/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Peripheral Zone	3	4	7	[Not Available]	Bilateral	[Not Available]	Male	YES	NO	-23924	No	No	2006	62	Normal (no evidence of prostate cancer) [cM0]	YES	62	No Evidence of Extraprostatic Extension	NO	[Not Available]	[Not Available]	YES	4	0	R0	Alive	882	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	821	0.01	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	65	M0	[Not Applicable]	[Not Available]	[Not Applicable]	0	[Not Available]	NOT HISPANIC OR LATINO	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T2b	[Not Applicable]	[Not Available]	WHITE	[Not Available]	[Not Applicable]	[Not Available]	CH	Prostate	LIVING	28.98	DiseaseFree	28.98
e27c50e2-2a41-4f8c-9ef8-2bc51fb0c23e	TCGA-EJ-5494	3/29/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	4	3	7	4	Bilateral	Apex|Middle	Male	YES	NO	-18596	No	No	2009	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	YES	17	0	R0	Alive	378	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	184	[Not Available]	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	50	M0	[Not Applicable]	T2a	[Not Applicable]	0	[Not Available]	NOT HISPANIC OR LATINO	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3a	[Not Applicable]	[Not Available]	WHITE	[Not Available]	[Not Applicable]	[Not Available]	EJ	Prostate	LIVING	48.52	DiseaseFree	48.52
962dd3d5-8501-4658-8cb9-2424b476124c	TCGA-EJ-5495	3/29/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	5	3	8	4	Bilateral	Middle|Base	Male	YES	NO	-24904	No	No	2009	26	Normal (no evidence of prostate cancer) [cM0]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	YES	18	1	R0	Alive	606	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	606	0.13	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	68	M0	[Not Applicable]	T1c	[Not Applicable]	0	[Not Available]	NOT HISPANIC OR LATINO	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N1	T3b	[Not Applicable]	[Not Available]	WHITE	[Not Available]	[Not Applicable]	[Not Available]	EJ	Prostate	LIVING	57.82	DiseaseFree	57.82
6755c231-355f-4cc3-85f1-6306c7f5d44b	TCGA-EJ-5496	3/30/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Overlapping / Multiple Zones	3	4	7	4	Bilateral	Apex|Middle|Base	Male	YES	NO	-21897	No	No	2009	15	Normal (no evidence of prostate cancer) [cM0]	YES	15	No Evidence of Extraprostatic Extension	NO	[Not Available]	[Not Available]	YES	26	0	R0	Alive	595	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	595	0.1	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	59	M0	[Not Applicable]	T1c	[Not Applicable]	0	[Not Available]	NOT HISPANIC OR LATINO	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T2c	[Not Applicable]	[Not Available]	WHITE	[Not Available]	[Not Applicable]	[Not Available]	EJ	Prostate	LIVING	19.55	DiseaseFree	19.55
dee02265-d8dd-4379-ae08-72d72b03a570	TCGA-EJ-5497	3/30/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Overlapping / Multiple Zones	3	4	7	3	Bilateral	Middle	Male	YES	NO	-17523	No	No	2009	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	YES	10	0	R0	Alive	405	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	204	0.1	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	47	M0	[Not Applicable]	T2c	[Not Applicable]	0	[Not Available]	NOT HISPANIC OR LATINO	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T2c	[Not Applicable]	[Not Available]	WHITE	[Not Available]	[Not Applicable]	[Not Available]	EJ	Prostate	LIVING	13.3	DiseaseFree	13.3
79ec7468-9aaf-4bb0-94c7-72be4f497868	TCGA-EJ-5498	3/30/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Overlapping / Multiple Zones	4	3	7	3	Bilateral	Middle	Male	YES	NO	-20472	No	No	2010	12	Normal (no evidence of prostate cancer) [cM0]	YES	12	No Evidence of Extraprostatic Extension	NO	[Not Available]	[Not Available]	YES	26	0	R0	Alive	537	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	537	0.1	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	56	[Not Available]	[Not Applicable]	T2c	[Not Applicable]	0	[Not Available]	NOT HISPANIC OR LATINO	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T2c	[Not Applicable]	[Not Available]	WHITE	[Not Available]	[Not Applicable]	[Not Available]	EJ	Prostate	LIVING	56.5	DiseaseFree	56.5
fd1aa612-df86-4d48-892d-2acebd76ea96	TCGA-EJ-5499	3/30/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Overlapping / Multiple Zones	4	3	7	3	Bilateral	Apex|Middle|Base	Male	YES	NO	-22286	No	No	2010	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	YES	19	0	R0	Alive	533	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	533	0.1	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	61	M0	[Not Applicable]	T2b	[Not Applicable]	0	[Not Available]	NOT HISPANIC OR LATINO	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3a	[Not Applicable]	[Not Available]	ASIAN	[Not Available]	[Not Applicable]	[Not Available]	EJ	Prostate	LIVING	46.48	DiseaseFree	46.48
8df0c1e8-966c-4f46-ad15-fae9e745a32e	TCGA-EJ-5501	3/30/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Overlapping / Multiple Zones	4	3	7	5	Bilateral	Middle|Base	Male	YES	NO	-20409	No	No	2010	9	Normal (no evidence of prostate cancer) [cM0]	YES	9	No Evidence of Extraprostatic Extension	NO	[Not Available]	[Not Available]	YES	11	0	R0	Alive	729	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	729	0.1	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	55	M0	[Not Applicable]	T2b	[Not Applicable]	0	[Not Available]	NOT HISPANIC OR LATINO	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3b	[Not Applicable]	[Not Available]	WHITE	[Not Available]	[Not Applicable]	[Not Available]	EJ	Prostate	LIVING	44.84	DiseaseFree	44.84
48e83a4c-c602-494a-80cd-e2f4b4dd701e	TCGA-EJ-5502	3/30/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Overlapping / Multiple Zones	4	3	7	3	Bilateral	Middle|Base	Male	YES	NO	-18447	No	No	2010	7	Normal (no evidence of prostate cancer) [cM0]	YES	7	No Evidence of Extraprostatic Extension	NO	[Not Available]	[Not Available]	YES	11	0	R0	Alive	245	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	603	0.1	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	50	M0	[Not Applicable]	T2c	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T2c	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	EJ	Prostate	LIVING	38.47	DiseaseFree	38.47
aa252f78-ebf3-42f9-86af-bb6e57345706	TCGA-EJ-5503	3/30/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Overlapping / Multiple Zones	5	3	8	4	Bilateral	Middle|Base	Male	YES	NO	-18395	No	No	2010	31	Normal (no evidence of prostate cancer) [cM0]	YES	31	No Evidence of Extraprostatic Extension	NO	[Not Available]	[Not Available]	YES	21	0	R0	Alive	530	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	530	0.1	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	50	M0	[Not Applicable]	T2b	[Not Applicable]	0	[Not Available]	NOT HISPANIC OR LATINO	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3a	[Not Applicable]	[Not Available]	WHITE	[Not Available]	[Not Applicable]	[Not Available]	EJ	Prostate	LIVING	45.7	DiseaseFree	45.7
e1c3d1bd-cf8f-4fa4-ac8e-bf9e54f7aad4	TCGA-EJ-5504	4/2/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Overlapping / Multiple Zones	4	3	7	5	Bilateral	Apex|Middle|Base	Male	YES	NO	-24072	No	No	2010	25	Normal (no evidence of prostate cancer) [cM0]	YES	25	Extraprostatic Extension (regional lymphadenopathy)[e.g. cN1]	NO	[Not Available]	[Not Available]	YES	18	1	R1	Alive	229	[Not Applicable]	[Not Available]	[Not Available]	WITH TUMOR	77	1	YES	[Not Available]	[Not Available]	[Not Available]	77	65	M0	[Not Applicable]	T2c	[Not Applicable]	0	[Not Available]	NOT HISPANIC OR LATINO	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N1	T3a	[Not Applicable]	[Not Available]	WHITE	[Not Available]	[Not Applicable]	[Not Available]	EJ	Prostate	LIVING	46.88	DiseaseFree	46.88
1ea3b879-5451-49fb-b930-16e9b5627f18	TCGA-EJ-5505	4/2/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	4	3	7	3	Bilateral	Apex|Middle|Base	Male	YES	NO	-21164	No	No	2010	12	Normal (no evidence of prostate cancer) [cM0]	YES	12	No Evidence of Extraprostatic Extension	NO	[Not Available]	[Not Available]	YES	24	0	R0	Alive	448	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	448	0.1	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	57	M0	[Not Applicable]	T1c	[Not Applicable]	0	[Not Available]	NOT HISPANIC OR LATINO	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T2c	[Not Applicable]	[Not Available]	WHITE	[Not Available]	[Not Applicable]	[Not Available]	EJ	Prostate	LIVING	30.29	DiseaseFree	30.29
e5e4d3b6-8e58-4dcf-8f67-a00e656a8e27	TCGA-EJ-5506	4/2/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	5	3	8	4	Bilateral	Apex|Middle|Base	Male	YES	NO	-24617	No	No	2010	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	YES	7	1	RX	Alive	356	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	356	0.1	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	67	M0	[Not Applicable]	T3b	[Not Applicable]	0	[Not Available]	NOT HISPANIC OR LATINO	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N1	T3b	[Not Applicable]	[Not Available]	WHITE	[Not Available]	[Not Applicable]	[Not Available]	EJ	Prostate	LIVING	45.37	DiseaseFree	45.37
607200f5-df80-4f5d-90fb-fdc455a7415b	TCGA-EJ-5507	4/2/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	4	5	9	4	Bilateral	Apex|Middle|Base	Male	YES	NO	-19759	No	No	2010	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	YES	21	2	R0	Alive	182	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	182	0.1	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	54	M0	[Not Applicable]	T2c	[Not Applicable]	0	[Not Available]	NOT HISPANIC OR LATINO	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N1	T3b	[Not Applicable]	[Not Available]	WHITE	[Not Available]	[Not Applicable]	[Not Available]	EJ	Prostate	LIVING	47.86	DiseaseFree	47.86
bd18dd01-d894-4bdd-9ce2-e25705a52a57	TCGA-EJ-5508	4/2/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	3	4	7	4	Bilateral	Middle|Base	Male	YES	NO	-23758	No	No	2008	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	YES	17	0	R0	Alive	907	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	907	0.1	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	65	M0	[Not Applicable]	T1c	[Not Applicable]	0	[Not Available]	NOT HISPANIC OR LATINO	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3a	[Not Applicable]	[Not Available]	WHITE	[Not Available]	[Not Applicable]	[Not Available]	EJ	Prostate	LIVING	64.55	DiseaseFree	64.55
13ce70a8-785c-4b59-b073-41922cb201f9	TCGA-EJ-5509	4/2/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	3	4	7	3	Bilateral	Apex|Middle|Base	Male	YES	NO	-23368	No	No	2009	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	YES	10	0	R0	Alive	1102	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	1102	0.1	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	63	M0	[Not Applicable]	T2a	[Not Applicable]	0	[Not Available]	NOT HISPANIC OR LATINO	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T2c	[Not Applicable]	[Not Available]	WHITE	[Not Available]	[Not Applicable]	[Not Available]	EJ	Prostate	LIVING	48.09	DiseaseFree	48.09
4a3d9efe-f24e-4135-8a70-e202651e7a81	TCGA-EJ-5510	4/2/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	4	3	7	3	Bilateral	[Not Available]	Male	YES	NO	-17895	No	No	2009	14	Normal (no evidence of prostate cancer) [cM0]	YES	14	No Evidence of Extraprostatic Extension	NO	[Not Available]	[Not Available]	YES	17	0	R0	Alive	738	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	738	0.1	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	48	M0	[Not Applicable]	T1c	[Not Applicable]	0	[Not Available]	NOT HISPANIC OR LATINO	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T2c	[Not Applicable]	[Not Available]	WHITE	[Not Available]	[Not Applicable]	[Not Available]	EJ	Prostate	LIVING	61.99	DiseaseFree	61.99
f8a42feb-fbc9-4a13-bad5-1dcefca2a9bf	TCGA-EJ-5511	4/3/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	3	4	7	4	Bilateral	Apex|Middle|Base	Male	YES	NO	-20409	No	No	2009	18	Normal (no evidence of prostate cancer) [cM0]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	YES	15	0	R0	Alive	788	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	788	0.04	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	55	M0	[Not Applicable]	T2b	[Not Applicable]	0	[Not Available]	NOT HISPANIC OR LATINO	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3a	[Not Applicable]	[Not Available]	BLACK OR AFRICAN AMERICAN	[Not Available]	[Not Applicable]	[Not Available]	EJ	Prostate	LIVING	48.49	DiseaseFree	48.49
c28f931f-5ab2-4899-9fe9-54024f082d92	TCGA-EJ-5512	4/3/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	3	4	7	3	Bilateral	Apex|Middle|Base	Male	YES	NO	-17127	No	No	2009	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	YES	13	0	R0	Alive	782	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	782	0	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	46	M0	[Not Applicable]	T1c	[Not Applicable]	0	[Not Available]	NOT HISPANIC OR LATINO	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T2c	[Not Applicable]	[Not Available]	WHITE	[Not Available]	[Not Applicable]	[Not Available]	EJ	Prostate	LIVING	56.93	DiseaseFree	56.93
f82d53b1-3df8-4249-a615-464c9f4e0a32	TCGA-EJ-5514	4/3/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	4	5	9	4	Bilateral	[Not Available]	Male	YES	NO	-24165	No	No	2009	7	Normal (no evidence of prostate cancer) [cM0]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	YES	12	0	R0	Alive	724	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	724	0.1	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	66	M0	[Not Applicable]	T1c	[Not Applicable]	0	[Not Available]	NOT HISPANIC OR LATINO	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T2c	[Not Applicable]	[Not Available]	WHITE	[Not Available]	[Not Applicable]	[Not Available]	EJ	Prostate	LIVING	60.09	DiseaseFree	60.09
19cf56b2-a85b-43e7-971f-5680b9b1a67a	TCGA-EJ-5515	4/3/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	3	4	7	4	Right	Apex|Middle|Base	Male	YES	NO	-22097	No	No	2009	30	Normal (no evidence of prostate cancer) [cM0]	YES	30	No Evidence of Extraprostatic Extension	NO	[Not Available]	[Not Available]	YES	20	0	R0	Alive	1061	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	1061	0.1	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	60	M0	[Not Applicable]	T1c	[Not Applicable]	0	[Not Available]	NOT HISPANIC OR LATINO	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3a	[Not Applicable]	[Not Available]	WHITE	[Not Available]	[Not Applicable]	[Not Available]	EJ	Prostate	LIVING	60.18	DiseaseFree	60.18
1fd06207-54e0-4aba-819c-c7f671871f39	TCGA-EJ-5516	4/3/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	3	4	7	3	Bilateral	[Not Available]	Male	YES	NO	-17980	No	No	2009	0	Normal (no evidence of prostate cancer) [cM0]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	YES	6	0	R0	Alive	783	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	730	0.12	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	49	M0	[Not Applicable]	T2b	[Not Applicable]	0	[Not Available]	NOT HISPANIC OR LATINO	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3a	[Not Applicable]	[Not Available]	WHITE	[Not Available]	[Not Applicable]	[Not Available]	EJ	Prostate	LIVING	62.06	DiseaseFree	62.06
4b9aa301-d2e3-47f3-b724-a34f420b2b6b	TCGA-EJ-5517	4/3/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	3	3	6	2	Bilateral	[Not Available]	Male	YES	NO	-20422	No	No	2008	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	YES	4	0	R0	Alive	850	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	187	0.1	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	55	M0	[Not Applicable]	T1c	[Not Applicable]	0	[Not Available]	NOT HISPANIC OR LATINO	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T2c	[Not Applicable]	[Not Available]	WHITE	[Not Available]	[Not Applicable]	[Not Available]	EJ	Prostate	LIVING	62.06	DiseaseFree	62.06
2b35c119-cdc1-49e2-8229-ca5cde9e63d0	TCGA-EJ-5518	4/3/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Overlapping / Multiple Zones	4	5	9	4	Bilateral	[Not Available]	Male	YES	NO	-24313	No	No	2008	32	Normal (no evidence of prostate cancer) [cM0]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	[Discrepancy]	3	0	R1	Alive	1195	[Not Applicable]	[Not Available]	[Not Available]	WITH TUMOR	1195	0.1	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	66	M0	[Not Applicable]	T3b	[Not Applicable]	0	[Not Available]	NOT HISPANIC OR LATINO	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T4	[Not Applicable]	[Not Available]	WHITE	[Not Available]	[Not Applicable]	[Not Available]	EJ	Prostate	LIVING	69.58	Recurred/Progressed	69.12
5313a055-c2d7-4cbd-a8c1-57ac85912d89	TCGA-EJ-5519	4/3/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Overlapping / Multiple Zones	4	4	8	3	Bilateral	Apex|Middle|Base	Male	YES	NO	-23669	No	No	2008	13	Normal (no evidence of prostate cancer) [cM0]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	YES	12	3	R0	Alive	1153	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	1153	0.2	YES	[Not Available]	[Not Available]	[Not Available]	84	64	M0	[Not Applicable]	T2c	[Not Applicable]	0	[Not Available]	NOT HISPANIC OR LATINO	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N1	T3b	[Not Applicable]	[Not Available]	WHITE	[Not Available]	[Not Applicable]	[Not Available]	EJ	Prostate	LIVING	64.45	DiseaseFree	64.45
d44d4bcb-beb1-4464-acd2-9972751f5018	TCGA-EJ-5521	4/4/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	3	4	7	3	Right	Middle|Base	Male	YES	NO	-23304	No	No	2008	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	YES	2	0	R0	Alive	842	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	240	0.1	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	63	M0	[Not Applicable]	T1c	[Not Applicable]	0	[Not Available]	NOT HISPANIC OR LATINO	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3a	[Not Applicable]	[Not Available]	WHITE	[Not Available]	[Not Applicable]	[Not Available]	EJ	Prostate	LIVING	74.87	DiseaseFree	74.87
214884ef-a932-4fc3-b6ff-16ce5164da3e	TCGA-EJ-5522	4/3/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Overlapping / Multiple Zones	3	4	7	3	Bilateral	Apex|Middle|Base	Male	YES	NO	-18802	No	No	2008	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	YES	22	0	R0	Alive	1403	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	1403	0.1	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	51	M0	[Not Applicable]	T2a	[Not Applicable]	0	[Not Available]	NOT HISPANIC OR LATINO	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T2c	[Not Applicable]	[Not Available]	WHITE	[Not Available]	[Not Applicable]	[Not Available]	EJ	Prostate	LIVING	68.3	DiseaseFree	68.3
4048c139-1329-4e6a-8d2f-c0aa104a68ee	TCGA-EJ-5524	4/4/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	4	5	9	3	Bilateral	Base	Male	YES	NO	-20854	No	No	2009	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	YES	17	0	R0	Alive	834	[Not Applicable]	[Not Available]	[Not Available]	WITH TUMOR	811	0.1	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	57	M0	[Not Applicable]	T2b	[Not Applicable]	0	[Not Available]	NOT HISPANIC OR LATINO	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3a	[Not Applicable]	[Not Available]	WHITE	[Not Available]	[Not Applicable]	[Not Available]	EJ	Prostate	LIVING	61.83	Recurred/Progressed	8.71
554a7381-46fd-4301-b91b-5af7f173c350	TCGA-EJ-5525	4/4/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	4	5	9	3	Bilateral	Apex|Base	Male	YES	NO	-24535	No	No	2009	-6	Normal (no evidence of prostate cancer) [cM0]	YES	-6	No Evidence of Extraprostatic Extension	NO	[Not Available]	[Not Available]	YES	8	0	R0	Alive	790	[Not Applicable]	[Not Available]	[Not Available]	WITH TUMOR	521	3	YES	[Not Available]	[Not Available]	[Not Available]	338	67	M0	[Not Applicable]	T3a	[Not Applicable]	0	[Not Available]	NOT HISPANIC OR LATINO	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T2c	[Not Applicable]	[Not Available]	WHITE	[Not Available]	[Not Applicable]	[Not Available]	EJ	Prostate	LIVING	36.63	Recurred/Progressed	17.94
eec48399-5660-4b25-8d34-191b54315c72	TCGA-EJ-5526	4/4/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	4	4	8	3	Bilateral	Middle|Base	Male	YES	NO	-20558	No	No	2009	19	Normal (no evidence of prostate cancer) [cM0]	YES	19	No Evidence of Extraprostatic Extension	NO	[Not Available]	[Not Available]	YES	27	1	R0	Alive	567	[Not Applicable]	[Not Available]	[Not Available]	WITH TUMOR	175	0.1	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	56	M0	[Not Applicable]	T1c	[Not Applicable]	0	[Not Available]	NOT HISPANIC OR LATINO	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N1	T3a	[Not Applicable]	[Not Available]	WHITE	[Not Available]	[Not Applicable]	[Not Available]	EJ	Prostate	LIVING	62.71	Recurred/Progressed	62.71
ba0c9096-5f35-4f0a-ae98-ee1a695b55f0	TCGA-EJ-5527	4/4/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	4	3	7	3	Bilateral	Apex|Middle	Male	YES	NO	-25234	No	No	2009	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	YES	9	0	R0	Alive	397	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	217	0.1	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	69	M0	[Not Applicable]	T2a	[Not Applicable]	0	[Not Available]	NOT HISPANIC OR LATINO	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3a	[Not Applicable]	[Not Available]	WHITE	[Not Available]	[Not Applicable]	[Not Available]	EJ	Prostate	LIVING	58.41	DiseaseFree	58.41
e4a755e3-4938-4321-b5a9-27a445036791	TCGA-EJ-5530	4/4/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	3	4	7	3	Bilateral	Apex|Middle	Male	YES	NO	-22316	No	No	2008	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	YES	6	0	R0	Alive	1272	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	586	0.1	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	61	M0	[Not Applicable]	T2c	[Not Applicable]	0	[Not Available]	NOT HISPANIC OR LATINO	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T2c	[Not Applicable]	[Not Available]	WHITE	[Not Available]	[Not Applicable]	[Not Available]	EJ	Prostate	LIVING	60.18	DiseaseFree	60.18
adf3c2f7-d5f9-41c3-bd8c-7f9f1f22ff73	TCGA-EJ-5531	4/4/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	4	3	7	3	Bilateral	Apex|Middle|Base	Male	YES	NO	-22760	No	No	2009	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	YES	35	0	R0	Alive	724	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	724	0.1	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	62	M0	[Not Applicable]	T2b	[Not Applicable]	0	[Not Available]	NOT HISPANIC OR LATINO	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3a	[Not Applicable]	[Not Available]	WHITE	[Not Available]	[Not Applicable]	[Not Available]	EJ	Prostate	LIVING	41.82	DiseaseFree	41.82
ae3a0c92-148d-4f1c-8563-06ac1050f53e	TCGA-EJ-5532	4/4/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	3	4	7	3	Bilateral	Middle|Base	Male	YES	NO	-21110	No	No	2009	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	YES	8	0	R0	Alive	926	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	926	0.1	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	57	M0	[Not Applicable]	T1c	[Not Applicable]	0	[Not Available]	NOT HISPANIC OR LATINO	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3a	[Not Applicable]	[Not Available]	WHITE	[Not Available]	[Not Applicable]	[Not Available]	EJ	Prostate	LIVING	60.05	DiseaseFree	60.05
5a92ec4c-36ee-4588-aca2-e3303f29c7ad	TCGA-EJ-5542	4/4/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	3	4	7	3	Bilateral	Apex|Middle|Base	Male	YES	NO	-21942	Yes	No	2010	8	Normal (no evidence of prostate cancer) [cM0]	YES	9	No Evidence of Extraprostatic Extension	YES	-21	No Evidence of Extraprostatic Extension	YES	17	0	R0	Alive	519	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	519	0.1	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	60	M0	[Not Applicable]	T2b	[Not Applicable]	0	[Not Available]	NOT HISPANIC OR LATINO	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3a	[Not Applicable]	[Not Available]	WHITE	[Not Available]	[Not Applicable]	[Not Available]	EJ	Prostate	LIVING	49.7	DiseaseFree	49.7
c606918f-e8c0-4019-ad6f-47d5cd7615c4	TCGA-EJ-7115	4/5/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	4	3	7	2	Bilateral	[Not Available]	Male	YES	NO	-23986	No	No	2006	10	Normal (no evidence of prostate cancer) [cM0]	YES	10	No Evidence of Extraprostatic Extension	NO	[Not Available]	[Not Available]	YES	21	0	R0	Alive	822	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	204	0.1	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	65	M0	[Not Applicable]	T1c	[Not Applicable]	0	[Not Available]	NOT HISPANIC OR LATINO	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3a	[Not Applicable]	[Not Available]	WHITE	[Not Available]	[Not Applicable]	[Not Available]	EJ	Prostate	LIVING	88.27	DiseaseFree	88.27
9519be01-d78d-462c-8a95-34149538afeb	TCGA-EJ-7123	4/5/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	3	4	7	3	Bilateral	Apex|Middle|Base	Male	YES	NO	-21741	Yes	No	2007	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	YES	22	0	R0	Alive	1491	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	1491	0.1	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	59	M0	[Not Applicable]	T1c	[Not Applicable]	0	[Not Available]	NOT HISPANIC OR LATINO	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T2c	[Not Applicable]	[Not Available]	WHITE	[Not Available]	[Not Applicable]	[Not Available]	EJ	Prostate	LIVING	84.49	DiseaseFree	84.49
aca312ab-6dbd-4183-8b22-8f37834f3426	TCGA-EJ-7125	4/5/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	3	4	7	3	Bilateral	Apex|Middle	Male	YES	NO	-16425	No	No	2005	12	Normal (no evidence of prostate cancer) [cM0]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	YES	13	0	R0	Alive	1860	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	1860	0.1	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	44	M0	[Not Applicable]	T1c	[Not Applicable]	0	[Not Available]	NOT HISPANIC OR LATINO	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T2c	[Not Applicable]	[Not Available]	WHITE	[Not Available]	[Not Applicable]	[Not Available]	EJ	Prostate	LIVING	93.63	DiseaseFree	93.63
d7763066-fb06-4519-9188-5de7dd12fdb7	TCGA-EJ-7218	3/3/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	3	4	7	[Not Available]	Bilateral	[Not Available]	Male	YES	NO	-26181	No	No	2006	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	YES	3	0	R0	Alive	2542	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	1473	0.1	NO	NO	Complete Remission/Response	NO	[Not Available]	71	M0	[Not Applicable]	T2a	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T2c	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	EJ	Prostate	LIVING	83.51	DiseaseFree	83.51
00dda860-53c3-4ab2-8294-73e291adf9d2	TCGA-EJ-7312	3/3/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	4	3	7	[Not Available]	Bilateral	[Not Available]	Male	YES	NO	-21292	Yes, History of Prior Malignancy	No	2011	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	YES	3	0	R0	Alive	663	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	376	0.1	NO	NO	Complete Remission/Response	NO	[Not Available]	58	M0	[Not Applicable]	T3b	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3b	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	EJ	Prostate	LIVING	36.1	DiseaseFree	36.1
88c87cce-4361-499c-9e3a-e9d9040af2db	TCGA-EJ-7314	4/5/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	4	3	7	5	Bilateral	Apex|Middle|Base	Male	YES	NO	-22766	No	No	2011	[Not Available]	[Not Available]	YES	14	No Evidence of Extraprostatic Extension	NO	[Not Available]	[Not Available]	YES	14	0	R0	Alive	295	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	295	0.1	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	62	M0	[Not Applicable]	T2c	[Not Applicable]	0	[Not Available]	NOT HISPANIC OR LATINO	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3b	[Not Applicable]	[Not Available]	WHITE	[Not Available]	[Not Applicable]	[Not Available]	EJ	Prostate	LIVING	37.78	DiseaseFree	37.78
2c7ec330-261e-49c7-9424-6d83641dba6d	TCGA-EJ-7315	4/5/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	4	3	7	5	Bilateral	Apex|Middle|Base	Male	YES	NO	-25154	No	No	2011	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	YES	7	0	R0	Alive	289	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	289	0.1	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	68	M0	[Not Applicable]	T2a	[Not Applicable]	0	[Not Available]	NOT HISPANIC OR LATINO	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3a	[Not Applicable]	[Not Available]	WHITE	[Not Available]	[Not Applicable]	[Not Available]	EJ	Prostate	LIVING	33.11	DiseaseFree	33.11
68fc3693-0910-4ee8-8997-99c6333b65f4	TCGA-EJ-7317	4/5/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	3	4	7	3	Bilateral	Apex|Middle	Male	YES	NO	-26064	No	No	2011	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	YES	40	0	R0	Alive	285	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	285	0.1	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	71	M0	[Not Applicable]	T1c	[Not Applicable]	0	[Not Available]	NOT HISPANIC OR LATINO	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T2c	[Not Applicable]	[Not Available]	WHITE	[Not Available]	[Not Applicable]	[Not Available]	EJ	Prostate	LIVING	25.33	DiseaseFree	25.33
5e2ff1e6-87bc-4b91-a959-f0f553af4e27	TCGA-EJ-7318	3/3/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	4	3	7	[Not Available]	Bilateral	[Not Available]	Male	YES	NO	-18686	No	No	2011	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	R0	Alive	510	[Not Applicable]	[Not Available]	[Not Available]	WITH TUMOR	189	0.08	YES	NO	Partial Remission/Response	YES	189	51	M0	[Not Applicable]	T3a	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	[Not Available]	T3a	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	EJ	Prostate	LIVING	33.8	Recurred/Progressed	12.48
804ee985-18dd-4f2d-a562-61b454601cdd	TCGA-EJ-7321	4/5/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	3	3	6	4	Bilateral	[Not Available]	Male	YES	NO	-21108	No	No	2011	10	Normal (no evidence of prostate cancer) [cM0]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	YES	25	0	R0	Alive	233	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	128	0.1	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	57	M0	[Not Applicable]	T1c	[Not Applicable]	0	[Not Available]	NOT HISPANIC OR LATINO	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3a	[Not Applicable]	[Not Available]	BLACK OR AFRICAN AMERICAN	[Not Available]	[Not Applicable]	[Not Available]	EJ	Prostate	LIVING	27.07	DiseaseFree	27.07
45a04209-8fac-4181-bba3-1437c8fd7f09	TCGA-EJ-7325	3/3/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	3	4	7	[Not Available]	Bilateral	[Not Available]	Male	YES	NO	-23029	Yes, History of Prior Malignancy	No	2011	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	YES	9	0	R0	Alive	533	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	507	0.1	NO	NO	Complete Remission/Response	NO	[Not Available]	63	M0	[Not Applicable]	T3b	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3b	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	EJ	Prostate	LIVING	35.15	DiseaseFree	35.15
e90ab72a-4bbb-4c37-b48a-8a1a85d79d04	TCGA-EJ-7327	4/5/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	3	4	7	5	Bilateral	Apex|Middle|Base	Male	YES	NO	-22475	No	No	2011	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	YES	17	0	R0	Alive	175	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	175	0.1	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	61	M0	[Not Applicable]	T2a	[Not Applicable]	0	[Not Available]	NOT HISPANIC OR LATINO	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3b	[Not Applicable]	[Not Available]	WHITE	[Not Available]	[Not Applicable]	[Not Available]	EJ	Prostate	LIVING	30.32	DiseaseFree	30.32
42b7d14f-09e5-4d91-bb98-5fe35907a6a9	TCGA-EJ-7328	4/5/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	4	3	7	5	Bilateral	Middle|Base	Male	YES	NO	-25756	No	No	2011	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	YES	9	0	R0	Alive	170	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	70	M0	[Not Applicable]	T1c	[Not Applicable]	0	[Not Available]	NOT HISPANIC OR LATINO	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3a	[Not Applicable]	[Not Available]	WHITE	[Not Available]	[Not Applicable]	[Not Available]	EJ	Prostate	LIVING	27.66	DiseaseFree	27.66
7bc369b7-007b-4b10-bd92-5d326dabf675	TCGA-EJ-7330	4/5/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	4	3	7	5	Bilateral	Apex|Middle|Base	Male	YES	NO	-25050	No	No	2011	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	YES	18	0	R0	Alive	191	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	191	0.1	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	68	M0	[Not Applicable]	T1c	[Not Applicable]	0	[Not Available]	NOT HISPANIC OR LATINO	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3a	[Not Applicable]	[Not Available]	WHITE	[Not Available]	[Not Applicable]	[Not Available]	EJ	Prostate	LIVING	6.27	DiseaseFree	6.27
b424b73a-2dfa-473f-ab56-ab382cd1cdef	TCGA-EJ-7331	4/5/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	3	4	7	3	Bilateral	Apex|Middle	Male	YES	NO	-23458	No	No	2011	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	YES	7	0	R0	Alive	9	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	189	0.8	YES	[Not Available]	[Not Available]	[Not Available]	189	64	M0	[Not Applicable]	T1c	[Not Applicable]	0	[Not Available]	NOT HISPANIC OR LATINO	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T2c	[Not Applicable]	[Not Available]	WHITE	[Not Available]	[Not Applicable]	[Not Available]	EJ	Prostate	LIVING	24.38	DiseaseFree	24.38
33283111-9a2f-4d5e-92a5-3435846404f7	TCGA-EJ-7781	4/6/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	3	4	7	5	Bilateral	[Not Available]	Male	YES	NO	-23937	No	No	2011	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	YES	17	0	R0	Alive	169	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	169	0.1	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	65	M0	[Not Applicable]	T1c	[Not Applicable]	0	[Not Available]	NOT HISPANIC OR LATINO	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T2c	[Not Applicable]	[Not Available]	WHITE	[Not Available]	[Not Applicable]	[Not Available]	EJ	Prostate	LIVING	35.25	DiseaseFree	35.25
1426b4bf-f4a5-477c-bbbb-e0e656549764	TCGA-EJ-7782	4/6/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	4	4	8	4	Bilateral	[Not Available]	Male	YES	NO	-25965	No	No	2010	49	Normal (no evidence of prostate cancer) [cM0]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	YES	17	0	R0	Alive	350	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	350	0.1	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	71	M0	[Not Applicable]	T2c	[Not Applicable]	0	[Not Available]	NOT HISPANIC OR LATINO	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T2c	[Not Applicable]	[Not Available]	BLACK OR AFRICAN AMERICAN	[Not Available]	[Not Applicable]	[Not Available]	EJ	Prostate	LIVING	38.34	DiseaseFree	38.34
181c6d37-9d8d-4ffa-827b-e3785450ff88	TCGA-EJ-7783	4/6/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	4	3	7	4	Bilateral	[Not Available]	Male	YES	NO	-25600	No	No	2011	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	YES	17	0	R0	Alive	172	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	172	0.7	YES	[Not Available]	[Not Available]	[Not Available]	81	70	M0	[Not Applicable]	T2c	[Not Applicable]	0	[Not Available]	NOT HISPANIC OR LATINO	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3a	[Not Applicable]	[Not Available]	WHITE	[Not Available]	[Not Applicable]	[Not Available]	EJ	Prostate	LIVING	25.85	DiseaseFree	25.85
4bc71292-60bb-4b63-86c1-0fe021083804	TCGA-EJ-7784	4/6/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	4	3	7	4	Bilateral	[Not Available]	Male	YES	NO	-23183	No	No	2011	0	Normal (no evidence of prostate cancer) [cM0]	YES	0	No Evidence of Extraprostatic Extension	NO	[Not Available]	[Not Available]	YES	13	0	R0	Alive	167	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	167	0.1	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	63	M0	[Not Applicable]	T2c	[Not Applicable]	0	[Not Available]	NOT HISPANIC OR LATINO	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T2c	[Not Applicable]	[Not Available]	WHITE	[Not Available]	[Not Applicable]	[Not Available]	EJ	Prostate	LIVING	25.66	DiseaseFree	25.66
2def2a53-d2e8-46f0-8b07-f32dbf1833a4	TCGA-EJ-7785	4/6/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	3	4	7	3	Bilateral	Middle|Base	Male	YES	NO	-19939	No	No	2011	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	YES	7	0	R0	Alive	259	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	259	0.1	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	54	M0	[Not Applicable]	T2b	[Not Applicable]	0	[Not Available]	NOT HISPANIC OR LATINO	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3a	[Not Applicable]	[Not Available]	WHITE	[Not Available]	[Not Applicable]	[Not Available]	EJ	Prostate	LIVING	38.67	DiseaseFree	38.67
9d499039-37ca-4300-ae95-04bbe007c0d2	TCGA-EJ-7786	4/6/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	3	4	7	3	Bilateral	[Not Available]	Male	YES	NO	-22793	No	No	2011	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	YES	5	0	R0	Alive	79	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	79	0.1	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	62	M0	[Not Applicable]	T1c	[Not Applicable]	0	[Not Available]	NOT HISPANIC OR LATINO	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T2c	[Not Applicable]	[Not Available]	WHITE	[Not Available]	[Not Applicable]	[Not Available]	EJ	Prostate	LIVING	36.01	DiseaseFree	36.01
e35336e1-e358-493f-9beb-276b5fc6685a	TCGA-EJ-7788	4/6/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	3	4	7	5	Bilateral	Middle|Base	Male	YES	NO	-19623	No	No	2011	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	YES	6	0	R0	Alive	52	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	52	0.2	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	53	M0	[Not Applicable]	T3b	[Not Applicable]	0	[Not Available]	NOT HISPANIC OR LATINO	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3b	[Not Applicable]	[Not Available]	WHITE	[Not Available]	[Not Applicable]	[Not Available]	EJ	Prostate	LIVING	28.22	DiseaseFree	28.22
1f4ff2c7-3fbb-46a1-99cf-68d2c33c5175	TCGA-EJ-7789	4/6/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	4	3	7	5	Bilateral	Base	Male	YES	NO	-24107	No	No	2011	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	YES	14	0	R0	Alive	70	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	66	M0	[Not Applicable]	T1c	[Not Applicable]	0	[Not Available]	NOT HISPANIC OR LATINO	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3a	[Not Applicable]	[Not Available]	BLACK OR AFRICAN AMERICAN	[Not Available]	[Not Applicable]	[Not Available]	EJ	Prostate	LIVING	36.3	DiseaseFree	36.3
4fe004e5-49f9-4336-a690-6ebad512c813	TCGA-EJ-7791	4/9/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	3	4	7	4	Bilateral	Apex|Middle	Male	YES	NO	-24621	No	No	2011	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	YES	18	0	R0	Alive	217	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	217	0.1	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	67	M0	[Not Applicable]	T1c	[Not Applicable]	0	[Not Available]	NOT HISPANIC OR LATINO	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T2c	[Not Applicable]	[Not Available]	WHITE	[Not Available]	[Not Applicable]	[Not Available]	EJ	Prostate	LIVING	36.73	DiseaseFree	36.73
28689d40-03e5-4e17-aba1-f2d571535eed	TCGA-EJ-7792	4/9/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	3	4	7	4	Bilateral	Apex|Middle	Male	YES	NO	-19454	No	No	2010	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	YES	35	0	R0	Alive	526	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	526	0.13	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	53	M0	[Not Applicable]	T1c	[Not Applicable]	0	[Not Available]	NOT HISPANIC OR LATINO	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T2c	[Not Applicable]	[Not Available]	WHITE	[Not Available]	[Not Applicable]	[Not Available]	EJ	Prostate	LIVING	45.86	DiseaseFree	45.86
da07da37-bde6-480a-a302-98683ae3931a	TCGA-EJ-7793	4/9/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	3	4	7	4	Bilateral	Apex|Middle	Male	YES	NO	-17982	No	No	2011	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	R0	Alive	114	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	114	0.1	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	49	M0	[Not Applicable]	T2c	[Not Applicable]	0	[Not Available]	NOT HISPANIC OR LATINO	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	[Not Available]	T2c	[Not Applicable]	[Not Available]	WHITE	[Not Available]	[Not Applicable]	[Not Available]	EJ	Prostate	LIVING	3.75	DiseaseFree	3.75
aeec3005-25d7-45fc-a9ff-014d57960216	TCGA-EJ-7794	4/9/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	3	4	7	3	Bilateral	[Not Available]	Male	YES	NO	-24478	No	No	2010	35	Normal (no evidence of prostate cancer) [cM0]	YES	35	No Evidence of Extraprostatic Extension	NO	[Not Available]	[Not Available]	YES	11	0	R0	Alive	285	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	285	0.1	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	67	M0	[Not Applicable]	T2c	[Not Applicable]	0	[Not Available]	NOT HISPANIC OR LATINO	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T2c	[Not Applicable]	[Not Available]	WHITE	[Not Available]	[Not Applicable]	[Not Available]	EJ	Prostate	LIVING	42.9	DiseaseFree	42.9
f98366df-9616-41c0-a6b8-ec92dca7177a	TCGA-EJ-7797	4/9/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	3	4	7	4	Bilateral	[Not Available]	Male	YES	NO	-19616	No	No	2011	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	YES	14	0	R0	Alive	187	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	187	0.1	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	53	M0	[Not Applicable]	T1c	[Not Applicable]	0	[Not Available]	NOT HISPANIC OR LATINO	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T2c	[Not Applicable]	[Not Available]	WHITE	[Not Available]	[Not Applicable]	[Not Available]	EJ	Prostate	LIVING	32.29	DiseaseFree	32.29
00b16434-0b3a-4194-8714-74dccbebe06c	TCGA-EJ-8468	10/12/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	4	4	8	3	Left	[Not Available]	Male	YES	NO	-23371	No	No	2007	23	Normal (no evidence of prostate cancer) [cM0]	YES	23	[Not Available]	[Not Available]	[Not Available]	[Not Available]	YES	7	0	R0	Alive	1961	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	1961	0.1	NO	NO	Complete Remission/Response	NO	[Not Available]	63	[Not Available]	[Not Applicable]	T3a	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3a	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	EJ	Prostate	LIVING	77.1	DiseaseFree	77.1
df4a7caa-6289-4157-8cb4-6ce8784e7506	TCGA-EJ-8469	10/14/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	4	5	9	3	Bilateral	[Not Available]	Male	YES	NO	-17014	No	No	2007	[Not Available]	[Not Available]	YES	30	No Evidence of Extraprostatic Extension	[Not Available]	[Not Available]	[Not Available]	YES	57	0	RX	Alive	1946	[Not Applicable]	[Not Available]	[Not Available]	WITH TUMOR	1925	3.1	YES	NO	Partial Remission/Response	YES	1925	46	M0	[Not Applicable]	T3a	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3a	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	EJ	Prostate	LIVING	76.35	Recurred/Progressed	63.24
1a8a887e-b9f0-42f5-8dce-4e58cb13844b	TCGA-EJ-8470	10/15/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	4	3	7	[Not Available]	Bilateral	[Not Available]	Male	YES	NO	-21209	No	No	2010	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	YES	21	0	[Not Available]	Alive	821	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	[Not Available]	[Not Available]	[Not Available]	NO	Complete Remission/Response	NO	[Not Available]	58	M0	[Not Applicable]	T2c	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T2c	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	EJ	Prostate	LIVING	38.07	DiseaseFree	38.07
ab378ad0-1881-403f-9e85-d6f97e7b7c81	TCGA-EJ-8472	10/19/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	4	4	8	3	[Not Available]	[Not Available]	Male	YES	NO	-23104	No	No	2011	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	YES	12	0	R0	Alive	756	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	196	0.4	YES	NO	Partial Remission/Response	YES	196	63	M0	[Not Applicable]	T3a	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3a	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	EJ	Prostate	LIVING	24.84	Recurred/Progressed	6.44
d57d3254-d8f3-4ca2-8b31-790d3ac9a63d	TCGA-EJ-8474	1/22/13	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	4	4	8	[Not Available]	Bilateral	[Not Available]	Male	YES	NO	-25561	No	No	2011	51	Normal (no evidence of prostate cancer) [cM0]	YES	7	No Evidence of Extraprostatic Extension	[Not Available]	[Not Available]	[Not Available]	YES	15	0	R0	Alive	314	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	766	0.01	NO	NO	Complete Remission/Response	NO	[Not Available]	69	M0	[Not Applicable]	T3a	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3a	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	EJ	Prostate	LIVING	25.16	DiseaseFree	25.16
1170F449-DFB5-417A-A89B-B2229A2785DB	TCGA-EJ-A46B	1/22/13	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	4	4	8	3	Bilateral	[Not Available]	Male	YES	NO	-24305	Yes, History of Prior Malignancy	No	2012	10	Normal (no evidence of prostate cancer) [cM0]	YES	10	No Evidence of Extraprostatic Extension	[Not Available]	[Not Available]	[Not Available]	YES	10	0	R0	Alive	162	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	157	0.1	NO	NO	Complete Remission/Response	NO	[Not Available]	66	M0	[Not Applicable]	T1c	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3a	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	EJ	Prostate	LIVING	21.58	DiseaseFree	21.58
93D10D8B-5F98-4D2C-8AF3-11471385D4D4	TCGA-EJ-A46D	1/22/13	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	3	5	8	4	Bilateral	[Not Available]	Male	YES	NO	-19466	No	No	2012	42	Normal (no evidence of prostate cancer) [cM0]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	YES	6	0	[Not Available]	Alive	129	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	122	0.03	NO	NO	Complete Remission/Response	NO	[Not Available]	53	M0	[Not Applicable]	T2c	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T2c	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	EJ	Prostate	LIVING	20.57	DiseaseFree	20.57
A608BF0E-A932-4541-8439-2FFB9F6294B0	TCGA-EJ-A46E	1/23/13	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	4	4	8	[Not Available]	Bilateral	[Not Available]	Male	YES	NO	-21054	No	No	2011	[Not Available]	Normal (no evidence of prostate cancer) [cM0]	YES	[Not Available]	No Evidence of Extraprostatic Extension	[Not Available]	[Not Available]	[Not Available]	YES	9	0	R0	Alive	524	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	503	0.1	NO	NO	Complete Remission/Response	NO	[Not Available]	57	M0	[Not Applicable]	T1c	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	EJ	Prostate	LIVING	17.21	DiseaseFree	17.21
08F11BDD-D665-45AB-B1A2-5485D91922C2	TCGA-EJ-A46F	1/24/13	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	4	4	8	3	Bilateral	[Not Available]	Male	YES	NO	-21160	No	No	2011	166	Normal (no evidence of prostate cancer) [cM0]	YES	166	[Not Available]	[Not Available]	[Not Available]	[Not Available]	YES	23	1	R0	Alive	299	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	215	19.8	YES	NO	Partial Remission/Response	YES	215	57	M0	[Not Applicable]	T2c	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N1	T3b	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	EJ	Prostate	LIVING	25.72	Recurred/Progressed	7.06
969399CD-47B6-4C0F-8939-3860BE3014F9	TCGA-EJ-A46G	1/24/13	Prostate Adenocarcinoma, Other Subtype	Adenocarcinoma prostate with prominent ductal differentiation identified	[Not Available]	4	4	8	5	Bilateral	[Not Available]	Male	YES	NO	-26219	Yes, History of Prior Malignancy	No	2012	28	Normal (no evidence of prostate cancer) [cM0]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	YES	17	0	R0	Alive	93	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	93	0.1	NO	NO	Complete Remission/Response	NO	[Not Available]	71	M0	[Not Applicable]	T3a	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8500/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3a	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	EJ	Prostate	LIVING	21.94	DiseaseFree	21.94
CEC1D2FF-36E6-497E-892C-B329724B4722	TCGA-EJ-A46H	1/24/13	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	3	4	7	[Not Available]	Bilateral	[Not Available]	Male	YES	NO	-22059	No	No	2012	-6	Normal (no evidence of prostate cancer) [cM0]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	YES	6	[Not Available]	R0	Alive	229	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	131	0.1	NO	NO	Complete Remission/Response	NO	[Not Available]	60	M0	[Not Applicable]	T1c	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T2c	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	EJ	Prostate	LIVING	23.78	DiseaseFree	23.78
9B59ED95-E97F-4356-B976-E3FA0E9EEE02	TCGA-EJ-A46I	1/24/13	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	3	4	7	[Not Available]	Bilateral	[Not Available]	Male	YES	NO	-21046	No	No	2011	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	R0	Alive	668	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	484	0.1	NO	NO	Complete Remission/Response	NO	[Not Available]	57	M0	[Not Applicable]	T1c	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	[Not Available]	[Not Applicable]	N0	T3a	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	EJ	Prostate	LIVING	21.94	DiseaseFree	21.94
DF3362CB-0F6B-412E-8AF4-C5606526BE17	TCGA-EJ-A65B	3/3/14	Prostate Adenocarcinoma, Other Subtype	Mixed	[Not Available]	4	5	9	[Not Available]	[Not Available]	[Not Available]	Male	YES	NO	-20204	No	No	2012	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	YES	13	0	R1	Alive	536	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	536	0.01	NO	NO	Complete Remission/Response	NO	[Not Available]	55	M0	[Not Applicable]	T3b	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8255/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3b	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	EJ	Prostate	LIVING	23.32	DiseaseFree	23.32
8E1FF72B-F1DB-4BF9-A8D3-F422E25A65E1	TCGA-EJ-A65D	3/5/14	Prostate Adenocarcinoma, Other Subtype	ductal	[Not Available]	4	4	8	[Not Available]	Bilateral	[Not Available]	Male	YES	NO	-24297	No	No	2012	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	YES	34	0	R0	Alive	393	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	393	0.1	NO	NO	Complete Remission/Response	NO	[Not Available]	66	M0	[Not Applicable]	T3a	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8500/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3a	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	EJ	Prostate	LIVING	12.91	DiseaseFree	12.91
37EC45FD-1C85-49CB-835E-FA7B2B8CE16F	TCGA-EJ-A65E	3/5/14	Prostate Adenocarcinoma, Other Subtype	mixed	[Not Available]	4	3	7	[Not Available]	Bilateral	[Not Available]	Male	YES	NO	-24558	No	No	2012	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	YES	23	0	R0	Alive	417	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	254	0.1	NO	NO	Complete Remission/Response	NO	[Not Available]	67	M0	[Not Applicable]	T3b	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8255/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3b	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	EJ	Prostate	LIVING	13.7	DiseaseFree	13.7
8631BB5E-6D08-4C20-A85E-CB84F5DAC290	TCGA-EJ-A65F	3/4/14	Prostate Adenocarcinoma, Other Subtype	acinar and cribriform	[Not Available]	4	5	9	[Not Available]	Bilateral	[Not Available]	Male	YES	NO	-21681	No	No	2012	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	YES	4	0	R0	Alive	560	[Not Applicable]	[Not Available]	[Not Available]	[Discrepancy]	75	0.8	YES	NO	Progressive Disease	YES	75	59	M0	[Not Applicable]	T3b	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8255/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3b	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	EJ	Prostate	LIVING	18.4	Recurred/Progressed	2.46
8BFAC5B9-FA2B-4B6E-9537-E9D8A2F0D1DC	TCGA-EJ-A65G	3/5/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	3	5	8	[Not Available]	Bilateral	[Not Available]	Male	YES	NO	-20821	No	No	2012	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	YES	24	0	R0	Alive	278	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	152	0.1	NO	NO	Complete Remission/Response	NO	[Not Available]	57	M0	[Not Applicable]	T2c	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Transurethral resection (TURBT)	[Not Applicable]	N0	T2c	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	EJ	Prostate	LIVING	21.88	DiseaseFree	21.88
89C150CF-F60C-4F11-8F3E-384B0E0902F9	TCGA-EJ-A65J	3/4/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	4	5	9	[Not Available]	Bilateral	[Not Available]	Male	YES	NO	-22904	Yes, History of Prior Malignancy	No	2012	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	YES	11	0	R0	Alive	91	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	91	0.1	NO	NO	Complete Remission/Response	NO	[Not Available]	62	M0	[Not Applicable]	T3a	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3a	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	EJ	Prostate	LIVING	14.82	DiseaseFree	14.82
D4FF9F1A-1D35-4AD6-9A36-059547081C7E	TCGA-EJ-A65M	3/4/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	3	3	6	[Not Available]	Bilateral	[Not Available]	Male	YES	NO	-23767	No	No	2013	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	YES	30	0	[Not Available]	Alive	230	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	230	0.1	NO	NO	Complete Remission/Response	NO	[Not Available]	65	M0	[Not Applicable]	T2c	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Transurethral resection (TURBT)	[Not Applicable]	N0	T2c	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	EJ	Prostate	LIVING	7.56	DiseaseFree	7.56
4EF24CCA-976B-4C2F-8810-4339967DA570	TCGA-EJ-A6RA	3/4/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	4	4	8	[Not Available]	Bilateral	[Not Available]	Male	YES	NO	-25679	No	No	2012	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	YES	18	1	R0	Alive	353	[Not Applicable]	[Not Available]	[Not Available]	WITH TUMOR	353	0.652	YES	NO	Partial Remission/Response	YES	353	70	M0	[Not Applicable]	T3b	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N1	T3b	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	EJ	Prostate	LIVING	11.6	Recurred/Progressed	11.6
AAE0FCA8-99E9-4FDE-A2E9-B0EA500737F8	TCGA-EJ-A6RC	3/4/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	4	3	7	[Not Available]	Bilateral	[Not Available]	Male	YES	NO	-23598	Yes, History of Prior Malignancy	No	2011	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	YES	38	0	R0	Alive	693	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	693	0.1	NO	NO	Complete Remission/Response	NO	[Not Available]	64	M0	[Not Applicable]	T1c	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Transurethral resection (TURBT)	[Not Applicable]	N0	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	EJ	Prostate	LIVING	28.68	DiseaseFree	28.68
F4478172-7727-4680-9934-DA755AB1825C	TCGA-EJ-A7NF	3/4/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	3	4	7	[Not Available]	Bilateral	[Not Available]	Male	YES	NO	-20587	No	No	2013	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	YES	29	0	R0	Alive	216	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	117	0.1	NO	NO	Complete Remission/Response	NO	[Not Available]	56	M0	[Not Applicable]	T2c	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Transurethral resection (TURBT)	[Not Applicable]	N0	T2c	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	EJ	Prostate	LIVING	8.21	DiseaseFree	8.21
607FD22B-F281-431B-848E-AE01E69567E2	TCGA-EJ-A7NG	3/4/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	3	4	7	[Not Available]	Bilateral	[Not Available]	Male	YES	NO	-23458	No	No	2013	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	YES	6	0	R0	Alive	264	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	264	0.1	NO	NO	Complete Remission/Response	NO	[Not Available]	64	M0	[Not Applicable]	T3a	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3a	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	EJ	Prostate	LIVING	14.19	DiseaseFree	14.19
0D498226-E22A-44A4-9EF8-1DA8E83FA55B	TCGA-EJ-A7NH	3/5/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	3	4	7	[Not Available]	Bilateral	[Not Available]	Male	YES	NO	-20734	No	No	2013	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	YES	4	[Not Available]	R0	Alive	172	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	105	0.1	NO	NO	Complete Remission/Response	NO	[Not Available]	56	M0	[Not Applicable]	T2c	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T2c	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	EJ	Prostate	LIVING	15.57	DiseaseFree	15.57
F6743FF8-542E-4FDE-8FF2-4878FCABFFDA	TCGA-EJ-A7NJ	3/4/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	4	4	8	[Not Available]	Bilateral	[Not Available]	Male	YES	NO	-21748	No	No	2013	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	YES	16	0	R0	Alive	197	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	92	0.1	NO	NO	Complete Remission/Response	NO	[Not Available]	59	M0	[Not Applicable]	T2c	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T2c	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	EJ	Prostate	LIVING	6.47	DiseaseFree	6.47
C362F6F9-4CE6-4659-8C36-4CD45C72FB03	TCGA-EJ-A7NK	3/4/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	3	4	7	[Not Available]	Bilateral	[Not Available]	Male	YES	NO	-21530	No	No	2012	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	YES	48	0	R0	Alive	295	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	295	0.1	NO	NO	Complete Remission/Response	NO	[Not Available]	58	M0	[Not Applicable]	T3a	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Transurethral resection (TURBT)	[Not Applicable]	N0	T3a	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	EJ	Prostate	LIVING	15.64	DiseaseFree	15.64
AA8B99FD-973F-465D-AE24-3421FE784687	TCGA-EJ-A7NM	3/4/14	Prostate Adenocarcinoma, Other Subtype	mixed acinar & ductal	[Not Available]	4	5	9	[Not Available]	Bilateral	[Not Available]	Male	YES	NO	-23603	No	No	2013	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	YES	29	3	R0	Alive	128	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	128	0.1	NO	NO	Complete Remission/Response	NO	[Not Available]	64	M0	[Not Applicable]	T3b	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8500/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N1	T3b	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	EJ	Prostate	LIVING	4.2	DiseaseFree	4.2
C8FAB4A7-FD7E-4D5E-A330-18C7E148B9D0	TCGA-EJ-A7NN	3/4/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	4	3	7	[Not Available]	Bilateral	[Not Available]	Male	YES	NO	-22499	No	No	2013	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	YES	25	3	R1	Alive	197	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	197	0.3	YES	NO	Complete Remission/Response	YES	197	61	M0	[Not Applicable]	T3b	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N1	T3b	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	EJ	Prostate	LIVING	6.47	Recurred/Progressed	6.47
EA770D22-2CBA-465C-9555-E0877DCECB9F	TCGA-EJ-A8FN	3/24/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	3	4	7	[Not Available]	Bilateral	[Not Available]	Male	YES	NO	-21506	No	No	2013	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	YES	25	0	R0	Alive	203	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	203	0.1	NO	NO	Complete Remission/Response	NO	[Not Available]	58	M0	[Not Applicable]	T2c	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T2c	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	EJ	Prostate	LIVING	10.81	DiseaseFree	10.81
B751083D-BE6D-45DA-BE97-A6D41D8EBE97	TCGA-EJ-A8FO	3/24/14	Prostate Adenocarcinoma, Other Subtype	acinar and ductal	[Not Available]	4	3	7	[Not Available]	Bilateral	[Not Available]	Male	YES	NO	-18875	No	No	2013	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	YES	37	0	R0	Alive	156	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	156	0.1	NO	NO	Complete Remission/Response	NO	[Not Available]	51	M0	[Not Applicable]	T3a	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8500/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3a	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	EJ	Prostate	LIVING	9.26	DiseaseFree	9.26
00F0F7DD-71DE-4E4F-B4B5-DF860324F2E8	TCGA-EJ-A8FP	3/24/14	Prostate Adenocarcinoma, Other Subtype	acinar and ductal	[Not Available]	3	5	8	[Not Available]	Bilateral	[Not Available]	Male	YES	NO	-21769	No	No	2013	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	YES	40	0	R0	Alive	117	[Not Applicable]	[Not Available]	[Not Available]	WITH TUMOR	117	0.2	YES	NO	Complete Remission/Response	YES	117	59	M0	[Not Applicable]	T2c	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8500/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T2c	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	EJ	Prostate	LIVING	9.82	Recurred/Progressed	3.84
9044098B-415D-4893-A682-3636F6B2B2DB	TCGA-EJ-A8FS	3/24/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	3	4	7	[Not Available]	Bilateral	[Not Available]	Male	YES	NO	-24380	No	No	2013	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	YES	69	0	R0	Alive	216	[Not Applicable]	[Not Available]	[Not Available]	WITH TUMOR	216	0.3	YES	NO	[Not Available]	YES	216	66	M0	[Not Applicable]	T3a	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Transurethral resection (TURBT)	[Not Applicable]	N0	T3a	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	EJ	Prostate	LIVING	8.74	Recurred/Progressed	7.1
23E56E08-E11D-4E83-88A8-1254675B3AF8	TCGA-EJ-A8FU	3/24/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	5	3	8	[Not Available]	Bilateral	[Not Available]	Male	YES	NO	-23472	No	No	2013	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	YES	29	0	R0	Alive	82	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	[Not Available]	[Not Available]	[Not Available]	NO	Complete Remission/Response	NO	[Not Available]	64	M0	[Not Applicable]	T3a	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3a	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	EJ	Prostate	LIVING	4.53	DiseaseFree	4.53
743FFC51-D613-407F-B040-E99969C31802	TCGA-EJ-AB20	6/23/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	3	3	6	[Not Available]	Bilateral	[Not Available]	Male	YES	NO	-22626	No	No	2013	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	YES	18	0	R0	Alive	131	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	131	0.1	NO	NO	Complete Remission/Response	NO	[Not Available]	61	M0	[Not Applicable]	T2c	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T2c	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	EJ	Prostate	LIVING	4.3	DiseaseFree	4.3
B7B61392-C085-4E28-892F-E9B6FE6ECE41	TCGA-EJ-AB27	6/24/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	3	3	6	[Not Available]	Bilateral	[Not Available]	Male	YES	NO	-18648	No	No	2013	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	YES	15	0	R0	Alive	145	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	145	0.1	NO	NO	Complete Remission/Response	NO	[Not Available]	51	M0	[Not Applicable]	T1c	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T2c	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	EJ	Prostate	LIVING	4.76	DiseaseFree	4.76
208a75b3-407c-4c5a-8938-3691547b6887	TCGA-FC-7708	2/17/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Overlapping / Multiple Zones	4	3	7	[Not Available]	Bilateral	Apex|Middle	Male	YES	NO	-19144	No	No	2011	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	YES	4	0	RX	Alive	32	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	52	M0	[Not Applicable]	T1c	[Not Applicable]	0	[Not Available]	NOT HISPANIC OR LATINO	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3a	[Not Applicable]	[Not Available]	ASIAN	[Not Available]	[Not Applicable]	[Not Available]	FC	Prostate	LIVING	28.38	DiseaseFree	28.38
a8d81122-3f2a-43f4-bdc1-479cab37a19d	TCGA-FC-7961	3/16/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Peripheral Zone	4	5	9	[Not Available]	Bilateral	Apex	Male	YES	NO	-22888	No	No	2011	[Not Available]	[Not Available]	YES	65	No Evidence of Extraprostatic Extension	[Not Available]	[Not Available]	[Not Available]	YES	3	0	[Not Available]	Alive	70	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	62	M0	[Not Applicable]	T1c	[Not Applicable]	0	[Not Available]	NOT HISPANIC OR LATINO	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3a	[Not Applicable]	[Not Available]	WHITE	[Not Available]	[Not Applicable]	[Not Available]	FC	Prostate	LIVING	15.41	DiseaseFree	15.41
30F623A3-DAE7-41DA-AB10-8786D094209E	TCGA-FC-A4JI	2/11/13	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Central Zone	5	3	8	[Not Available]	Bilateral	Apex|Middle|Base	Male	YES	NO	-25931	No	No	2012	12	Normal (no evidence of prostate cancer) [cM0]	YES	16	Extraprostatic Extension  Localized (e.g. seminal vesicles)	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	R0	Alive	29	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	[Not Available]	[Not Available]	[Not Available]	YES	[Not Applicable]	NO	[Not Available]	70	M0	[Not Applicable]	T4	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	[Not Available]	T3a	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	YES	FC	Prostate	LIVING	28.81	DiseaseFree	28.81
F7238E82-A394-4A7C-8514-6241D0AA17E3	TCGA-FC-A5OB	7/12/13	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Overlapping / Multiple Zones	4	5	9	[Not Available]	Bilateral	Middle|Base	Male	YES	NO	-19413	No	No	2012	9	Abnormal (not related to prostate cancer)	YES	9	No Evidence of Extraprostatic Extension	NO	[Not Available]	[Not Available]	YES	9	0	R1	Alive	273	[Not Applicable]	[Not Available]	[Not Available]	WITH TUMOR	110	5.22	NO	[Not Available]	[Not Available]	NO	[Not Available]	53	M0	[Not Applicable]	T3a	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3b	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	FC	Prostate	LIVING	22.34	DiseaseFree	22.34
7466D120-6A6E-40A0-96D3-4979816D6278	TCGA-FC-A66V	7/12/13	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Overlapping / Multiple Zones	4	3	7	[Not Available]	Bilateral	Middle|Base	Male	YES	NO	-27282	No	No	2012	28	Normal (no evidence of prostate cancer) [cM0]	YES	27	No Evidence of Extraprostatic Extension	NO	[Not Available]	[Not Available]	YES	2	0	R0	Alive	122	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	-164	10.8	NO	NO	Complete Remission/Response	[Not Available]	[Not Available]	74	M0	[Not Applicable]	T3b	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3b	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	FC	Prostate	LIVING	17.21	DiseaseFree	17.21
F97FED28-FDF3-4C82-8B6D-1015848B80DC	TCGA-FC-A6HD	10/17/13	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Overlapping / Multiple Zones	4	3	7	[Not Available]	Bilateral	Middle	Male	YES	NO	-28197	No	No	2013	33	Normal (no evidence of prostate cancer) [cM0]	YES	33	No Evidence of Extraprostatic Extension	NO	[Not Available]	[Not Available]	YES	10	0	R0	Alive	54	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	NO	[Not Available]	77	M0	[Not Applicable]	T3a	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3a	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	FC	Prostate	LIVING	25.92	DiseaseFree	25.92
7EEA6FD7-733C-44EB-B4B7-50BB3A2628A0	TCGA-FC-A8O0	2/27/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Peripheral Zone	3	3	6	4	Bilateral	Base	Male	YES	NO	-25115	No	No	2013	[Not Available]	[Not Available]	YES	10	Extraprostatic Extension  Localized (e.g. seminal vesicles)	YES	-8	Extraprostatic Extension Localized (e.g. seminal vesicles)|Extraprostatic Extension (regional lymphadenopathy) [e.g. cN1]	YES	12	0	R0	Alive	54	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	18	7.82	NO	[Not Available]	Complete Remission/Response	NO	[Not Available]	68	M0	[Not Applicable]	T2c	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3a	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	FC	Prostate	LIVING	20.24	DiseaseFree	20.24
a08fd0a6-a89a-4adb-b641-d4c1238abb71	TCGA-G9-6329	3/20/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	3	4	7	[Not Available]	Bilateral	[Not Available]	Male	NO	YES	-24797	No	No	2009	10	Normal (no evidence of prostate cancer) [cM0]	YES	10	No Evidence of Extraprostatic Extension	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	R0	Alive	923	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	923	0.03	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	67	M0	[Not Applicable]	T1c	[Not Applicable]	0	[Not Available]	NOT HISPANIC OR LATINO	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	[Not Available]	T2c	[Not Applicable]	[Not Available]	WHITE	[Not Available]	[Not Applicable]	[Not Available]	G9	Prostate	LIVING	41.59	DiseaseFree	41.59
c46022f8-b122-4367-836b-ec1ae641a87d	TCGA-G9-6332	3/20/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	4	3	7	[Not Available]	Bilateral	Apex|Base	Male	NO	YES	-20166	No	No	2005	11	Normal (no evidence of prostate cancer) [cM0]	YES	11	No Evidence of Extraprostatic Extension	NO	[Not Available]	[Not Available]	YES	7	0	R0	Alive	2328	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	2090	0.73	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	55	M0	[Not Applicable]	T2b	[Not Applicable]	0	[Not Available]	NOT HISPANIC OR LATINO	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3a	[Not Applicable]	[Not Available]	WHITE	[Not Available]	[Not Applicable]	[Not Available]	G9	Prostate	LIVING	87.29	Recurred/Progressed	42.21
64bf32c9-9466-404a-a147-e7a0b9e91e34	TCGA-G9-6333	3/19/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	4	3	7	[Not Available]	Bilateral	Apex|Base	Male	NO	YES	-24249	No	No	2006	1102	Normal (no evidence of prostate cancer) [cM0]	YES	1102	No Evidence of Extraprostatic Extension	NO	[Not Available]	[Not Available]	YES	13	0	R0	Alive	1925	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	1920	0.03	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	66	M0	[Not Applicable]	T1c	[Not Applicable]	0	[Not Available]	NOT HISPANIC OR LATINO	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T2c	[Not Applicable]	[Not Available]	WHITE	[Not Available]	[Not Applicable]	[Not Available]	G9	Prostate	LIVING	80.98	DiseaseFree	80.98
59207bcd-f127-481f-b576-8716da7d7d97	TCGA-G9-6336	3/19/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	3	4	7	[Not Available]	Bilateral	Apex|Base	Male	NO	YES	-20851	No	No	2007	98	Normal (no evidence of prostate cancer) [cM0]	YES	104	No Evidence of Extraprostatic Extension	NO	[Not Available]	[Not Available]	YES	5	0	R1	Alive	1669	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	1669	0.1	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	57	M0	[Not Applicable]	T2c	[Not Applicable]	0	[Not Available]	NOT HISPANIC OR LATINO	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	[Not Available]	[Not Applicable]	[Not Available]	WHITE	[Not Available]	[Not Applicable]	[Not Available]	G9	Prostate	LIVING	67.94	DiseaseFree	67.94
2c48b1bf-4e49-4869-874b-f08787fa04b5	TCGA-G9-6338	3/16/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	4	3	7	[Not Available]	Bilateral	Apex	Male	NO	YES	-22360	No	No	2007	13	Normal (no evidence of prostate cancer) [cM0]	YES	82	No Evidence of Extraprostatic Extension	NO	[Not Available]	[Not Available]	YES	2	0	R1	Alive	1649	[Not Applicable]	[Not Available]	[Not Available]	WITH TUMOR	1634	0.05	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	61	M0	[Not Applicable]	T1c	[Not Applicable]	0	[Not Available]	NOT HISPANIC OR LATINO	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3a	[Not Applicable]	[Not Available]	WHITE	[Not Available]	[Not Applicable]	[Not Available]	G9	Prostate	LIVING	66.62	DiseaseFree	66.62
d39d1a49-fcc0-4f2c-9338-df904e7f6a09	TCGA-G9-6339	10/29/13	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	3	4	7	[Not Available]	Bilateral	Apex|Middle|Base	Male	NO	YES	-21305	No	No	2007	4	Normal (no evidence of prostate cancer) [cM0]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	YES	6	0	R0	Alive	2110	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	2110	0.03	NO	NO	Complete Remission/Response	YES	1634	58	M0	[Not Applicable]	T3b	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3b	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	G9	Prostate	LIVING	83.8	Recurred/Progressed	53.68
00e41e6a-9fe7-44f9-978b-7b05b179506a	TCGA-G9-6342	3/16/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	3	3	6	4	Bilateral	Apex|Base	Male	NO	YES	-22472	No	No	2008	32	Normal (no evidence of prostate cancer) [cM0]	YES	36	No Evidence of Extraprostatic Extension	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	R0	Alive	1338	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	1338	0.05	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	61	M0	[Not Applicable]	T2c	[Not Applicable]	0	[Not Available]	NOT HISPANIC OR LATINO	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	[Not Available]	T3a	[Not Applicable]	[Not Available]	WHITE	[Not Available]	[Not Applicable]	[Not Available]	G9	Prostate	LIVING	55.72	DiseaseFree	55.72
36b87d12-9f96-460f-a3b5-a4c08cbf5b07	TCGA-G9-6343	3/16/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	4	3	7	[Not Available]	Bilateral	Apex|Base	Male	NO	YES	-22843	No	No	2008	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	R0	Alive	554	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	554	0.03	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	62	M0	[Not Applicable]	T2a	[Not Applicable]	0	[Not Available]	NOT HISPANIC OR LATINO	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	[Not Available]	T2c	[Not Applicable]	[Not Available]	WHITE	[Not Available]	[Not Applicable]	[Not Available]	G9	Prostate	LIVING	80.49	DiseaseFree	80.49
b5268f49-2710-4d17-a78b-4a05412e8375	TCGA-G9-6347	10/29/13	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Peripheral Zone	3	3	6	[Not Available]	Bilateral	Apex|Middle	Male	NO	YES	-21721	No	No	2008	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	R0	Alive	1718	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	1718	0.03	NO	NO	Complete Remission/Response	NO	[Not Available]	59	M0	[Not Applicable]	T1c	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	[Not Available]	T2c	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	G9	Prostate	LIVING	68.63	DiseaseFree	68.63
8ad78c4f-c84c-4f9e-88c9-42a05eb65498	TCGA-G9-6348	3/15/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	3	4	7	[Not Available]	Bilateral	Apex|Base	Male	NO	YES	-24936	No	No	2008	31	Abnormal (not related to prostate cancer)	YES	31	No Evidence of Extraprostatic Extension	NO	[Not Available]	[Not Available]	[Discrepancy]	15	0	R0	Alive	1144	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	1136	0.02	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	68	M0	[Not Applicable]	T3a	[Not Applicable]	0	[Not Available]	NOT HISPANIC OR LATINO	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T2c	[Not Applicable]	[Not Available]	WHITE	[Not Available]	[Not Applicable]	[Not Available]	G9	Prostate	LIVING	49.77	DiseaseFree	49.77
f59b9c65-46e8-4cc3-aa71-8844f6c2273c	TCGA-G9-6351	3/14/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	3	4	7	[Not Available]	Bilateral	Apex	Male	NO	YES	-18723	No	No	2008	8	Normal (no evidence of prostate cancer) [cM0]	YES	11	No Evidence of Extraprostatic Extension	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	R1	Alive	1215	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	1215	0.03	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	51	M0	[Not Applicable]	T1c	[Not Applicable]	0	[Not Available]	NOT HISPANIC OR LATINO	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	[Not Available]	T2c	[Not Applicable]	[Not Available]	WHITE	[Not Available]	[Not Applicable]	[Not Available]	G9	Prostate	LIVING	67.28	DiseaseFree	67.28
bcc94953-ce79-428e-99c1-632e42c1b9bc	TCGA-G9-6353	3/14/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Peripheral Zone	3	4	7	[Not Available]	Bilateral	Apex|Middle	Male	NO	YES	-21221	No	No	2009	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	R1	Alive	848	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	590	0.1	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	58	M0	[Not Applicable]	T1c	[Not Applicable]	0	[Not Available]	NOT HISPANIC OR LATINO	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	[Not Available]	T3a	[Not Applicable]	[Not Available]	WHITE	[Not Available]	[Not Applicable]	[Not Available]	G9	Prostate	LIVING	50.66	DiseaseFree	50.66
6bbbe263-3632-4567-912c-95bc9940a1dd	TCGA-G9-6354	10/29/13	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	3	4	7	[Not Available]	Right	Apex|Base	Male	NO	YES	-20403	No	No	2009	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	R0	Alive	1501	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	525	0.03	NO	NO	Complete Remission/Response	NO	[Not Available]	55	M0	[Not Applicable]	T1c	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	[Not Available]	T2b	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	G9	Prostate	LIVING	67.87	DiseaseFree	67.87
1d7ffbe7-6139-412b-8739-8082a63a2b33	TCGA-G9-6356	3/14/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	4	5	9	3	Bilateral	Apex|Base	Male	NO	YES	-22010	No	No	2009	24	Normal (no evidence of prostate cancer) [cM0]	YES	21	No Evidence of Extraprostatic Extension	NO	[Not Available]	[Not Available]	YES	5	0	R1	Alive	1000	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	986	0.13	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	60	M0	[Not Applicable]	T1c	[Not Applicable]	0	[Not Available]	NOT HISPANIC OR LATINO	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3b	[Not Applicable]	[Not Available]	WHITE	[Not Available]	[Not Applicable]	[Not Available]	G9	Prostate	LIVING	47.11	DiseaseFree	47.11
71d14304-ccb0-4a4c-b935-8c014ca75fd0	TCGA-G9-6361	3/13/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	3	4	7	[Not Available]	Bilateral	Apex|Base	Male	NO	YES	-22565	No	No	2009	38	Normal (no evidence of prostate cancer) [cM0]	YES	31	No Evidence of Extraprostatic Extension	NO	[Not Available]	[Not Available]	YES	12	0	R1	Alive	1008	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	1002	0.1	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	61	M0	[Not Applicable]	T2c	[Not Applicable]	0	[Not Available]	NOT HISPANIC OR LATINO	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3a	[Not Applicable]	[Not Available]	WHITE	[Not Available]	[Not Applicable]	[Not Available]	G9	Prostate	LIVING	46.48	DiseaseFree	46.48
f228ef91-ecfb-4d1e-8e6a-b43d2185270e	TCGA-G9-6362	3/13/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	4	3	7	5	Bilateral	Apex|Base	Male	NO	YES	-21149	No	No	2009	8	Normal (no evidence of prostate cancer) [cM0]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	YES	2	0	R1	Alive	822	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	815	0.07	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	57	M0	[Not Applicable]	T1c	[Not Applicable]	0	[Not Available]	NOT HISPANIC OR LATINO	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3a	[Not Applicable]	[Not Available]	WHITE	[Not Available]	[Not Applicable]	[Not Available]	G9	Prostate	LIVING	47.4	DiseaseFree	47.4
b5b3871c-078c-46a7-ac50-ef916d4a6781	TCGA-G9-6363	3/9/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	4	3	7	[Not Available]	Bilateral	Base	Male	NO	YES	-23480	No	No	2009	58	Normal (no evidence of prostate cancer) [cM0]	YES	23	No Evidence of Extraprostatic Extension	NO	[Not Available]	[Not Available]	YES	6	0	R0	Alive	993	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	993	0.03	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	64	M0	[Not Applicable]	T2b	[Not Applicable]	0	[Not Available]	NOT HISPANIC OR LATINO	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T4	[Not Applicable]	[Not Available]	WHITE	[Not Available]	[Not Applicable]	[Not Available]	G9	Prostate	LIVING	45.27	DiseaseFree	45.27
f8d8b417-5945-42a5-850a-fbc04b4f0e61	TCGA-G9-6364	3/9/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	3	4	7	[Not Available]	Bilateral	[Not Available]	Male	NO	YES	-26603	Yes	No	2009	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	YES	25	0	R0	Alive	841	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	841	0.03	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	72	M0	[Not Applicable]	[Not Available]	[Not Applicable]	0	[Not Available]	NOT HISPANIC OR LATINO	[Not Applicable]	C61	8550/3	C61.9	YES	Transurethral resection (TURBT)	[Not Applicable]	N0	T3a	[Not Applicable]	[Not Available]	WHITE	[Not Available]	[Not Applicable]	[Not Available]	G9	Prostate	LIVING	39.36	DiseaseFree	39.36
6845076e-e940-4437-8618-81db4a447544	TCGA-G9-6365	3/9/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	3	4	7	[Not Available]	Bilateral	Apex|Base	Male	NO	YES	-26207	No	No	2009	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	YES	13	0	R1	Alive	804	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	804	0.01	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	71	[Not Available]	[Not Applicable]	T2a	[Not Applicable]	0	[Not Available]	NOT HISPANIC OR LATINO	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T4	[Not Applicable]	[Not Available]	WHITE	[Not Available]	[Not Applicable]	[Not Available]	G9	Prostate	LIVING	44.78	DiseaseFree	44.78
df3abb97-c790-4ff6-a726-6645b3058d72	TCGA-G9-6366	3/8/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	4	3	7	[Not Available]	Left	Apex|Base	Male	NO	YES	-22428	No	No	2009	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	R0	Alive	101	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	101	0.1	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	61	[Not Available]	[Not Applicable]	T1c	[Not Applicable]	0	[Not Available]	NOT HISPANIC OR LATINO	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	[Not Available]	T3b	[Not Applicable]	[Not Available]	WHITE	[Not Available]	[Not Applicable]	[Not Available]	G9	Prostate	LIVING	63.96	DiseaseFree	63.96
9f751c9d-ad41-4f02-b7f8-12423857d418	TCGA-G9-6367	3/8/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	4	5	9	3	Bilateral	Apex|Base	Male	NO	YES	-22176	No	No	2009	30	Normal (no evidence of prostate cancer) [cM0]	YES	30	No Evidence of Extraprostatic Extension	NO	[Not Available]	[Not Available]	YES	5	0	R1	Alive	875	[Not Applicable]	[Not Available]	[Not Available]	WITH TUMOR	836	0.42	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	60	M0	[Not Applicable]	T2b	[Not Applicable]	0	[Not Available]	NOT HISPANIC OR LATINO	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3a	[Not Applicable]	[Not Available]	WHITE	[Not Available]	[Not Applicable]	[Not Available]	G9	Prostate	LIVING	40.14	DiseaseFree	40.14
e0ff90e5-e6c3-4fb5-9512-6f09a891378b	TCGA-G9-6369	3/7/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	4	3	7	[Not Available]	Bilateral	Base	Male	NO	YES	-20238	No	No	2009	35	Normal (no evidence of prostate cancer) [cM0]	YES	23	No Evidence of Extraprostatic Extension	NO	[Not Available]	[Not Available]	YES	21	0	R0	Alive	851	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	851	0.03	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	55	M0	[Not Applicable]	T1c	[Not Applicable]	0	[Not Available]	NOT HISPANIC OR LATINO	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T2c	[Not Applicable]	[Not Available]	WHITE	[Not Available]	[Not Applicable]	[Not Available]	G9	Prostate	LIVING	39.91	DiseaseFree	39.91
f947b0bc-bdac-44e8-b5b9-ffae4147740a	TCGA-G9-6370	3/7/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	3	4	7	[Not Available]	Bilateral	Apex|Base	Male	NO	YES	-19149	No	No	2009	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	YES	1	0	R0	Alive	806	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	806	0.03	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	52	M0	[Not Applicable]	T1c	[Not Applicable]	0	[Not Available]	NOT HISPANIC OR LATINO	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3b	[Not Applicable]	[Not Available]	WHITE	[Not Available]	[Not Applicable]	[Not Available]	G9	Prostate	LIVING	37.98	DiseaseFree	37.98
d5c43a14-21ab-4178-ae33-2d8b7baa256f	TCGA-G9-6371	3/6/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	3	3	6	[Not Available]	Bilateral	Apex|Base	Male	NO	YES	-21365	No	No	2009	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	R1	Alive	846	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	846	0.03	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	58	M0	[Not Applicable]	T1c	[Not Applicable]	0	[Not Available]	NOT HISPANIC OR LATINO	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	[Not Available]	T2c	[Not Applicable]	[Not Available]	WHITE	[Not Available]	[Not Applicable]	[Not Available]	G9	Prostate	LIVING	40.28	DiseaseFree	40.28
c3a509c6-35a6-4d17-a9fd-0aa8884b33a0	TCGA-G9-6373	3/6/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	4	3	7	[Not Available]	Bilateral	Apex|Base	Male	NO	YES	-24887	No	No	2009	29	Normal (no evidence of prostate cancer) [cM0]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	R0	Alive	505	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	68	M0	[Not Applicable]	T2b	[Not Applicable]	0	[Not Available]	NOT HISPANIC OR LATINO	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	[Not Available]	T3a	[Not Applicable]	[Not Available]	WHITE	[Not Available]	[Not Applicable]	[Not Available]	G9	Prostate	LIVING	26.64	DiseaseFree	26.64
007f9081-5093-4323-b4f8-cd510bf20705	TCGA-G9-6377	3/5/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	3	4	7	[Not Available]	Bilateral	Apex|Base	Male	NO	YES	-22419	No	No	2009	36	Abnormal (not related to prostate cancer)	YES	11	No Evidence of Extraprostatic Extension	NO	[Not Available]	[Not Available]	YES	6	0	R0	Alive	518	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	518	0.03	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	61	M0	[Not Applicable]	T2b	[Not Applicable]	0	[Not Available]	NOT HISPANIC OR LATINO	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T2c	[Not Applicable]	[Not Available]	WHITE	[Not Available]	[Not Applicable]	[Not Available]	G9	Prostate	LIVING	31.47	DiseaseFree	31.47
12f225d0-cbff-44eb-9183-bacc7f33b090	TCGA-G9-6378	3/5/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	3	4	7	[Not Available]	Bilateral	Apex|Base	Male	NO	YES	-19879	No	No	2009	-176	Normal (no evidence of prostate cancer) [cM0]	YES	100	No Evidence of Extraprostatic Extension	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	R1	Alive	664	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	223	0.03	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	54	M0	[Not Applicable]	T1c	[Not Applicable]	0	[Not Available]	NOT HISPANIC OR LATINO	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	[Not Available]	T2c	[Not Applicable]	[Not Available]	BLACK OR AFRICAN AMERICAN	[Not Available]	[Not Applicable]	[Not Available]	G9	Prostate	LIVING	37.94	DiseaseFree	37.94
d33074f0-5f88-4995-9439-76068a9f4836	TCGA-G9-6379	10/29/13	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	4	3	7	5	Bilateral	Apex	Male	NO	YES	-25126	No	No	2009	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	YES	6	0	R1	Alive	1393	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	1393	0.03	NO	NO	Complete Remission/Response	NO	[Not Available]	68	M0	[Not Applicable]	T1b	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3b	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	G9	Prostate	LIVING	58.41	DiseaseFree	58.41
a279d5aa-51f7-4e75-9e14-b206b97ec4bd	TCGA-G9-6384	3/2/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	3	4	7	[Not Available]	Bilateral	Apex|Base	Male	NO	YES	-19620	No	No	2010	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	YES	14	0	R0	Alive	390	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	390	0.03	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	53	M0	[Not Applicable]	T1c	[Not Applicable]	0	[Not Available]	NOT HISPANIC OR LATINO	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3a	[Not Applicable]	[Not Available]	WHITE	[Not Available]	[Not Applicable]	[Not Available]	G9	Prostate	LIVING	25.13	DiseaseFree	25.13
e82a04cf-e81e-43c6-9cd9-0e29fa0f00ae	TCGA-G9-6385	3/2/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	3	4	7	[Not Available]	Bilateral	Base	Male	NO	YES	-24399	No	No	2010	12	Normal (no evidence of prostate cancer) [cM0]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	R0	Alive	356	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	336	0.064	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	66	M0	[Not Applicable]	T1c	[Not Applicable]	0	[Not Available]	NOT HISPANIC OR LATINO	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	[Not Available]	T2c	[Not Applicable]	[Not Available]	WHITE	[Not Available]	[Not Applicable]	[Not Available]	G9	Prostate	LIVING	27.27	DiseaseFree	27.27
0c459149-0dfe-4206-b50b-db79180ebb57	TCGA-G9-6494	4/6/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	4	3	7	[Not Available]	Bilateral	Base	Male	NO	YES	-24381	No	No	2008	-13	Normal (no evidence of prostate cancer) [cM0]	YES	-13	No Evidence of Extraprostatic Extension	NO	[Not Available]	[Not Available]	YES	2	0	R1	Alive	1442	[Not Applicable]	[Not Available]	[Not Available]	WITH TUMOR	1423	1.13	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	66	M0	[Not Applicable]	T1c	[Not Applicable]	0	[Not Available]	NOT HISPANIC OR LATINO	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T4	[Not Applicable]	[Not Available]	WHITE	[Not Available]	[Not Applicable]	[Not Available]	G9	Prostate	LIVING	58.18	DiseaseFree	58.18
ce2b7e17-424e-4954-8a68-19d7f98d2e7e	TCGA-G9-6496	3/21/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	4	3	7	[Not Available]	Bilateral	Apex|Base	Male	NO	YES	-22602	No	No	2008	19	Normal (no evidence of prostate cancer) [cM0]	YES	20	No Evidence of Extraprostatic Extension	NO	[Not Available]	[Not Available]	YES	15	0	R0	Alive	1014	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	703	0.03	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	61	M0	[Not Applicable]	T1c	[Not Applicable]	0	[Not Available]	NOT HISPANIC OR LATINO	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T2c	[Not Applicable]	[Not Available]	WHITE	[Not Available]	[Not Applicable]	[Not Available]	G9	Prostate	LIVING	56.7	DiseaseFree	56.7
b8fbfe87-e92c-4d54-a620-17b2dcde6d53	TCGA-G9-6498	10/29/13	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	3	4	7	[Not Available]	Bilateral	Apex	Male	NO	YES	-19568	No	No	2008	47	Normal (no evidence of prostate cancer) [cM0]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	R1	Alive	1608	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	1608	0.03	NO	NO	Complete Remission/Response	YES	1342	53	M0	[Not Applicable]	T1c	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	[Not Available]	T3a	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	G9	Prostate	LIVING	64.13	Recurred/Progressed	44.09
acd5ceef-c5cf-4e95-9394-c50fdbc70c8d	TCGA-G9-6499	3/20/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	4	5	9	[Not Available]	Bilateral	Apex|Base	Male	NO	YES	-24388	No	No	2008	56	Equivocal	YES	421	No Evidence of Extraprostatic Extension	NO	[Not Available]	[Not Available]	YES	13	0	R0	Alive	1109	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	1109	0.11	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	66	M0	[Not Applicable]	T3a	[Not Applicable]	0	[Not Available]	NOT HISPANIC OR LATINO	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3a	[Not Applicable]	[Not Available]	WHITE	[Not Available]	[Not Applicable]	[Not Available]	G9	Prostate	LIVING	50.69	DiseaseFree	50.69
7d0c6960-710f-42c7-889e-c3a7d4a30b3c	TCGA-G9-7509	5/14/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	3	3	6	4	Bilateral	Apex|Middle|Base	Male	NO	YES	-17538	No	No	2009	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	R0	Alive	1164	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	352	0.03	NO	NO	Complete Remission/Response	NO	[Not Available]	48	M0	[Not Applicable]	T1c	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	[Not Available]	T2c	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	G9	Prostate	LIVING	52.89	DiseaseFree	52.89
f211f7a9-cf3b-432c-9ea0-1172cce14e9d	TCGA-G9-7510	5/31/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	4	4	8	5	Bilateral	Apex	Male	NO	YES	-24187	No	No	2010	22	Normal (no evidence of prostate cancer) [cM0]	YES	22	Extraprostatic Extension (regional lymphadenopathy)[e.g. cN1]	NO	[Not Available]	[Not Available]	YES	10	0	R1	Alive	674	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	674	0.03	NO	NO	Complete Remission/Response	NO	[Not Available]	66	M0	[Not Applicable]	T1c	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3a	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	G9	Prostate	LIVING	38.93	DiseaseFree	38.93
0f01ec33-00a8-4188-a8f0-e90d46ad9bc7	TCGA-G9-7519	5/31/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	3	4	7	[Not Available]	Bilateral	Apex|Base	Male	NO	YES	-21276	No	No	2010	7	Abnormal (not related to prostate cancer)	YES	7	No Evidence of Extraprostatic Extension	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	R0	Alive	457	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	457	0.03	NO	NO	Complete Remission/Response	NO	[Not Available]	58	M0	[Not Applicable]	T1c	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	[Not Available]	T2c	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	G9	Prostate	LIVING	27.89	DiseaseFree	27.89
cf70909e-5143-47ae-b8ca-c3ae6ace7be2	TCGA-G9-7521	5/31/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	4	4	8	5	Bilateral	Apex|Base	Male	NO	YES	-19216	No	No	2010	13	Normal (no evidence of prostate cancer) [cM0]	YES	12	No Evidence of Extraprostatic Extension	YES	45	No Evidence of Extraprostatic Extension	YES	9	1	R0	Alive	487	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	487	0.06	NO	NO	[Not Available]	NO	[Not Available]	52	M0	[Not Applicable]	T3a	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N1	T3a	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	YES	G9	Prostate	LIVING	30.95	DiseaseFree	30.95
87959988-bb25-47ee-afc1-9af92592bbe7	TCGA-G9-7522	5/31/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	3	4	7	[Not Available]	Bilateral	Apex	Male	NO	YES	-18033	No	No	2011	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	YES	9	0	R0	Alive	452	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	452	0.1	NO	NO	Complete Remission/Response	NO	[Not Available]	49	M0	[Not Applicable]	T1c	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T2c	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	G9	Prostate	LIVING	35.41	DiseaseFree	35.41
93e78f4c-e74b-4675-8d2c-d641fa25d8f2	TCGA-G9-7523	5/31/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	5	5	10	[Not Available]	Bilateral	Apex|Base	Male	NO	YES	-16269	No	No	2011	20	Abnormal (not related to prostate cancer)	YES	20	No Evidence of Extraprostatic Extension	NO	[Not Available]	[Not Available]	YES	10	0	R1	Alive	324	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	324	0.03	NO	NO	Complete Remission/Response	NO	[Not Available]	44	M0	[Not Applicable]	T1c	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3a	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	G9	Prostate	LIVING	28.15	DiseaseFree	28.15
f4e17ba1-f14f-480e-8fe3-415909fc320a	TCGA-G9-7525	5/31/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	4	3	7	[Not Available]	Bilateral	Base	Male	NO	YES	-23481	No	No	2010	12	Normal (no evidence of prostate cancer) [cM0]	YES	12	No Evidence of Extraprostatic Extension	NO	[Not Available]	[Not Available]	YES	6	0	R0	Alive	512	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	512	0.03	NO	NO	Complete Remission/Response	NO	[Not Available]	64	M0	[Not Applicable]	T1c	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T2c	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	G9	Prostate	LIVING	32.65	DiseaseFree	32.65
084AC674-F4CF-4A4A-A6A2-687C05C272EA	TCGA-G9-A9S0	6/17/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Overlapping / Multiple Zones	4	4	8	5	Bilateral	Apex|Middle|Base	Male	NO	YES	-19530	No	No	2011	73	Normal (no evidence of prostate cancer) [cM0]	YES	73	No Evidence of Extraprostatic Extension	NO	[Not Available]	[Not Available]	YES	13	5	R1	Dead	[Not Available]	791	Prostate Cancer	Medical Record	WITH TUMOR	759	10.87	YES	YES	Progressive Disease	YES	429	53	M0	[Not Applicable]	T2a	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Transurethral resection (TURBT)	[Not Applicable]	N1	T3b	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	YES	G9	Prostate	DECEASED	25.99	Recurred/Progressed	21.35
A8573F49-9FED-4C85-9E1D-40ABAB7F86EC	TCGA-G9-A9S4	6/18/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Overlapping / Multiple Zones	4	4	8	5	Bilateral	Apex|Middle|Base	Male	NO	YES	-22684	No	No	2012	14	Normal (no evidence of prostate cancer) [cM0]	YES	14	Extraprostatic Extension  Localized (e.g. seminal vesicles)	NO	[Not Available]	[Not Available]	YES	10	4	R1	Alive	757	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	753	0.03	NO	NO	Complete Remission/Response	NO	[Not Available]	62	M0	[Not Applicable]	T2a	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N1	T3b	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	YES	G9	Prostate	LIVING	29.76	DiseaseFree	29.76
27953774-E97B-48E7-B966-1EC1E9C830B4	TCGA-G9-A9S7	7/14/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Overlapping / Multiple Zones	4	4	8	[Not Available]	Bilateral	Apex|Middle	Male	NO	YES	-20213	No	No	2012	32	Abnormal (not related to prostate cancer)	YES	32	No Evidence of Extraprostatic Extension	NO	[Not Available]	[Not Available]	YES	8	0	R0	Alive	643	[Not Applicable]	[Not Available]	[Not Available]	WITH TUMOR	643	0.13	NO	YES	Partial Remission/Response	NO	[Not Available]	55	M0	[Not Applicable]	T2a	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3a	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	G9	Prostate	LIVING	23.92	DiseaseFree	23.92
ecade538-f882-4f29-a363-7acb89fd0576	TCGA-H9-7775	2/8/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	3	4	7	0	Right	[Not Available]	Male	YES	NO	-24898	No	No	2011	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	[Not Available]	Alive	44	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	73	0.04	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	68	[Not Available]	[Not Applicable]	[Not Available]	[Not Applicable]	0	[Not Available]	NOT HISPANIC OR LATINO	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	[Not Available]	T2c	[Not Applicable]	[Not Available]	WHITE	[Not Available]	[Not Applicable]	[Not Available]	H9	Prostate	LIVING	6.08	DiseaseFree	6.08
3BA3D23D-67E2-4F38-9951-F5CFA1131F9F	TCGA-H9-A6BX	11/26/13	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	3	3	6	[Not Available]	Bilateral	[Not Available]	Male	YES	NO	-22039	No	No	2012	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	R0	Alive	570	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	570	0.04	NO	NO	Complete Remission/Response	NO	[Not Available]	60	[Not Available]	[Not Applicable]	[Not Available]	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	[Not Available]	[Not Applicable]	[Not Available]	T2c	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	H9	Prostate	LIVING	30.91	DiseaseFree	30.91
701991DA-6DEB-41DF-B9CC-E5049A886B5B	TCGA-H9-A6BY	12/2/13	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Overlapping / Multiple Zones	3	4	7	[Not Available]	Bilateral	[Not Available]	Male	YES	NO	-23297	No	No	2012	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	YES	19	0	RX	Alive	112	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	NO	[Not Available]	63	[Not Available]	[Not Applicable]	T1c	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3a	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	H9	Prostate	LIVING	3.68	DiseaseFree	3.68
5dd69c3e-9a3d-450c-9f10-10b4d6daeeba	TCGA-HC-7075	3/29/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	3	3	6	[Not Available]	Right	[Not Available]	Male	NO	YES	[Not Available]	No	No	2010	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	R0	Alive	63	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	96	0.01	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	63	M0	[Not Applicable]	T1c	[Not Applicable]	0	[Not Available]	NOT HISPANIC OR LATINO	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	[Not Available]	T2a	[Not Applicable]	[Not Available]	WHITE	[Not Available]	[Not Applicable]	[Not Available]	HC	Prostate	LIVING	19.74	DiseaseFree	19.74
92252560-5984-41f6-a4b5-a3aa8654c0c8	TCGA-HC-7077	4/9/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	3	3	6	[Not Available]	Bilateral	[Not Available]	Male	NO	YES	-23636	No	No	2006	-14	Normal (no evidence of prostate cancer) [cM0]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	R0	Alive	77	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	1749	0.83	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	64	M0	[Not Applicable]	T1c	[Not Applicable]	0	[Not Available]	NOT HISPANIC OR LATINO	[Not Applicable]	C61	8550/3	C61.9	YES	Transurethral resection (TURBT)	[Not Applicable]	[Not Available]	T3a	[Not Applicable]	[Not Available]	BLACK OR AFRICAN AMERICAN	[Not Available]	[Not Applicable]	[Not Available]	HC	Prostate	LIVING	69.48	DiseaseFree	69.48
9f802576-1e98-496c-bda4-4b1dd2e411c8	TCGA-HC-7078	4/10/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	3	4	7	[Not Available]	Bilateral	[Not Available]	Male	NO	YES	-25402	No	No	2007	[Not Available]	Normal (no evidence of prostate cancer) [cM0]	NO	[Not Available]	No Evidence of Extraprostatic Extension	NO	[Not Available]	[Not Available]	YES	3	0	R0	Alive	162	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	1409	0.01	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	69	M0	[Not Applicable]	T1c	[Not Applicable]	0	[Not Available]	NOT HISPANIC OR LATINO	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3a	[Not Applicable]	[Not Available]	WHITE	[Not Available]	[Not Applicable]	[Not Available]	HC	Prostate	LIVING	65.21	DiseaseFree	65.21
10fbe481-f111-4f88-ae45-4d67cb265567	TCGA-HC-7079	4/10/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	3	4	7	[Not Available]	Bilateral	Apex|Middle|Base	Male	NO	YES	-18734	No	No	2010	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	YES	4	0	R0	Alive	126	[Not Applicable]	[Not Available]	[Not Available]	WITH TUMOR	126	0.1	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	51	M0	[Not Applicable]	T3a	[Not Applicable]	0	[Not Available]	NOT HISPANIC OR LATINO	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3a	[Not Applicable]	[Not Available]	WHITE	[Not Available]	[Not Applicable]	[Not Available]	HC	Prostate	LIVING	38.9	Recurred/Progressed	12.48
fd50ff41-ec9d-4db1-a673-36ba0ca1eac8	TCGA-HC-7080	4/9/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	3	4	7	[Not Available]	Right	Apex|Middle	Male	NO	YES	-24243	No	No	2010	19	Normal (no evidence of prostate cancer) [cM0]	YES	19	No Evidence of Extraprostatic Extension	NO	[Not Available]	[Not Available]	YES	2	0	R0	Alive	104	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	104	0.1	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	66	M0	[Not Applicable]	T2a	[Not Applicable]	0	[Not Available]	NOT HISPANIC OR LATINO	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T2a	[Not Applicable]	[Not Available]	WHITE	[Not Available]	[Not Applicable]	[Not Available]	HC	Prostate	LIVING	36.33	Recurred/Progressed	29.37
3da2e90e-6450-4286-8c74-08dbecbfd788	TCGA-HC-7081	4/11/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	4	5	9	[Not Available]	Bilateral	[Not Available]	Male	YES	NO	[Not Available]	No	No	2010	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	R2	Alive	72	[Not Applicable]	[Not Available]	[Not Available]	WITH TUMOR	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	62	[Not Available]	[Not Applicable]	[Not Available]	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	[Not Available]	T3b	[Not Applicable]	[Not Available]	WHITE	[Not Available]	[Not Applicable]	[Not Available]	HC	Prostate	LIVING	37.32	DiseaseFree	37.32
582d1177-73b0-4a9c-8505-70d6b402bd01	TCGA-HC-7209	4/10/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	3	3	6	[Not Available]	Bilateral	Apex|Middle|Base	Male	YES	NO	-22129	No	No	2011	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	YES	2	0	R0	Alive	41	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	108	0.05	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	60	[Not Available]	[Not Applicable]	T2b	[Not Applicable]	0	[Not Available]	NOT HISPANIC OR LATINO	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T2c	[Not Applicable]	[Not Available]	WHITE	[Not Available]	[Not Applicable]	[Not Available]	HC	Prostate	LIVING	14.45	DiseaseFree	14.45
6a5af80e-07ad-4cd3-aaab-5db1090835d9	TCGA-HC-7210	4/10/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	3	4	7	[Not Available]	Right	[Not Available]	Male	YES	NO	-27343	No	No	2011	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	YES	7	0	R0	Alive	149	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	149	0.1	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	74	[Not Available]	[Not Applicable]	[Not Available]	[Not Applicable]	0	[Not Available]	NOT HISPANIC OR LATINO	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T2a	[Not Applicable]	[Not Available]	WHITE	[Not Available]	[Not Applicable]	[Not Available]	HC	Prostate	LIVING	28.52	DiseaseFree	28.52
ec3870c9-4930-4af7-b2eb-1e16c9ec9f14	TCGA-HC-7211	4/11/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	3	4	7	[Not Available]	Bilateral	Apex|Middle|Base	Male	NO	YES	-22768	No	No	2010	14	Normal (no evidence of prostate cancer) [cM0]	YES	14	No Evidence of Extraprostatic Extension	NO	[Not Available]	[Not Available]	YES	10	0	R0	Alive	24	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	-17	10.9	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	62	M0	[Not Applicable]	T2a	[Not Applicable]	0	[Not Available]	NOT HISPANIC OR LATINO	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T2c	[Not Applicable]	[Not Available]	WHITE	[Not Available]	[Not Applicable]	[Not Available]	HC	Prostate	LIVING	40.11	DiseaseFree	40.11
907b64d6-a26a-4092-a247-ac9af444d1c7	TCGA-HC-7212	4/11/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	3	4	7	[Not Available]	Right	[Not Available]	Male	YES	NO	-20576	No	No	2011	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	YES	4	0	[Not Available]	Alive	41	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	424	0.28	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	56	M0	[Not Applicable]	[Not Available]	[Not Applicable]	0	[Not Available]	NOT HISPANIC OR LATINO	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T2a	[Not Applicable]	[Not Available]	WHITE	[Not Available]	[Not Applicable]	[Not Available]	HC	Prostate	LIVING	28.58	DiseaseFree	28.58
26eefaa1-1666-4ce1-8cf4-f6fabff81fd2	TCGA-HC-7213	4/10/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	4	5	9	[Not Available]	Bilateral	Apex|Middle|Base	Male	YES	NO	-19699	No	No	2010	[Not Available]	[Not Available]	YES	22	No Evidence of Extraprostatic Extension	YES	34	Extraprostatic Extension Localized (e.g. seminal vesicles)	YES	4	0	R0	Alive	60	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	170	4.09	YES	[Not Available]	[Not Available]	[Not Available]	170	53	M0	[Not Applicable]	T3b	[Not Applicable]	0	[Not Available]	NOT HISPANIC OR LATINO	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3b	[Not Applicable]	[Not Available]	WHITE	[Not Available]	[Not Applicable]	[Not Available]	HC	Prostate	LIVING	40.05	Recurred/Progressed	5.58
03c66cf8-bc68-4ee1-a322-689a29b72262	TCGA-HC-7230	10/6/11	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	3	4	7	[Not Available]	[Not Available]	[Not Available]	Male	YES	NO	-18577	No	No	2011	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	YES	3	0	R0	Alive	51	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	[Not Available]	3	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	50	[Not Available]	[Not Applicable]	[Not Available]	[Not Applicable]	0	[Not Available]	NOT HISPANIC OR LATINO	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T2c	[Not Applicable]	[Not Available]	WHITE	[Not Available]	[Not Applicable]	[Not Available]	HC	Prostate	LIVING	32.88	DiseaseFree	32.88
b182bda9-3d9f-4958-96eb-bd6cc441830c	TCGA-HC-7231	10/6/11	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	3	4	7	[Not Available]	Bilateral	[Not Available]	Male	YES	NO	-24278	No	No	2011	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	R0	Alive	72	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	66	M0	[Not Applicable]	T1c	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	[Not Available]	T2c	[Not Applicable]	[Not Available]	WHITE	[Not Available]	[Not Applicable]	[Not Available]	HC	Prostate	LIVING	30.85	DiseaseFree	30.85
ce3585d3-7388-4d05-84c8-64e0883003b3	TCGA-HC-7232	4/11/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	4	5	9	[Not Available]	Bilateral	[Not Available]	Male	YES	NO	-24324	No	No	2011	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	R0	Alive	89	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	66	[Not Available]	[Not Applicable]	[Not Available]	[Not Applicable]	0	[Not Available]	NOT HISPANIC OR LATINO	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	[Not Available]	T3b	[Not Applicable]	[Not Available]	WHITE	[Not Available]	[Not Applicable]	[Not Available]	HC	Prostate	LIVING	38.14	Recurred/Progressed	25.16
e2b33861-2247-413f-b2e5-9be3b604666c	TCGA-HC-7233	4/11/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	4	3	7	[Not Available]	Left	Apex	Male	NO	YES	[Not Available]	Yes	No	2010	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	YES	2	0	R1	Alive	52	[Not Applicable]	[Not Available]	[Not Available]	WITH TUMOR	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	73	[Not Available]	[Not Applicable]	[Not Available]	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T2a	[Not Applicable]	[Not Available]	WHITE	[Not Available]	[Not Applicable]	[Not Available]	HC	Prostate	LIVING	44.51	DiseaseFree	44.51
922e5166-85f5-4365-9c09-f8bdc1722da6	TCGA-HC-7736	4/11/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	3	4	7	[Not Available]	Bilateral	Middle|Base	Male	NO	YES	-21703	No	No	2010	[Not Available]	[Not Available]	YES	-21	No Evidence of Extraprostatic Extension	[Not Available]	[Not Available]	[Not Available]	YES	13	0	R0	Alive	22	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	102	0.02	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	59	M0	[Not Applicable]	T2b	[Not Applicable]	0	[Not Available]	NOT HISPANIC OR LATINO	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T2c	[Not Applicable]	[Not Available]	WHITE	[Not Available]	[Not Applicable]	[Not Available]	HC	Prostate	LIVING	36.24	DiseaseFree	36.24
73f875cb-bcfc-43ba-ab97-4e94caf836d4	TCGA-HC-7737	4/11/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	3	4	7	[Not Available]	Bilateral	[Not Available]	Male	NO	YES	-20122	No	No	2010	9	Normal (no evidence of prostate cancer) [cM0]	YES	9	No Evidence of Extraprostatic Extension	NO	[Not Available]	[Not Available]	YES	8	1	R0	Alive	64	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	147	0.1	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	55	M0	[Not Applicable]	T1c	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N1	T2c	[Not Applicable]	[Not Available]	BLACK OR AFRICAN AMERICAN	[Not Available]	[Not Applicable]	[Not Available]	HC	Prostate	LIVING	35.81	DiseaseFree	35.81
698ce9a9-6512-4fb8-a574-a26ee259414c	TCGA-HC-7738	3/29/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	3	4	7	[Not Available]	Bilateral	Apex	Male	YES	NO	-21195	No	No	2011	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	R0	Alive	81	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	58	M0	[Not Applicable]	[Not Available]	[Not Applicable]	0	[Not Available]	NOT HISPANIC OR LATINO	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	[Not Available]	T2c	[Not Applicable]	[Not Available]	WHITE	[Not Available]	[Not Applicable]	[Not Available]	HC	Prostate	LIVING	31.67	Recurred/Progressed	13.8
91e249a6-b0b0-487e-9fad-0e9f5798dcae	TCGA-HC-7740	4/11/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	3	4	7	[Not Available]	Bilateral	Apex|Middle|Base	Male	YES	NO	-21883	No	No	2011	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	YES	4	0	R0	Alive	53	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	154	0	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	59	M0	[Not Applicable]	T2a	[Not Applicable]	0	[Not Available]	NOT HISPANIC OR LATINO	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T2c	[Not Applicable]	[Not Available]	WHITE	[Not Available]	[Not Applicable]	[Not Available]	HC	Prostate	LIVING	23.55	DiseaseFree	23.55
231a45e7-ad33-4789-a9fc-74ce7a18fcc3	TCGA-HC-7741	6/20/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	3	4	7	[Not Available]	Bilateral	Apex|Middle|Base	Male	NO	YES	-24608	No	No	2006	9	Normal (no evidence of prostate cancer) [cM0]	YES	9	[Not Available]	[Not Available]	[Not Available]	[Not Available]	YES	2	0	R0	Alive	1752	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	146	0.1	NO	NO	Complete Remission/Response	NO	[Not Available]	67	M0	[Not Applicable]	[Not Available]	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3b	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	HC	Prostate	LIVING	89.52	DiseaseFree	89.52
0730216b-c201-443c-9092-81e23fd13c6c	TCGA-HC-7742	4/11/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	3	4	7	[Not Available]	[Not Available]	[Not Available]	Male	YES	NO	-21323	No	No	2011	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	YES	2	0	R0	Alive	113	[Not Applicable]	[Not Available]	[Not Available]	WITH TUMOR	113	0.1	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	58	M0	[Not Applicable]	[Not Available]	[Not Applicable]	0	[Not Available]	NOT HISPANIC OR LATINO	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3a	[Not Applicable]	[Not Available]	WHITE	[Not Available]	[Not Applicable]	[Not Available]	HC	Prostate	LIVING	30.81	DiseaseFree	30.81
f6381367-142c-45d0-92b3-c1727d1813ce	TCGA-HC-7744	4/11/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	4	3	7	[Not Available]	Bilateral	Apex|Middle|Base	Male	YES	NO	-17065	No	No	2011	10	Normal (no evidence of prostate cancer) [cM0]	YES	40	[Not Available]	YES	42	Extraprostatic Extension Localized (e.g. seminal vesicles)	YES	8	0	R1	Alive	51	[Not Applicable]	[Not Available]	[Not Available]	WITH TUMOR	282	0.04	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	46	M0	[Not Applicable]	[Not Available]	[Not Applicable]	0	[Not Available]	NOT HISPANIC OR LATINO	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3b	[Not Applicable]	[Not Available]	WHITE	[Not Available]	[Not Applicable]	[Not Available]	HC	Prostate	LIVING	17.44	DiseaseFree	17.44
6641a298-1dbd-445d-a4ab-95ceb98e1427	TCGA-HC-7745	4/11/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	4	3	7	[Not Available]	Bilateral	Middle	Male	YES	NO	-24078	No	No	2011	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	YES	3	0	R0	Alive	63	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	65	[Not Available]	[Not Applicable]	[Not Available]	[Not Applicable]	0	[Not Available]	NOT HISPANIC OR LATINO	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3b	[Not Applicable]	[Not Available]	WHITE	[Not Available]	[Not Applicable]	[Not Available]	HC	Prostate	LIVING	23.69	DiseaseFree	23.69
f25bae1a-8627-46a8-87af-07f82773c68a	TCGA-HC-7747	4/12/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	3	4	7	[Not Available]	Bilateral	Apex|Middle|Base	Male	YES	NO	-19188	No	No	2011	25	Normal (no evidence of prostate cancer) [cM0]	YES	25	No Evidence of Extraprostatic Extension	NO	[Not Available]	[Not Available]	YES	4	0	[Not Available]	Alive	57	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	392	0.19	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	52	M0	[Not Applicable]	T2b	[Not Applicable]	0	[Not Available]	NOT HISPANIC OR LATINO	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T2c	[Not Applicable]	[Not Available]	WHITE	[Not Available]	[Not Applicable]	[Not Available]	HC	Prostate	LIVING	24.57	DiseaseFree	24.57
f6040682-4999-4d71-abc2-354b473c6980	TCGA-HC-7748	4/12/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	3	3	6	[Not Available]	Right	[Not Available]	Male	YES	NO	-22072	Yes	No	2011	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	YES	10	0	R0	Alive	62	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	99	0.1	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	60	[Not Available]	[Not Applicable]	[Not Available]	[Not Applicable]	0	[Not Available]	NOT HISPANIC OR LATINO	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T2a	[Not Applicable]	[Not Available]	WHITE	[Not Available]	[Not Applicable]	[Not Available]	HC	Prostate	LIVING	26.02	DiseaseFree	26.02
13a63fd0-6c8c-4707-9135-8052f454d1ac	TCGA-HC-7749	4/20/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	4	3	7	5	Right	Middle|Base	Male	YES	NO	-25688	No	No	2011	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	YES	10	0	R0	Alive	60	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	102	0.1	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	70	M0	[Not Applicable]	[Not Available]	[Not Applicable]	0	[Not Available]	NOT HISPANIC OR LATINO	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3a	[Not Applicable]	[Not Available]	WHITE	[Not Available]	[Not Applicable]	[Not Available]	HC	Prostate	LIVING	23.78	DiseaseFree	23.78
2d350c73-2a0b-4a3c-8d30-c6fcf6c3ffba	TCGA-HC-7750	4/20/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	3	4	7	[Not Available]	Left	Apex|Middle|Base	Male	YES	NO	-18580	No	No	2011	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	R0	Alive	34	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	83	0.1	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	50	M0	[Not Applicable]	T2b	[Not Applicable]	0	[Not Available]	NOT HISPANIC OR LATINO	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	[Not Available]	T2c	[Not Applicable]	[Not Available]	WHITE	[Not Available]	[Not Applicable]	[Not Available]	HC	Prostate	LIVING	17.15	DiseaseFree	17.15
9b84601b-ee05-4c15-afe3-7bfa7ca5ffac	TCGA-HC-7752	4/20/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	3	4	7	[Not Available]	Bilateral	Base	Male	YES	NO	-22366	No	No	2011	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	YES	6	0	R0	Alive	98	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	138	0.1	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	61	M0	[Not Applicable]	[Not Available]	[Not Applicable]	0	[Not Available]	NOT HISPANIC OR LATINO	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T2c	[Not Applicable]	[Not Available]	WHITE	[Not Available]	[Not Applicable]	[Not Available]	HC	Prostate	LIVING	25.69	DiseaseFree	25.69
f3aa40b9-7b4d-465a-b7c9-591aebdb56c2	TCGA-HC-7817	6/20/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	4	3	7	[Not Available]	Bilateral	Apex|Middle|Base	Male	YES	NO	-19207	No	No	2011	[Not Available]	Normal (no evidence of prostate cancer) [cM0]	YES	[Not Available]	No Evidence of Extraprostatic Extension	YES	[Not Available]	No Evidence of Extraprostatic Extension	NO	[Not Available]	[Not Available]	[Not Available]	Alive	32	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	171	0.1	NO	[Not Available]	[Not Available]	NO	[Not Available]	52	M0	[Not Applicable]	[Not Available]	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	[Not Available]	T3b	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	HC	Prostate	LIVING	30.49	DiseaseFree	30.49
ebe711e4-45af-4082-bdf6-b0f7ac899b3e	TCGA-HC-7818	4/20/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	3	4	7	[Not Available]	Bilateral	Apex|Middle|Base	Male	YES	NO	-24391	No	No	2011	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	YES	6	0	R0	Alive	45	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	99	0.01	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	66	M0	[Not Applicable]	T2b	[Not Applicable]	0	[Not Available]	NOT HISPANIC OR LATINO	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T2c	[Not Applicable]	[Not Available]	WHITE	[Not Available]	[Not Applicable]	[Not Available]	HC	Prostate	LIVING	30.81	DiseaseFree	30.81
d1fd7be0-6daa-4f1f-a198-3dca7a797e49	TCGA-HC-7819	4/20/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Central Zone	4	4	8	4	Bilateral	[Not Available]	Male	YES	NO	-19663	No	No	2011	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	YES	-73	No Evidence of Extraprostatic Extension	YES	3	0	R2	Alive	1	[Not Applicable]	[Not Available]	[Not Available]	WITH TUMOR	172	0.01	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	53	M0	[Not Applicable]	T2c	[Not Applicable]	0	[Not Available]	NOT HISPANIC OR LATINO	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T2c	[Not Applicable]	[Not Available]	WHITE	[Not Available]	[Not Applicable]	[Not Available]	HC	Prostate	LIVING	17.84	DiseaseFree	17.84
a3cd3599-7c18-491d-be09-6fc7e526c9b1	TCGA-HC-7820	4/20/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	3	4	7	[Not Available]	Bilateral	[Not Available]	Male	YES	NO	-26576	No	No	2011	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	R0	Alive	102	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	72	[Not Available]	[Not Applicable]	[Not Available]	[Not Applicable]	0	[Not Available]	NOT HISPANIC OR LATINO	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	[Not Available]	T2c	[Not Applicable]	[Not Available]	WHITE	[Not Available]	[Not Applicable]	[Not Available]	HC	Prostate	LIVING	24.54	DiseaseFree	24.54
929837f9-297a-47c0-ac9a-a142eef620d3	TCGA-HC-7821	4/20/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	4	4	8	[Not Available]	Bilateral	Apex|Middle|Base	Male	YES	NO	-19894	Yes	No	2011	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	YES	7	2	[Not Available]	Alive	56	[Not Applicable]	[Not Available]	[Not Available]	WITH TUMOR	236	0.01	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	54	M0	[Not Applicable]	[Not Available]	[Not Applicable]	0	[Not Available]	NOT HISPANIC OR LATINO	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N1	T3b	[Not Applicable]	[Not Available]	WHITE	[Not Available]	[Not Applicable]	[Not Available]	HC	Prostate	LIVING	31.41	DiseaseFree	31.41
57284c88-b9aa-4455-a07f-7009e1732cfb	TCGA-HC-8212	6/17/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	3	4	7	[Not Available]	Bilateral	[Not Available]	Male	NO	YES	-19539	No	No	2007	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	YES	3	0	R0	Alive	1017	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	640	3.27	[Not Available]	NO	Complete Remission/Response	NO	[Not Available]	53	[Not Available]	[Not Applicable]	[Not Available]	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3a	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	HC	Prostate	LIVING	71.58	DiseaseFree	71.58
53c43d14-2310-41e9-ac43-3cc298404338	TCGA-HC-8213	7/8/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	3	3	6	[Not Available]	Bilateral	[Not Available]	Male	YES	NO	-17673	No	No	2011	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	R0	Alive	1	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	NO	[Not Available]	48	[Not Available]	[Not Applicable]	[Not Available]	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8550/3	C61.9	YES	[Not Available]	[Not Applicable]	[Not Available]	T2c	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	HC	Prostate	LIVING	19.35	DiseaseFree	19.35
89afdebe-456e-4128-8902-1001876a2106	TCGA-HC-8216	6/17/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	4	3	7	5	Right	Middle|Base	Male	YES	NO	-21428	No	No	2011	10	Normal (no evidence of prostate cancer) [cM0]	YES	10	No Evidence of Extraprostatic Extension	NO	[Not Available]	[Not Available]	YES	3	0	R0	Alive	42	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	137	0.19	[Not Available]	[Not Available]	[Not Available]	NO	[Not Available]	58	M0	[Not Applicable]	T2a	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3a	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	HC	Prostate	LIVING	22.4	DiseaseFree	22.4
89a297be-ebb5-4b9f-8eda-0e548d14ad91	TCGA-HC-8256	6/13/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	3	4	7	[Not Available]	Bilateral	[Not Available]	Male	YES	NO	-19598	No	No	2011	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	R0	Alive	95	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	[Not Available]	[Not Available]	[Not Available]	NO	Complete Remission/Response	NO	[Not Available]	53	M0	[Not Applicable]	[Not Available]	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	[Not Available]	T2c	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	HC	Prostate	LIVING	28.25	DiseaseFree	28.25
270447ca-19ee-45a2-982e-032325dab05f	TCGA-HC-8257	10/1/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	3	4	7	[Not Available]	Bilateral	[Not Available]	Male	YES	NO	-25629	No	No	2011	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	YES	8	1	R1	Alive	29	[Not Applicable]	[Not Available]	[Not Available]	WITH TUMOR	726	0.1	NO	NO	Complete Remission/Response	NO	[Not Available]	70	[Not Available]	[Not Applicable]	[Not Available]	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8550/3	C61.9	YES	[Not Available]	[Not Applicable]	N1	T3b	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	YES	HC	Prostate	LIVING	23.85	DiseaseFree	23.85
da5b0169-e4f4-4674-b348-220af03ff4b5	TCGA-HC-8258	6/20/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	3	3	6	[Not Available]	Bilateral	[Not Available]	Male	YES	NO	-20703	No	No	2011	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	YES	2	0	[Not Available]	Alive	66	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	162	0.01	NO	[Not Available]	[Not Available]	NO	[Not Available]	56	[Not Available]	[Not Applicable]	[Not Available]	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T2c	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	HC	Prostate	LIVING	27.83	DiseaseFree	27.83
07ccb4e9-a2a9-4bfd-97bd-13873b01977a	TCGA-HC-8259	6/20/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	3	3	6	[Not Available]	Left	[Not Available]	Male	YES	NO	-18309	No	No	2011	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	R0	Alive	123	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	123	0.01	NO	NO	Complete Remission/Response	NO	[Not Available]	50	M0	[Not Applicable]	T1c	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	[Not Available]	T2a	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	HC	Prostate	LIVING	30.35	DiseaseFree	30.35
3971a2f0-7263-4cda-aa01-9a2ebb2c2ff2	TCGA-HC-8260	6/20/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Peripheral Zone	3	4	7	[Not Available]	Bilateral	Apex	Male	YES	NO	-15884	No	No	2011	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	YES	9	0	R1	Alive	106	[Not Applicable]	[Not Available]	[Not Available]	WITH TUMOR	106	0.01	NO	[Not Available]	[Not Available]	NO	[Not Available]	43	M0	[Not Applicable]	[Not Available]	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T2c	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	HC	Prostate	LIVING	22.54	DiseaseFree	22.54
f16ce517-d51d-499a-a4c4-a6844fefa52c	TCGA-HC-8261	6/13/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	3	4	7	[Not Available]	Bilateral	[Not Available]	Male	YES	NO	-17874	No	No	2011	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	R0	Alive	62	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	[Not Available]	[Not Available]	[Not Available]	NO	Complete Remission/Response	NO	[Not Available]	48	[Not Available]	[Not Applicable]	[Not Available]	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	[Not Available]	T2c	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	HC	Prostate	LIVING	17.94	DiseaseFree	17.94
fb7e9935-32a2-422b-8004-88b827a686c2	TCGA-HC-8262	6/20/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	4	4	8	[Not Available]	Bilateral	[Not Available]	Male	YES	NO	-20946	No	No	2011	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	YES	8	0	R0	Alive	76	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	112	0.1	NO	[Not Available]	[Not Available]	NO	[Not Available]	57	[Not Available]	[Not Applicable]	[Not Available]	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T2c	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	HC	Prostate	LIVING	22.31	DiseaseFree	22.31
8740555d-8bf0-40ba-b868-99eef27662a4	TCGA-HC-8264	1/25/13	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	4	5	9	[Not Available]	Bilateral	[Not Available]	Male	YES	NO	-22177	No	No	2011	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	YES	2	1	R1	Alive	48	[Not Applicable]	[Not Available]	[Not Available]	WITH TUMOR	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	[Not Available]	60	[Not Available]	[Not Applicable]	[Not Available]	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N1	T3b	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	HC	Prostate	LIVING	1.58	DiseaseFree	1.58
3e290dc6-aba3-4135-b844-3e8c4cc8a25f	TCGA-HC-8265	6/20/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	3	5	8	[Not Available]	Bilateral	[Not Available]	Male	YES	NO	-24382	No	No	2011	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	YES	8	0	R1	Alive	70	[Not Applicable]	[Not Available]	[Not Available]	WITH TUMOR	119	0.1	NO	[Not Available]	[Not Available]	NO	[Not Available]	66	[Not Available]	[Not Applicable]	[Not Available]	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3a	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	HC	Prostate	LIVING	15.87	DiseaseFree	15.87
fb447e0f-7cf0-49bf-8b15-aae932f8094d	TCGA-HC-8266	10/1/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	4	4	8	[Not Available]	Bilateral	[Not Available]	Male	YES	NO	-20280	No	No	2012	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	YES	5	0	R1	Alive	35	[Not Applicable]	[Not Available]	[Not Available]	WITH TUMOR	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	[Not Available]	55	M0	[Not Applicable]	[Not Available]	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8550/3	C61.9	YES	[Not Available]	[Not Applicable]	N0	T3b	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	HC	Prostate	LIVING	15.54	DiseaseFree	15.54
FF49E0F9-4007-4761-845E-B676B0FC9646	TCGA-HC-A48F	2/21/13	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Overlapping / Multiple Zones	4	4	8	[Not Available]	Bilateral	[Not Available]	Male	YES	NO	-17434	No	No	2012	29	Normal (no evidence of prostate cancer) [cM0]	YES	30	No Evidence of Extraprostatic Extension	NO	[Not Available]	[Not Available]	YES	10	1	R1	Alive	46	[Not Applicable]	[Not Available]	[Not Available]	WITH TUMOR	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	NO	[Not Available]	47	M0	[Not Applicable]	T1c	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N1	T2c	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	HC	Prostate	LIVING	22.34	DiseaseFree	22.34
BB8E6886-EDC7-4127-A85B-C4F3769B6681	TCGA-HC-A4ZV	3/15/13	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Overlapping / Multiple Zones	5	4	9	[Not Available]	Bilateral	[Not Available]	Male	YES	NO	-20634	No	No	2012	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	YES	13	0	R1	Alive	23	[Not Applicable]	[Not Available]	[Not Available]	WITH TUMOR	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	NO	[Not Available]	56	[Not Available]	[Not Applicable]	T2c	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3b	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	HC	Prostate	LIVING	0.76	DiseaseFree	0.76
DB4793DC-CD45-4B81-93CE-8322031C2AA3	TCGA-HC-A631	4/22/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	4	5	9	3	Bilateral	[Not Available]	Male	YES	NO	-24749	No	No	2012	25	Normal (no evidence of prostate cancer) [cM0]	YES	21	No Evidence of Extraprostatic Extension	[Not Available]	[Not Available]	[Not Available]	YES	2	0	R1	Alive	54	[Not Applicable]	[Not Available]	[Not Available]	WITH TUMOR	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	[Not Available]	67	M0	[Not Applicable]	T2	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T2c	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	HC	Prostate	LIVING	1.77	DiseaseFree	1.77
E457EB5D-120E-41F4-8455-2ED8D534FF02	TCGA-HC-A632	10/15/13	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	4	5	9	[Not Available]	Bilateral	[Not Available]	Male	YES	NO	-24916	No	No	2013	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	YES	5	0	R0	Alive	61	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	NO	[Not Available]	68	M0	[Not Applicable]	T1c	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3a	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	HC	Prostate	LIVING	2	DiseaseFree	2
E6CBF99D-4A10-4C11-9AC2-EB26EF57331F	TCGA-HC-A6AL	9/19/13	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	3	4	7	[Not Available]	Bilateral	[Not Available]	Male	YES	NO	-23618	No	No	2012	[Not Available]	[Not Available]	YES	21	No Evidence of Extraprostatic Extension	NO	[Not Available]	[Not Available]	YES	3	0	R0	Alive	67	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	NO	[Not Available]	64	M0	[Not Applicable]	T1c	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T2c	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	HC	Prostate	LIVING	2.2	DiseaseFree	2.2
3FAE5B76-9E22-4EAB-A7FC-13139B2B97C4	TCGA-HC-A6AN	4/22/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	4	3	7	[Not Available]	Bilateral	[Not Available]	Male	YES	NO	-24697	No	No	2012	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	YES	1	0	R1	Alive	49	[Not Applicable]	[Not Available]	[Not Available]	WITH TUMOR	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	[Not Available]	67	M0	[Not Applicable]	T1c	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3a	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	HC	Prostate	LIVING	1.61	DiseaseFree	1.61
4045F40B-D42A-4598-9EE2-0D371A776D3F	TCGA-HC-A6AO	9/19/13	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	4	3	7	[Not Available]	Bilateral	[Not Available]	Male	YES	NO	-19298	No	No	2012	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	YES	[Not Available]	Extraprostatic Extension Localized (e.g. seminal vesicles)	NO	[Not Available]	[Not Available]	R0	Alive	167	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	NO	[Not Available]	52	M0	[Not Applicable]	T1c	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	[Not Available]	T2c	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	HC	Prostate	LIVING	17.41	DiseaseFree	17.41
EAD15A1B-726A-46AA-9005-A22F4B89D011	TCGA-HC-A6AP	9/19/13	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Overlapping / Multiple Zones	3	4	7	[Not Available]	Bilateral	[Not Available]	Male	YES	NO	-22318	No	No	2012	[Not Available]	[Not Available]	YES	15	No Evidence of Extraprostatic Extension	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	RX	Alive	71	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	NO	[Not Available]	61	M0	[Not Applicable]	T1c	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	[Not Available]	T2c	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	HC	Prostate	LIVING	2.33	DiseaseFree	2.33
3FA83688-1724-42CB-A600-472E4C500E89	TCGA-HC-A6AQ	9/19/13	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	3	4	7	[Not Available]	Bilateral	[Not Available]	Male	YES	NO	-22208	Yes, History of Prior Malignancy	No	2012	15	Normal (no evidence of prostate cancer) [cM0]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	R0	Alive	106	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	NO	[Not Available]	60	M0	[Not Applicable]	T1c	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	[Not Available]	T2c	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	HC	Prostate	LIVING	3.48	DiseaseFree	3.48
6B3F53AB-00F4-4C45-9BB5-5C8ADBC66084	TCGA-HC-A6AS	9/19/13	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	3	4	7	[Not Available]	Right	[Not Available]	Male	YES	NO	-25661	No	No	2012	27	Normal (no evidence of prostate cancer) [cM0]	YES	27	No Evidence of Extraprostatic Extension	NO	[Not Available]	[Not Available]	YES	5	0	R0	Alive	44	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	NO	[Not Available]	70	M0	[Not Applicable]	T1c	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T2a	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	HC	Prostate	LIVING	1.45	DiseaseFree	1.45
F3E93819-A8F5-4D15-A416-3EDD42AA52D1	TCGA-HC-A6HX	9/19/13	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	4	3	7	5	Bilateral	[Not Available]	Male	YES	NO	-20263	No	No	2013	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	YES	4	0	R0	Alive	38	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	NO	[Not Available]	55	M0	[Not Applicable]	T1c	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T2c	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	HC	Prostate	LIVING	1.25	DiseaseFree	1.25
3D6ABC44-D094-4250-8DFC-347AE9C741F2	TCGA-HC-A6HY	9/19/13	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	3	4	7	[Not Available]	Bilateral	[Not Available]	Male	YES	NO	-18779	No	No	2012	[Not Available]	[Not Available]	YES	92	No Evidence of Extraprostatic Extension	[Not Available]	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	R0	Alive	134	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	NO	[Not Available]	51	M0	[Not Applicable]	T1c	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	[Not Available]	T2c	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	HC	Prostate	LIVING	4.4	DiseaseFree	4.4
5F69CA7D-F8E0-4F5B-9987-1E5C234EB759	TCGA-HC-A76W	3/28/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	3	4	7	[Not Available]	Bilateral	Apex|Middle|Base	Male	YES	NO	-26755	Yes, History of Synchronous/Bilateral Malignancy	No	2012	62	Normal (no evidence of prostate cancer) [cM0]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	YES	4	0	R1	Alive	213	[Not Applicable]	[Not Available]	[Not Available]	WITH TUMOR	213	0.01	NO	[Not Available]	[Not Available]	NO	[Not Available]	73	M0	[Not Applicable]	T2	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3b	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	HC	Prostate	LIVING	7	DiseaseFree	7
105E12BF-4F39-4D7A-870F-FBC329EE210A	TCGA-HC-A76X	3/28/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	3	4	7	[Not Available]	Bilateral	Apex|Middle|Base	Male	YES	NO	-22756	No	No	2013	10	Normal (no evidence of prostate cancer) [cM0]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	YES	1	0	R0	Alive	150	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	150	0.01	NO	[Not Available]	[Not Available]	NO	[Not Available]	62	M0	[Not Applicable]	T1c	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T2c	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	HC	Prostate	LIVING	4.93	DiseaseFree	4.93
B6F54BDC-9B1B-4465-A6E3-F0524885E10E	TCGA-HC-A8CY	3/28/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Overlapping / Multiple Zones	5	4	9	[Not Available]	Bilateral	[Not Available]	Male	YES	NO	-23154	No	No	2013	41	Abnormal (not related to prostate cancer)	YES	41	No Evidence of Extraprostatic Extension	NO	[Not Available]	[Not Available]	YES	3	1	R1	Alive	290	[Not Applicable]	[Not Available]	[Not Available]	WITH TUMOR	290	0.9	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	63	M0	[Not Applicable]	T1c	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N1	T3a	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	HC	Prostate	LIVING	9.53	DiseaseFree	9.53
0AFA0E02-DAAE-47E6-9CCB-9DE8E4FEB73C	TCGA-HC-A8D0	3/28/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Overlapping / Multiple Zones	3	4	7	[Not Available]	Left	Apex|Middle	Male	YES	NO	-22465	No	No	2012	11	Normal (no evidence of prostate cancer) [cM0]	YES	11	No Evidence of Extraprostatic Extension	YES	14	No Evidence of Extraprostatic Extension	YES	10	0	R0	Alive	110	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	110	0.01	NO	[Not Available]	[Not Available]	NO	[Not Available]	61	M0	[Not Applicable]	T1c	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T2a	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	HC	Prostate	LIVING	25.46	DiseaseFree	25.46
341940FC-DD2A-485C-A359-D5E5EDB22312	TCGA-HC-A8D1	3/28/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	3	4	7	[Not Available]	Bilateral	[Not Available]	Male	YES	NO	-25137	No	No	2012	14	Normal (no evidence of prostate cancer) [cM0]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	YES	6	0	R0	Alive	168	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	168	0.01	NO	[Not Available]	[Not Available]	NO	[Not Available]	68	M0	[Not Applicable]	T2	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T2c	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	HC	Prostate	LIVING	18.82	DiseaseFree	18.82
C51CCFF8-2502-40E1-B130-FE655C119169	TCGA-HC-A9TE	6/10/15	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Overlapping / Multiple Zones	5	4	9	3	Bilateral	Apex|Middle|Base	Male	YES	NO	-23543	No	No	2013	13	Normal (no evidence of prostate cancer) [cM0]	YES	16	No Evidence of Extraprostatic Extension	NO	[Not Available]	[Not Available]	YES	7	1	R1	Alive	134	[Not Applicable]	[Not Available]	[Not Available]	WITH TUMOR	134	0.064	NO	NO	Partial Remission/Response	NO	[Not Available]	64	M0	[Not Applicable]	T2c	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Transurethral resection (TURBT)	[Not Applicable]	N0	T3b	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	HC	Prostate	LIVING	19.28	Recurred/Progressed	7.1
433D1441-6D5B-4455-A731-65F172BB016D	TCGA-HC-A9TH	6/10/15	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	5	4	9	5	Bilateral	Apex|Middle|Base	Male	YES	NO	-21460	No	No	2013	155	Normal (no evidence of prostate cancer) [cM0]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	YES	2	0	R1	Alive	295	[Not Applicable]	[Not Available]	[Not Available]	WITH TUMOR	295	0.38	NO	[Not Available]	Partial Remission/Response	NO	[Not Available]	58	M0	[Not Applicable]	T1b	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Transurethral resection (TURBT)	[Not Applicable]	N0	T3b	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	HC	Prostate	LIVING	27.73	Recurred/Progressed	11.53
25d70934-01a5-45a2-9960-68d3058b6965	TCGA-HI-7168	2/20/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	4	5	9	[Not Available]	Bilateral	[Not Available]	Male	NO	YES	-22881	No	No	2005	19	Normal (no evidence of prostate cancer) [cM0]	NO	[Not Available]	[Not Available]	YES	19	No Evidence of Extraprostatic Extension	YES	9	0	R0	Alive	2315	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	2289	0.3	YES	[Not Available]	[Not Available]	[Not Available]	308	62	M0	[Not Applicable]	T1c	[Not Applicable]	0	[Not Available]	NOT HISPANIC OR LATINO	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3b	[Not Applicable]	[Not Available]	WHITE	[Not Available]	[Not Applicable]	[Not Available]	HI	Prostate	LIVING	109.17	Recurred/Progressed	82.29
11fb5853-8eeb-4ad8-825d-3eaaf3fa08d6	TCGA-HI-7169	2/21/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	3	4	7	[Not Available]	Bilateral	Apex	Male	NO	YES	-20133	No	No	2006	33	Normal (no evidence of prostate cancer) [cM0]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	YES	4	0	R1	Alive	1949	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	1941	0.1	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	55	M0	[Not Applicable]	T2b	[Not Applicable]	0	[Not Available]	NOT HISPANIC OR LATINO	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3a	[Not Applicable]	[Not Available]	WHITE	[Not Available]	[Not Applicable]	[Not Available]	HI	Prostate	LIVING	88.17	DiseaseFree	88.17
6394e00a-1f6f-4ea2-b885-373bbb59def9	TCGA-HI-7170	2/21/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	3	3	6	[Not Available]	Bilateral	Apex	Male	NO	YES	-21199	No	No	2006	-96	Normal (no evidence of prostate cancer) [cM0]	YES	-92	No Evidence of Extraprostatic Extension	YES	-78	No Evidence of Extraprostatic Extension	YES	6	0	R0	Alive	1780	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	1746	0.1	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	58	M0	[Not Applicable]	T1c	[Not Applicable]	0	[Not Available]	NOT HISPANIC OR LATINO	[Not Applicable]	C61	8550/3	C61.9	YES	Transurethral resection (TURBT)	[Not Applicable]	N0	T2c	[Not Applicable]	[Not Available]	WHITE	[Not Available]	[Not Applicable]	[Not Available]	HI	Prostate	LIVING	82.85	DiseaseFree	82.85
931feb14-3f69-41c1-8435-5fd4fb775bdf	TCGA-HI-7171	2/22/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	5	4	9	[Not Available]	Bilateral	Apex|Middle|Base	Male	NO	YES	-20776	No	No	2008	[Not Available]	Normal (no evidence of prostate cancer) [cM0]	NO	[Not Available]	[Not Available]	YES	[Not Available]	No Evidence of Extraprostatic Extension	YES	7	0	R1	Dead	[Not Available]	1329	[Not Available]	[Not Available]	WITH TUMOR	631	0.7	YES	[Not Available]	[Not Available]	[Not Available]	218	56	M0	[Not Applicable]	T3a	[Not Applicable]	0	[Not Available]	NOT HISPANIC OR LATINO	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3b	[Not Applicable]	[Not Available]	WHITE	[Not Available]	[Not Applicable]	[Not Available]	HI	Prostate	DECEASED	43.66	[Not Available]	[Not Available]
a1e64294-1264-498d-b18b-c9b4c729c2f2	TCGA-J4-8198	6/6/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	4	3	7	5	Bilateral	Apex|Middle|Base	Male	YES	NO	-17935	No	No	2011	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	[Not Available]	Alive	98	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	76	0.1	NO	NO	[Not Available]	NO	[Not Available]	49	M0	[Not Applicable]	T1c	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	[Not Available]	T3b	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	J4	Prostate	LIVING	20.17	DiseaseFree	20.17
897a2af4-55af-4245-8629-1a71b622c17e	TCGA-J4-8200	6/6/12	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Overlapping / Multiple Zones	3	4	7	[Not Available]	Bilateral	[Not Available]	Male	YES	NO	-17167	No	No	2011	41	Normal (no evidence of prostate cancer) [cM0]	YES	41	No Evidence of Extraprostatic Extension	NO	[Not Available]	[Not Available]	YES	4	0	R0	Alive	196	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	196	0.1	NO	NO	[Not Available]	NO	[Not Available]	47	M0	[Not Applicable]	T2	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T2c	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	J4	Prostate	LIVING	40.01	DiseaseFree	40.01
C4C1B5BE-A0E7-4968-92DE-7F34C71207FB	TCGA-J4-A67K	8/16/13	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Peripheral Zone	4	3	7	[Not Available]	Bilateral	[Not Available]	Male	YES	NO	-24908	No	No	2011	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	R0	Alive	662	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	557	0.1	NO	NO	Complete Remission/Response	NO	[Not Available]	68	M0	[Not Applicable]	T2b	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	[Not Available]	T2c	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	J4	Prostate	LIVING	32.98	DiseaseFree	32.98
29BD2C05-254B-4BB2-AE32-5B328F772441	TCGA-J4-A67L	8/16/13	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Peripheral Zone	3	4	7	[Not Available]	Left	Apex|Middle|Base	Male	YES	NO	-20034	No	No	2011	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	YES	1	0	R0	Alive	518	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	518	0.01	NO	NO	Complete Remission/Response	NO	[Not Available]	54	M0	[Not Applicable]	T2a	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3a	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	J4	Prostate	LIVING	25.3	DiseaseFree	25.3
67CD72E2-A4CF-48E4-943E-406C252F056A	TCGA-J4-A67M	8/16/13	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Peripheral Zone	4	3	7	[Not Available]	Bilateral	Apex|Middle|Base	Male	YES	NO	-20211	No	No	2011	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	YES	6	0	R0	Alive	488	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	482	0.1	NO	NO	Complete Remission/Response	NO	[Not Available]	55	M0	[Not Applicable]	T2a	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3a	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	J4	Prostate	LIVING	30.91	DiseaseFree	30.91
00F7F9D3-7A34-4A5B-9D19-38810DCABBBA	TCGA-J4-A67N	8/16/13	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Peripheral Zone	3	4	7	[Not Available]	Bilateral	Apex|Middle|Base	Male	YES	NO	-22420	No	No	2011	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	YES	8	0	R0	Alive	503	[Not Applicable]	[Not Available]	[Not Available]	WITH TUMOR	503	0.7	YES	NO	Partial Remission/Response	YES	442	61	M0	[Not Applicable]	T2a	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3a	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	J4	Prostate	LIVING	30.78	Recurred/Progressed	14.52
3FC9E3B4-8BC5-4BF8-BFF6-DD90346B83A1	TCGA-J4-A67O	8/16/13	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Peripheral Zone	3	4	7	[Not Available]	Bilateral	Apex	Male	YES	NO	-21714	No	No	2012	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	YES	2	0	R0	Alive	491	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	490	0.1	NO	NO	Complete Remission/Response	NO	[Not Available]	59	M0	[Not Applicable]	T2a	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T2c	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	J4	Prostate	LIVING	27.56	DiseaseFree	27.56
1CBAA137-C3B0-46A2-9B23-208682C2A438	TCGA-J4-A67Q	8/16/13	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Peripheral Zone	3	3	6	[Not Available]	Bilateral	Apex|Middle	Male	YES	NO	-28447	No	No	2011	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	[Not Available]	Alive	624	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	616	0.1	NO	NO	Complete Remission/Response	NO	[Not Available]	77	M0	[Not Applicable]	T2b	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	[Not Available]	T2c	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	J4	Prostate	LIVING	32.03	DiseaseFree	32.03
DB2779F6-8FE2-48C3-988B-81DB1815A678	TCGA-J4-A67R	8/16/13	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Peripheral Zone	4	3	7	[Not Available]	Bilateral	Middle|Base	Male	YES	NO	-23807	No	No	2012	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	YES	4	0	R0	Alive	454	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	454	0.1	NO	NO	Complete Remission/Response	NO	[Not Available]	65	M0	[Not Applicable]	T1c	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T2c	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	J4	Prostate	LIVING	29.89	DiseaseFree	29.89
9FE9CBAE-37B9-4030-A204-4502760F5DAB	TCGA-J4-A67S	8/16/13	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Peripheral Zone	3	4	7	[Not Available]	Bilateral	Apex|Middle|Base	Male	YES	NO	-23332	No	No	2012	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	YES	3	0	R1	Alive	523	[Not Applicable]	[Not Available]	[Not Available]	WITH TUMOR	522	0.1	NO	NO	[Not Available]	NO	[Not Available]	63	M0	[Not Applicable]	T2b	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3a	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	J4	Prostate	LIVING	27.37	Recurred/Progressed	23.26
432F15BA-7401-4827-83A5-3EAAFAAA4BEA	TCGA-J4-A67T	8/16/13	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Peripheral Zone	3	4	7	[Not Available]	Bilateral	Apex|Middle	Male	YES	NO	-23211	No	No	2012	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	R0	Alive	183	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	154	0.1	NO	NO	Complete Remission/Response	NO	[Not Available]	63	M0	[Not Applicable]	T1c	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	[Not Available]	T2c	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	J4	Prostate	LIVING	6.01	DiseaseFree	6.01
F9F136A5-3CCB-42B3-BA60-C667FBB0846D	TCGA-J4-A6G1	9/12/13	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Peripheral Zone	4	4	8	3	Bilateral	[Not Available]	Male	YES	NO	-24945	No	No	2012	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	YES	34	Extraprostatic Extension Localized (e.g. seminal vesicles)	YES	2	0	R0	Alive	405	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	178	0.1	NO	YES	[Not Available]	NO	[Not Available]	68	M0	[Not Applicable]	T2b	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3a	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	J4	Prostate	LIVING	25.26	DiseaseFree	25.26
9B015929-99EB-4E74-8FBF-6B2E6D7F08E4	TCGA-J4-A6G3	9/12/13	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Peripheral Zone	4	4	8	[Not Available]	Bilateral	[Not Available]	Male	YES	NO	-20836	No	No	2012	17	Normal (no evidence of prostate cancer) [cM0]	NO	[Not Available]	[Not Available]	YES	15	Extraprostatic Extension Localized (e.g. seminal vesicles)|Extraprostatic Extension (regional lymphadenopathy) [e.g. cN1]	YES	5	0	R1	Alive	528	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	528	0.4	NO	YES	[Not Available]	NO	[Not Available]	57	M0	[Not Applicable]	T2	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3b	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	J4	Prostate	LIVING	27.89	Recurred/Progressed	20.3
F00B4A22-C327-4FBB-A9A3-4418C13E2A48	TCGA-J4-A6M7	9/23/13	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Peripheral Zone	3	4	7	[Not Available]	Bilateral	Apex|Middle	Male	YES	NO	-19640	No	No	2012	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	R0	Alive	279	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	279	0.1	NO	NO	Complete Remission/Response	NO	[Not Available]	53	M0	[Not Applicable]	T2	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	[Not Available]	T2c	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	J4	Prostate	LIVING	16.82	DiseaseFree	16.82
5DC7E186-7E01-4A54-8AE8-350DACE2297B	TCGA-J4-A83I	1/20/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Peripheral Zone	4	3	7	[Not Available]	Bilateral	Apex|Middle|Base	Male	YES	NO	-23240	No	No	2013	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	YES	2	0	R0	Alive	279	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	257	0.1	NO	NO	Complete Remission/Response	NO	[Not Available]	63	M0	[Not Applicable]	T1c	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3a	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	J4	Prostate	LIVING	22.5	DiseaseFree	22.5
98240F19-BCA7-4001-8AA2-4D790C7C4C53	TCGA-J4-A83J	1/20/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Peripheral Zone	3	4	7	[Not Available]	Bilateral	Apex|Middle|Base	Male	YES	NO	-24960	No	No	2013	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	YES	1	0	R1	Alive	310	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	235	0.04	NO	NO	Complete Remission/Response	NO	[Not Available]	68	M0	[Not Applicable]	T1c	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T2c	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	J4	Prostate	LIVING	22.86	DiseaseFree	22.86
256F5BCF-10A9-47BE-B265-CFA707D24097	TCGA-J4-A83K	1/20/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Peripheral Zone	3	3	6	[Not Available]	Bilateral	Apex|Middle|Base	Male	YES	NO	-19299	No	No	2013	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	R0	Alive	206	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	205	0.1	NO	NO	Complete Remission/Response	NO	[Not Available]	52	M0	[Not Applicable]	T1c	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	[Not Available]	T2c	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	J4	Prostate	LIVING	10.78	DiseaseFree	10.78
8CC7679D-B963-4B45-B3F8-DCF80EA6CC71	TCGA-J4-A83L	1/20/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Central Zone	3	4	7	[Not Available]	Bilateral	Apex|Middle|Base	Male	YES	NO	-22338	No	No	2013	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	YES	5	0	R0	Alive	316	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	316	0.1	NO	NO	Complete Remission/Response	NO	[Not Available]	61	M0	[Not Applicable]	T1c	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T2c	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	J4	Prostate	LIVING	23.65	DiseaseFree	23.65
D6974DB6-2BD3-4082-B48E-9C60F7FE3A1F	TCGA-J4-A83M	1/20/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Peripheral Zone	4	3	7	[Not Available]	Bilateral	Apex|Middle	Male	YES	NO	-23624	No	No	2012	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	YES	4	0	R1	Alive	437	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	437	0.2	NO	NO	Complete Remission/Response	NO	[Not Available]	64	M0	[Not Applicable]	T2c	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T2c	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	J4	Prostate	LIVING	17.84	Recurred/Progressed	17.12
C024C4B6-0143-4071-9175-7435F1EAAC58	TCGA-J4-A83N	1/20/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Overlapping / Multiple Zones	3	4	7	[Not Available]	Bilateral	Apex|Middle|Base	Male	YES	NO	-20841	No	No	2012	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	R0	Alive	617	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	530	0.1	NO	NO	Complete Remission/Response	YES	[Not Available]	57	M0	[Not Applicable]	T1c	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	[Not Available]	T2c	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	J4	Prostate	LIVING	32.59	Recurred/Progressed	14.22
FADD80E3-8087-4494-A8F0-1CAA92ACBB67	TCGA-J4-AATV	8/13/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	3	3	6	[Not Available]	Bilateral	[Not Available]	Male	YES	NO	-25943	No	No	2013	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	YES	4	[Not Available]	R1	Alive	358	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	358	0	NO	NO	[Discrepancy]	NO	[Not Available]	71	M0	[Not Applicable]	[Not Available]	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T2c	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	J4	Prostate	LIVING	18.17	DiseaseFree	18.17
73B7D4BC-6B56-4AE8-BE7F-074745563BEE	TCGA-J4-AATZ	8/14/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Peripheral Zone	4	5	9	[Not Available]	Bilateral	Apex	Male	YES	NO	-24226	No	No	2013	33	Normal (no evidence of prostate cancer) [cM0]	[Not Available]	23	No Evidence of Extraprostatic Extension	YES	23	No Evidence of Extraprostatic Extension	YES	4	0	R1	Alive	412	[Not Applicable]	[Not Available]	[Not Available]	WITH TUMOR	386	0	NO	YES	Complete Remission/Response	YES	79	66	M0	[Not Applicable]	[Not Available]	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3a	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	YES	J4	Prostate	LIVING	13.53	Recurred/Progressed	2.6
F0F637B5-DE40-4853-B54B-08468D45B195	TCGA-J4-AAU2	8/14/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	3	3	6	[Not Available]	Bilateral	[Not Available]	Male	YES	NO	-21656	No	No	2012	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	YES	1	0	R0	Alive	304	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	224	0	NO	NO	Complete Remission/Response	NO	[Not Available]	59	M0	[Not Applicable]	[Not Available]	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T2c	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	J4	Prostate	LIVING	27.1	DiseaseFree	27.1
2ECCAABE-0783-4596-B674-D59846373A1D	TCGA-J9-A52B	3/14/13	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Overlapping / Multiple Zones	5	4	9	[Not Available]	Bilateral	Apex|Middle|Base	Male	NO	YES	-22849	No	No	2012	11	Normal (no evidence of prostate cancer) [cM0]	YES	11	No Evidence of Extraprostatic Extension	NO	[Not Available]	[Not Available]	YES	7	0	R1	Alive	422	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	414	0.01	NO	NO	Complete Remission/Response	YES	85	62	[Not Available]	[Not Applicable]	T3b	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3b	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	J9	Prostate	LIVING	13.86	Recurred/Progressed	1.87
1940166E-AEDC-4DC5-90A5-609871F9F7DA	TCGA-J9-A52C	3/14/13	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Overlapping / Multiple Zones	4	5	9	3	Bilateral	Apex|Middle|Base	Male	YES	NO	-20966	No	No	2012	38	Normal (no evidence of prostate cancer) [cM0]	YES	62	No Evidence of Extraprostatic Extension	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	R0	Alive	178	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	178	0.03	NO	NO	[Not Applicable]	NO	[Not Available]	57	[Not Available]	[Not Applicable]	T1c	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	[Not Available]	T3b	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	J9	Prostate	LIVING	5.85	DiseaseFree	5.85
C03AE0F2-DDE3-47E8-A046-CE85C86DD77D	TCGA-J9-A52D	4/9/14	Prostate Adenocarcinoma, Other Subtype	Prostate Adenocarcinoma, Not Otherwised Specified, with ductal featues	Transition Zone	4	5	9	3	Bilateral	Apex|Middle	Male	NO	YES	-26023	No	No	2012	-6	Normal (no evidence of prostate cancer) [cM0]	YES	21	No Evidence of Extraprostatic Extension	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	R0	Alive	212	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	146	0.059	NO	NO	[Not Available]	NO	[Not Available]	71	M0	[Not Applicable]	T2b	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8500/3	C61.9	YES	Core needle biopsy	[Not Applicable]	[Not Available]	T3a	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	J9	Prostate	LIVING	6.96	DiseaseFree	6.96
30ABA886-5152-4E25-B36F-6CE7009D419E	TCGA-J9-A52E	3/15/13	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Overlapping / Multiple Zones	4	5	9	3	Bilateral	Apex|Middle|Base	Male	NO	YES	-23741	No	No	2012	15	Normal (no evidence of prostate cancer) [cM0]	YES	12	No Evidence of Extraprostatic Extension	NO	[Not Available]	[Not Available]	YES	8	0	R1	Alive	323	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	393	0.01	NO	NO	Partial Remission/Response	YES	89	65	[Not Available]	[Not Applicable]	T2c	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8550/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3b	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	J9	Prostate	LIVING	10.61	DiseaseFree	10.61
EB80244A-5F20-49A8-8F73-E92C14395895	TCGA-J9-A8CK	2/6/15	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Overlapping / Multiple Zones	4	5	9	3	Bilateral	Apex|Middle|Base	Male	YES	NO	-24285	No	No	2012	8	Normal (no evidence of prostate cancer) [cM0]	YES	8	No Evidence of Extraprostatic Extension	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	R1	Alive	321	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	321	0.01	NO	NO	[Not Applicable]	NO	[Not Available]	66	M0	[Not Applicable]	T3a	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	[Not Available]	T3a	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	J9	Prostate	LIVING	10.55	DiseaseFree	10.55
1122FA92-0073-4F59-9880-3F1A34620758	TCGA-J9-A8CL	1/27/15	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Overlapping / Multiple Zones	4	5	9	3	Bilateral	Apex|Middle|Base	Male	YES	NO	-24145	No	No	2013	6	Equivocal	YES	11	No Evidence of Extraprostatic Extension	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	R1	Alive	405	[Not Applicable]	[Not Available]	[Not Available]	WITH TUMOR	405	12.01	YES	[Not Available]	[Not Available]	YES	132	66	M0	[Not Applicable]	T3a	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	[Not Available]	T3b	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	J9	Prostate	LIVING	13.3	Recurred/Progressed	4.34
DECEB7DF-6EDC-41F0-99AA-C4AC7E764074	TCGA-J9-A8CM	2/1/15	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Peripheral Zone	5	4	9	3	Bilateral	Apex|Middle|Base	Male	YES	NO	-24118	No	No	2013	14	Normal (no evidence of prostate cancer) [cM0]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	YES	14	1	R1	Alive	463	[Not Applicable]	[Not Available]	[Not Available]	WITH TUMOR	463	0.55	YES	NO	Partial Remission/Response	YES	344	66	M0	[Not Applicable]	T2c	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N1	T3b	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	J9	Prostate	LIVING	15.21	Recurred/Progressed	11.3
186D7F36-4E93-4AB2-BC23-95D5CD296656	TCGA-J9-A8CN	2/1/15	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Transition Zone	3	3	6	4	Bilateral	Apex|Middle	Male	YES	NO	-19662	Yes, History of Prior Malignancy	No	2011	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	R1	Alive	1237	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	963	0.03	NO	NO	Complete Remission/Response	NO	[Not Available]	53	M0	[Not Applicable]	T1c	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	[Not Available]	T3a	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	J9	Prostate	LIVING	40.64	DiseaseFree	40.64
5B12458B-F5D7-41DE-A4E1-26D39DCA9B17	TCGA-J9-A8CP	2/1/15	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Overlapping / Multiple Zones	4	3	7	[Not Available]	Bilateral	Apex|Middle	Male	YES	NO	-24299	No	No	2013	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	R0	Alive	386	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	298	0.01	NO	NO	Complete Remission/Response	NO	[Not Available]	66	M0	[Not Applicable]	T2a	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	[Not Available]	T3a	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	J9	Prostate	LIVING	12.68	DiseaseFree	12.68
5089A8D2-A353-4150-8A6B-6478C5BB29BB	TCGA-KC-A4BL	1/23/15	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Peripheral Zone	3	4	7	5	Bilateral	Middle|Base	Male	NO	YES	-24081	No	Yes, Pharmaceutical Treatment Prior to Resection	2006	38	Abnormal (not related to prostate cancer)	YES	38	No Evidence of Extraprostatic Extension	YES	66	No Evidence of Extraprostatic Extension	YES	4	0	R0	Alive	934	[Not Applicable]	[Not Available]	[Not Available]	WITH TUMOR	206	3.15	YES	[Not Available]	Partial Remission/Response	YES	193	65	M0	[Not Applicable]	T1c	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T2c	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	KC	Prostate	LIVING	30.68	Recurred/Progressed	6.34
5A468990-D76D-4C67-8437-62689B593AE2	TCGA-KC-A4BN	7/22/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	3	4	7	[Not Available]	Right	Middle	Male	NO	YES	-20392	No	No	2009	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	YES	44	No Evidence of Extraprostatic Extension	YES	6	0	R0	Alive	1815	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	529	0	NO	NO	Complete Remission/Response	[Not Available]	[Not Available]	55	M0	[Not Applicable]	T1c	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T2a	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	KC	Prostate	LIVING	59.63	DiseaseFree	59.63
9A05AA6D-6215-4584-90FC-09A0371A19ED	TCGA-KC-A4BO	1/23/15	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Peripheral Zone	3	4	7	5	Bilateral	Apex|Middle	Male	NO	YES	-20368	No	No	2010	21	Abnormal (not related to prostate cancer)	YES	21	No Evidence of Extraprostatic Extension	YES	98	No Evidence of Extraprostatic Extension	YES	13	0	R0	Alive	607	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	478	0.04	NO	NO	Complete Remission/Response	NO	[Not Available]	55	M0	[Not Applicable]	T1c	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T2c	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	KC	Prostate	LIVING	19.94	DiseaseFree	19.94
3E71FA1C-855C-475A-9DD0-A314A3ECD48D	TCGA-KC-A4BR	1/23/15	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Peripheral Zone	4	5	9	[Not Available]	Bilateral	Apex|Middle|Base	Male	NO	YES	-27741	No	No	2009	15	Abnormal (not related to prostate cancer)	YES	-8	No Evidence of Extraprostatic Extension	YES	90	No Evidence of Extraprostatic Extension	YES	11	1	R0	Alive	1349	[Not Applicable]	[Not Available]	[Not Available]	WITH TUMOR	1258	0	NO	NO	Complete Remission/Response	YES	1022	75	M0	[Not Applicable]	T2	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N1	T3b	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	KC	Prostate	LIVING	44.32	Recurred/Progressed	33.57
A8C954B7-3077-4FF1-B311-D4B4BFA49786	TCGA-KC-A4BV	7/22/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Overlapping / Multiple Zones	4	5	9	3	Bilateral	Apex|Middle|Base	Male	NO	YES	-24138	No	No	2010	16	Normal (no evidence of prostate cancer) [cM0]	YES	18	No Evidence of Extraprostatic Extension	YES	81	Extraprostatic Extension Localized (e.g. seminal vesicles)	YES	10	0	R0	Alive	1328	[Not Applicable]	[Not Available]	[Not Available]	WITH TUMOR	1328	0.53	YES	NO	Complete Remission/Response	YES	1328	66	M0	[Not Applicable]	T2	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3a	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	KC	Prostate	LIVING	43.63	Recurred/Progressed	43.63
827CAF2C-A94B-4EEE-86B3-1155A16DAF4A	TCGA-KC-A7F3	1/23/15	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Peripheral Zone	3	4	7	[Not Available]	Bilateral	Apex	Male	NO	YES	-24676	No	No	2013	32	Normal (no evidence of prostate cancer) [cM0]	YES	32	No Evidence of Extraprostatic Extension	YES	43	No Evidence of Extraprostatic Extension	YES	19	0	R0	Alive	665	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	664	0	NO	NO	Complete Remission/Response	NO	[Not Available]	67	M0	[Not Applicable]	T1c	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T2c	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	KC	Prostate	LIVING	21.85	DiseaseFree	21.85
3A6E0FD1-6E06-4002-9D1A-88EDF7944567	TCGA-KC-A7F5	1/25/15	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Peripheral Zone	4	3	7	5	Right	Apex|Middle|Base	Male	NO	YES	-20015	No	No	2013	5	Normal (no evidence of prostate cancer) [cM0]	YES	5	No Evidence of Extraprostatic Extension	YES	-56	Extraprostatic Extension Localized (e.g. seminal vesicles)	YES	16	0	R0	Alive	91	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	91	0	NO	NO	Complete Remission/Response	NO	[Not Available]	54	M0	[Not Applicable]	T2c	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T2c	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	KC	Prostate	LIVING	2.99	DiseaseFree	2.99
FC823AB7-9390-4C57-9883-3E32EE17E794	TCGA-KC-A7F6	1/25/15	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Peripheral Zone	3	4	7	[Not Available]	Bilateral	Apex|Middle	Male	NO	YES	-23367	No	No	2013	44	Abnormal (not related to prostate cancer)	YES	44	No Evidence of Extraprostatic Extension	YES	-121	No Evidence of Extraprostatic Extension	YES	23	0	R0	Alive	263	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	193	0	NO	NO	Complete Remission/Response	NO	[Not Available]	63	M0	[Not Applicable]	T1c	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T2c	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	KC	Prostate	LIVING	8.64	DiseaseFree	8.64
3F3128C9-1072-443C-B6AE-8B63166FA9A4	TCGA-KC-A7FA	1/25/15	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Peripheral Zone	3	4	7	[Not Available]	Bilateral	Apex|Middle|Base	Male	NO	YES	-23208	Yes, History of Prior Malignancy	No	2013	70	Abnormal (not related to prostate cancer)	YES	62	No Evidence of Extraprostatic Extension	YES	40	No Evidence of Extraprostatic Extension	YES	24	0	R0	Alive	598	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	161	0	NO	NO	Complete Remission/Response	NO	[Not Available]	63	M0	[Not Applicable]	T2c	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3a	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	KC	Prostate	LIVING	19.65	DiseaseFree	19.65
88658B66-F293-4AFF-9E33-05ABFAFD3B43	TCGA-KC-A7FD	1/25/15	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Peripheral Zone	3	4	7	[Not Available]	Bilateral	Apex|Middle|Base	Male	NO	YES	-22745	No	No	2013	[Not Available]	[Not Available]	YES	29	No Evidence of Extraprostatic Extension	YES	45	No Evidence of Extraprostatic Extension	YES	16	0	R0	Alive	270	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	144	0	NO	NO	Complete Remission/Response	NO	[Not Available]	62	M0	[Not Applicable]	T1c	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3a	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	KC	Prostate	LIVING	8.87	DiseaseFree	8.87
7C40C747-5000-4F66-AAB5-C53FB96337CB	TCGA-KC-A7FE	1/25/15	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Peripheral Zone	3	4	7	[Not Available]	Bilateral	Apex|Middle	Male	NO	YES	-22718	No	No	2013	76	Abnormal (not related to prostate cancer)	YES	76	No Evidence of Extraprostatic Extension	YES	53	No Evidence of Extraprostatic Extension	YES	2	0	R1	Alive	352	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	185	0	NO	NO	Complete Remission/Response	NO	[Not Available]	62	M0	[Not Applicable]	T1c	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T2c	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	KC	Prostate	LIVING	11.56	DiseaseFree	11.56
9E48644F-D498-42B0-871B-D11F676241E2	TCGA-KK-A59V	3/27/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Peripheral Zone	4	5	9	[Not Available]	Bilateral	Apex|Middle|Base	Male	NO	YES	-23483	No	No	2005	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	YES	9	0	R0	Alive	2859	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	2500	0.1	NO	NO	[Not Applicable]	NO	[Not Available]	64	M0	[Not Applicable]	T3a	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3b	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	KK	Prostate	LIVING	113.01	DiseaseFree	113.01
629855EA-551E-456C-B421-83B9A4EB3269	TCGA-KK-A59X	5/28/13	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Peripheral Zone	5	4	9	[Not Available]	Bilateral	Apex|Middle|Base	Male	NO	YES	-20416	No	No	2008	12	Normal (no evidence of prostate cancer) [cM0]	YES	12	No Evidence of Extraprostatic Extension	NO	[Not Available]	[Not Available]	YES	14	2	R1	Alive	1712	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	[Not Available]	[Not Available]	[Not Available]	NO	[Not Available]	NO	[Not Available]	55	M0	[Not Applicable]	T3a	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N1	T3b	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	KK	Prostate	LIVING	83.28	Recurred/Progressed	73.36
4C197D76-DAF6-474D-B561-DED42905F52A	TCGA-KK-A59Y	5/28/13	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Peripheral Zone	4	5	9	[Not Available]	Bilateral	Apex|Middle|Base	Male	NO	YES	-20768	No	No	2009	13	Normal (no evidence of prostate cancer) [cM0]	YES	13	No Evidence of Extraprostatic Extension	NO	[Not Available]	[Not Available]	YES	4	2	RX	Alive	1359	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	1359	0.1	NO	NO	[Not Applicable]	NO	[Not Available]	56	M0	[Not Applicable]	T3a	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N1	T3a	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	KK	Prostate	LIVING	64.65	DiseaseFree	64.65
DF7BBD9C-0B35-4855-ACDE-46F4956F4DF1	TCGA-KK-A59Z	5/28/13	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Peripheral Zone	4	3	7	[Not Available]	Bilateral	Apex|Middle|Base	Male	NO	YES	-24306	No	No	2007	24	Normal (no evidence of prostate cancer) [cM0]	YES	20	No Evidence of Extraprostatic Extension	NO	[Not Available]	[Not Available]	YES	2	0	R0	Alive	1879	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	849	0.1	NO	NO	[Not Applicable]	NO	[Not Available]	66	M0	[Not Applicable]	T2b	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T2c	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	KK	Prostate	LIVING	86.33	DiseaseFree	86.33
436B242C-AD5F-432E-A684-27BBA4C1C8A2	TCGA-KK-A5A1	5/28/13	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Overlapping / Multiple Zones	4	5	9	[Not Available]	Bilateral	Apex|Middle|Base	Male	NO	YES	-26415	No	No	2003	57	Normal (no evidence of prostate cancer) [cM0]	YES	14	[Not Available]	NO	[Not Available]	[Not Available]	YES	3	0	R1	Dead	2364	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	420	0.1	NO	NO	Partial Remission/Response	YES	[Not Available]	72	M0	[Not Applicable]	T3a	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3b	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	KK	Prostate	DECEASED	81.11	Recurred/Progressed	6.67
B1BDAF2D-7D84-4409-9427-5390150BB96D	TCGA-KK-A6DY	3/27/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Peripheral Zone	3	4	7	[Not Available]	Bilateral	Apex|Middle|Base	Male	NO	YES	-18420	No	No	2002	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	YES	12	0	R1	Alive	3524	[Not Applicable]	[Not Available]	[Not Available]	WITH TUMOR	903	0.1	NO	NO	[Not Applicable]	NO	[Not Available]	50	M0	[Not Applicable]	T1c	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T2c	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	KK	Prostate	LIVING	141.1	DiseaseFree	141.1
D112136D-34FA-426E-B432-4D1E4286ADF8	TCGA-KK-A6E0	3/27/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Peripheral Zone	4	5	9	[Not Available]	Right	Apex|Middle|Base	Male	NO	YES	-21700	No	No	2011	11	Normal (no evidence of prostate cancer) [cM0]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	YES	9	0	R0	Alive	913	[Not Applicable]	[Not Available]	[Not Available]	WITH TUMOR	941	0.3	YES	YES	[Not Available]	YES	941	59	M0	[Not Applicable]	T2b	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3a	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	YES	KK	Prostate	LIVING	48.72	Recurred/Progressed	30.91
DEB57BD8-545F-477A-9A86-6BC6DB257270	TCGA-KK-A6E1	3/28/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Overlapping / Multiple Zones	4	5	9	[Not Available]	Bilateral	Apex|Middle|Base	Male	NO	YES	-21063	No	No	2008	-24	Normal (no evidence of prostate cancer) [cM0]	YES	-24	No Evidence of Extraprostatic Extension	NO	[Not Available]	[Not Available]	YES	24	5	RX	Alive	1659	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	356	0.1	NO	YES	Complete Remission/Response	NO	[Not Available]	57	M0	[Not Applicable]	T2c	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N1	T3b	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	YES	KK	Prostate	LIVING	72.21	DiseaseFree	72.21
56C88739-C076-42CC-A2CB-FD613AB567B5	TCGA-KK-A6E2	3/27/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Transition Zone	3	4	7	[Not Available]	Bilateral	Apex|Middle|Base	Male	NO	YES	-19974	No	No	2000	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	YES	5	0	R0	Alive	4604	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	438	0.1	NO	NO	[Not Available]	NO	[Not Available]	54	M0	[Not Applicable]	T2a	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T2c	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	KK	Prostate	LIVING	165.05	DiseaseFree	165.05
38A2B705-D8A4-45CA-8BCD-96DBF93D8E4D	TCGA-KK-A6E3	3/27/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Transition Zone	3	4	7	[Not Available]	Bilateral	Apex|Middle|Base	Male	NO	YES	-20547	No	No	2004	10	Normal (no evidence of prostate cancer) [cM0]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	YES	3	0	R0	Alive	2056	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	1065	0.1	NO	NO	[Not Available]	NO	[Not Available]	56	M0	[Not Applicable]	T1c	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T2c	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	KK	Prostate	LIVING	67.54	DiseaseFree	67.54
DCF383D5-B25A-4EA9-A3F4-4D7EA5DDD9EF	TCGA-KK-A6E4	3/27/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Peripheral Zone	3	4	7	[Not Available]	Right	Apex|Middle|Base	Male	NO	YES	-25338	No	No	2004	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	YES	4	0	R0	Dead	2753	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	890	0.1	NO	NO	[Not Available]	NO	[Not Available]	69	M0	[Not Applicable]	T1c	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T2b	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	KK	Prostate	DECEASED	115.05	[Not Available]	[Not Available]
0FB599CE-5E10-4571-8160-4F5160791A3F	TCGA-KK-A6E5	3/27/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Peripheral Zone	4	3	7	[Not Available]	Bilateral	Apex|Middle|Base	Male	NO	YES	-23144	No	No	2009	-19	Normal (no evidence of prostate cancer) [cM0]	YES	-19	No Evidence of Extraprostatic Extension	NO	[Not Available]	[Not Available]	YES	27	0	R0	Alive	1498	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	1496	0.1	NO	NO	Complete Remission/Response	NO	[Not Available]	63	M0	[Not Applicable]	T1c	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3b	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	KK	Prostate	LIVING	68.1	DiseaseFree	68.1
E377F873-C0D1-4810-9F3D-E551723858E1	TCGA-KK-A6E6	3/27/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Peripheral Zone	4	5	9	[Not Available]	Bilateral	Apex|Middle|Base	Male	NO	YES	-25320	No	No	2002	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	YES	5	0	R0	Alive	3447	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	3447	0.1	NO	NO	[Not Available]	NO	[Not Available]	69	M0	[Not Applicable]	T2b	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3a	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	KK	Prostate	LIVING	113.24	DiseaseFree	113.24
25C669B3-4D4A-4142-A403-677BE8522875	TCGA-KK-A6E7	3/27/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Transition Zone	5	4	9	[Not Available]	Bilateral	Apex|Middle	Male	NO	YES	-17074	No	No	2007	-46	Normal (no evidence of prostate cancer) [cM0]	YES	-45	No Evidence of Extraprostatic Extension	YES	8	No Evidence of Extraprostatic Extension|Equivocal	YES	11	1	R1	Alive	2040	[Not Applicable]	[Not Available]	[Not Available]	WITH TUMOR	1847	0.1	NO	NO	[Not Available]	NO	[Not Available]	46	M0	[Not Applicable]	T1c	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N1	T3a	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	KK	Prostate	LIVING	90.67	Recurred/Progressed	30.39
8990CE28-C671-4487-8DDA-864F0675BBB3	TCGA-KK-A6E8	3/27/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Transition Zone	4	5	9	[Not Available]	Bilateral	Apex|Middle|Base	Male	NO	YES	-25026	No	No	2007	97	Normal (no evidence of prostate cancer) [cM0]	NO	[Not Available]	[Not Available]	YES	104	No Evidence of Extraprostatic Extension	YES	14	0	RX	Alive	1770	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	1769	0.1	NO	NO	[Not Available]	NO	[Not Available]	68	M0	[Not Applicable]	T1c	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T2c	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	KK	Prostate	LIVING	58.15	DiseaseFree	58.15
F4E9A9F9-263C-4CED-A8FB-6CB0FB088983	TCGA-KK-A7AP	6/6/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Overlapping / Multiple Zones	4	5	9	[Not Available]	Right	Apex|Middle|Base	Male	NO	YES	-20403	Yes, History of Prior Malignancy	No	2010	175	Normal (no evidence of prostate cancer) [cM0]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	YES	15	2	R1	Alive	196	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	55	M0	[Not Applicable]	T2b	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N1	T3b	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	KK	Prostate	LIVING	6.44	DiseaseFree	6.44
CECF4EE9-7610-4F47-A825-7FDE8233B75D	TCGA-KK-A7AQ	8/19/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Peripheral Zone	4	3	7	5	Bilateral	Apex|Middle	Male	NO	YES	-22731	No	No	2010	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	YES	38	No Evidence of Extraprostatic Extension	YES	11	0	R0	Alive	1386	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	1385	0.1	NO	NO	Complete Remission/Response	YES	1217	62	M0	[Not Applicable]	T2a	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T2c	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	KK	Prostate	LIVING	52.89	Recurred/Progressed	39.98
39303E7C-5BAF-479D-A112-D8F03A18C621	TCGA-KK-A7AU	8/28/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Peripheral Zone	4	5	9	[Not Available]	Bilateral	Apex|Middle|Base	Male	NO	YES	-23118	No	No	2010	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	YES	123	No Evidence of Extraprostatic Extension	YES	11	3	R1	Alive	1621	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	1621	0	NO	NO	Progressive Disease	YES	207	63	M0	[Not Applicable]	T2b	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N1	T3b	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	KK	Prostate	LIVING	58.31	Recurred/Progressed	6.8
BF462E14-F9E8-4531-905D-1FB59D9088CB	TCGA-KK-A7AV	8/28/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Peripheral Zone	3	4	7	[Not Available]	Bilateral	Apex|Middle|Base	Male	NO	YES	-21192	No	No	2012	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	YES	48	No Evidence of Extraprostatic Extension	YES	23	0	RX	Alive	822	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	822	0.1	NO	NO	Complete Remission/Response	NO	[Not Available]	58	M0	[Not Applicable]	T1c	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T2c	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	KK	Prostate	LIVING	27	DiseaseFree	27
2F231B79-84BC-4256-BF26-7CE64083D438	TCGA-KK-A7AW	8/19/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Peripheral Zone	4	3	7	[Not Available]	Right	Apex|Middle|Base	Male	NO	YES	-20869	No	No	2010	[Not Available]	[Not Available]	YES	11	[Not Available]	NO	[Not Available]	[Not Available]	YES	9	1	R0	Alive	1054	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	204	0.8	YES	[Not Available]	[Not Available]	[Not Available]	204	57	M0	[Not Applicable]	T2a	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N1	T3a	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	KK	Prostate	LIVING	34.63	DiseaseFree	34.63
F4AEBD64-A356-4C05-B847-6DD28CF26339	TCGA-KK-A7AY	8/28/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Peripheral Zone	4	3	7	[Not Available]	Bilateral	Apex|Middle|Base	Male	NO	YES	-22220	No	No	2010	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	YES	8	0	R0	Alive	1572	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	1572	0.2	NO	NO	Complete Remission/Response	YES	1124	60	M0	[Not Applicable]	T2a	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T2c	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	KK	Prostate	LIVING	57.62	Recurred/Progressed	36.93
7D931C19-1FCE-4409-8A9C-9C65631CCBAC	TCGA-KK-A7AZ	8/19/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Peripheral Zone	4	3	7	[Not Available]	Right	Apex|Middle|Base	Male	NO	YES	-20507	No	No	2010	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	YES	141	Equivocal	YES	14	0	R0	Alive	840	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	56	[Not Available]	[Not Applicable]	T2b	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3a	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	KK	Prostate	LIVING	49.9	DiseaseFree	49.9
73D4E806-2C15-4C9E-A978-106FB9494E82	TCGA-KK-A7B0	8/28/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Overlapping / Multiple Zones	4	5	9	[Not Available]	Bilateral	Apex|Middle|Base	Male	NO	YES	-24756	No	No	2011	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	YES	17	0	R0	Alive	999	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	999	0.1	NO	NO	Stable Disease	YES	606	67	M0	[Not Applicable]	T2b	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3b	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	KK	Prostate	LIVING	43.66	Recurred/Progressed	19.91
7315BB0A-96A1-45AB-A704-B084D237CF5C	TCGA-KK-A7B1	6/6/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Peripheral Zone	4	3	7	[Not Available]	Bilateral	Apex|Middle|Base	Male	NO	YES	-23803	No	No	2011	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	YES	52	No Evidence of Extraprostatic Extension	YES	21	0	R0	Alive	1063	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	179	0.1	NO	NO	Complete Remission/Response	[Not Available]	[Not Available]	65	M0	[Not Applicable]	T1c	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3a	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	KK	Prostate	LIVING	34.92	DiseaseFree	34.92
000D566C-96C7-4F1C-B36E-FA2222467983	TCGA-KK-A7B2	6/6/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Overlapping / Multiple Zones	4	5	9	[Not Available]	Left	Apex|Middle|Base	Male	NO	YES	-24845	No	No	2012	58	Normal (no evidence of prostate cancer) [cM0]	YES	58	No Evidence of Extraprostatic Extension	NO	[Not Available]	[Not Available]	YES	13	1	R0	Alive	692	[Not Applicable]	[Not Available]	[Not Available]	WITH TUMOR	845	0.3	NO	NO	Stable Disease	NO	[Not Available]	68	M0	[Not Applicable]	T1c	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N1	T3a	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	KK	Prostate	LIVING	36.1	Recurred/Progressed	22.73
AAEB1D59-D6CE-4422-9639-F1E83C002D84	TCGA-KK-A7B3	8/28/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Peripheral Zone	4	5	9	[Not Available]	Bilateral	Apex|Middle|Base	Male	NO	YES	-22830	Yes, History of Prior Malignancy	No	2012	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	YES	112	Extraprostatic Extension Localized (e.g. seminal vesicles)	YES	17	0	R0	Alive	637	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	637	0.1	NO	NO	Complete Remission/Response	NO	[Not Available]	62	M0	[Not Applicable]	T3a	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3b	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	KK	Prostate	LIVING	29.53	Recurred/Progressed	9.66
5447A0E0-80CA-40FB-8233-504FDE51F22C	TCGA-KK-A7B4	8/28/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Overlapping / Multiple Zones	4	5	9	[Not Available]	Bilateral	Apex|Middle|Base	Male	NO	YES	-23644	Yes, History of Prior Malignancy	No	2012	29	Equivocal	NO	[Not Available]	[Not Available]	YES	29	Equivocal	YES	20	8	R1	Alive	637	[Not Applicable]	[Not Available]	[Not Available]	WITH TUMOR	637	0.6	YES	NO	Stable Disease	YES	637	64	M0	[Not Applicable]	T3b	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N1	T3b	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	YES	KK	Prostate	LIVING	32.42	Recurred/Progressed	31.64
9A8CAEF5-6543-4391-8A55-4999035693C5	TCGA-KK-A8I4	8/28/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Peripheral Zone	4	3	7	5	Left	Apex|Middle|Base	Male	NO	YES	-23706	No	No	2008	70	Normal (no evidence of prostate cancer) [cM0]	NO	[Not Available]	[Not Available]	YES	70	No Evidence of Extraprostatic Extension	YES	15	1	R0	Alive	2068	[Not Applicable]	[Not Available]	[Not Available]	WITH TUMOR	1964	0.2	NO	NO	Progressive Disease	YES	1155	64	M0	[Not Applicable]	T2c	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N1	T3b	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	KK	Prostate	LIVING	74.21	Recurred/Progressed	71.02
7CE45134-5B1F-4EA7-ACE9-7E463B034A43	TCGA-KK-A8I5	8/18/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Peripheral Zone	3	4	7	[Not Available]	Right	Apex|Middle|Base	Male	NO	YES	-20337	No	No	2006	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	YES	6	[Not Available]	R0	Alive	2553	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	1979	0.1	NO	NO	Complete Remission/Response	NO	[Not Available]	55	M0	[Not Applicable]	T2a	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T2b	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	KK	Prostate	LIVING	101.71	DiseaseFree	101.71
6E3154D4-2EF6-403D-9DE1-7B6233C4D505	TCGA-KK-A8I6	8/18/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Peripheral Zone	4	3	7	[Not Available]	Bilateral	Apex|Middle|Base	Male	NO	YES	-21499	No	No	2011	-14	Normal (no evidence of prostate cancer) [cM0]	YES	-13	No Evidence of Extraprostatic Extension	YES	17	No Evidence of Extraprostatic Extension	YES	23	0	R0	Alive	668	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	668	0.2	NO	NO	Complete Remission/Response	NO	[Not Available]	58	M0	[Not Applicable]	T2b	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3a	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	KK	Prostate	LIVING	21.94	DiseaseFree	21.94
108DEE1E-B27D-4056-A167-261725F548C1	TCGA-KK-A8I7	8/18/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Peripheral Zone	4	5	9	[Not Available]	Bilateral	Apex|Middle|Base	Male	NO	YES	-20256	No	No	2009	[Not Available]	[Not Available]	YES	24	No Evidence of Extraprostatic Extension	NO	[Not Available]	[Not Available]	YES	9	0	R1	Alive	1891	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	1877	0.1	NO	NO	Progressive Disease	YES	1088	55	M0	[Not Applicable]	T2c	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3b	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	KK	Prostate	LIVING	65.77	Recurred/Progressed	57.69
30FA311B-05A2-43E4-9EDC-02B327898132	TCGA-KK-A8I8	8/18/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Peripheral Zone	4	5	9	[Not Available]	Bilateral	Apex|Middle|Base	Male	NO	YES	-25546	No	No	2012	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	YES	31	No Evidence of Extraprostatic Extension	YES	27	[Not Available]	R1	Alive	774	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	757	0.1	NO	YES	Complete Remission/Response	NO	[Not Available]	69	M0	[Not Applicable]	T2a	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3b	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	KK	Prostate	LIVING	31.77	DiseaseFree	31.77
261C3D74-706E-4751-BD15-8F3C1A402FF0	TCGA-KK-A8I9	8/18/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Peripheral Zone	4	4	8	[Not Available]	Bilateral	Apex|Middle|Base	Male	NO	YES	-22295	No	No	2012	0	Normal (no evidence of prostate cancer) [cM0]	YES	-3	No Evidence of Extraprostatic Extension	YES	0	No Evidence of Extraprostatic Extension	YES	14	[Not Available]	RX	Alive	721	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	721	0.1	NO	YES	Complete Remission/Response	NO	[Not Available]	61	M0	[Not Applicable]	T2b	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3a	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	YES	KK	Prostate	LIVING	32.88	Recurred/Progressed	30.88
17916C4E-FEBE-48C6-B475-AD29397425E8	TCGA-KK-A8IA	8/18/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Peripheral Zone	4	5	9	[Not Available]	Bilateral	Apex|Middle|Base	Male	NO	YES	-25284	No	No	2009	26	Normal (no evidence of prostate cancer) [cM0]	YES	26	No Evidence of Extraprostatic Extension	NO	[Not Available]	[Not Available]	YES	19	3	RX	Alive	1439	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	1383	0.1	NO	NO	[Not Available]	NO	[Not Available]	69	M0	[Not Applicable]	T3b	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N1	T3b	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	YES	KK	Prostate	LIVING	63.44	DiseaseFree	63.44
88705B03-AA27-45C5-BEF0-BB697799F9DF	TCGA-KK-A8IB	8/19/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Peripheral Zone	4	5	9	[Not Available]	Bilateral	Apex|Middle|Base	Male	NO	YES	-24041	Yes, History of Prior Malignancy	No	2012	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	YES	21	[Not Available]	R0	Alive	83	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	65	M0	[Not Applicable]	T2a	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3a	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	KK	Prostate	LIVING	2.73	DiseaseFree	2.73
70C6C3A0-B422-4541-A60F-355356A9A340	TCGA-KK-A8IC	8/28/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Peripheral Zone	4	5	9	[Not Available]	Bilateral	Apex|Middle|Base	Male	NO	YES	-19902	No	No	2008	7	Normal (no evidence of prostate cancer) [cM0]	YES	6	No Evidence of Extraprostatic Extension	NO	[Not Available]	[Not Available]	YES	38	[Not Available]	R0	Alive	2051	[Not Applicable]	[Not Available]	[Not Available]	WITH TUMOR	2047	0.9	YES	NO	Progressive Disease	YES	1060	54	M0	[Not Applicable]	T1c	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3b	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	KK	Prostate	LIVING	67.38	Recurred/Progressed	34.82
717C0FD3-527B-4D5E-A9AB-0F141FCC84E8	TCGA-KK-A8ID	8/18/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Overlapping / Multiple Zones	5	4	9	[Not Available]	Bilateral	Apex|Middle|Base	Male	NO	YES	-25851	No	No	2009	43	Normal (no evidence of prostate cancer) [cM0]	YES	-5	No Evidence of Extraprostatic Extension	NO	[Not Available]	[Not Available]	YES	19	2	R1	Alive	1973	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	1924	0.1	NO	NO	Complete Remission/Response	NO	[Not Available]	70	M0	[Not Applicable]	T2b	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N1	T3b	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	YES	KK	Prostate	LIVING	69.22	DiseaseFree	69.22
3F5270A2-3284-4523-BD81-54FC98C2B933	TCGA-KK-A8IF	8/18/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Transition Zone	4	3	7	[Not Available]	Bilateral	Apex|Middle|Base	Male	NO	YES	-20888	No	No	2007	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	YES	522	No Evidence of Extraprostatic Extension	YES	33	[Not Available]	R0	Alive	804	[Not Applicable]	[Not Available]	[Not Available]	WITH TUMOR	788	0.7	YES	[Not Available]	[Not Available]	YES	648	57	M0	[Not Applicable]	T2a	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3a	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	KK	Prostate	LIVING	26.41	Recurred/Progressed	21.29
1E3C1D8F-B3C9-47BE-89E4-22E6B16ED2AE	TCGA-KK-A8IG	8/19/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Transition Zone	4	3	7	[Not Available]	Bilateral	Apex|Middle	Male	NO	YES	-20266	No	No	2008	63	Normal (no evidence of prostate cancer) [cM0]	YES	63	No Evidence of Extraprostatic Extension	NO	[Not Available]	[Not Available]	YES	19	[Not Available]	R1	Alive	2211	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	2211	0.1	NO	NO	Complete Remission/Response	NO	[Not Available]	55	M0	[Not Applicable]	T2a	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3a	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	KK	Prostate	LIVING	82.29	DiseaseFree	82.29
89B995BA-D13A-461B-ADE4-D791844C1A0C	TCGA-KK-A8IH	8/19/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Peripheral Zone	4	3	7	5	Bilateral	Apex|Middle|Base	Male	NO	YES	-18560	No	No	2009	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	YES	10	[Not Available]	R0	Alive	1635	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	1634	0.1	NO	NO	Complete Remission/Response	NO	[Not Available]	50	M0	[Not Applicable]	T2b	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3a	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	KK	Prostate	LIVING	66.13	DiseaseFree	66.13
D05681CC-DFFA-44D0-B6A1-0A99A4CE3BE5	TCGA-KK-A8II	8/28/14	Prostate Adenocarcinoma, Other Subtype	Mixed ductal (65%) and Acinar	Peripheral Zone	4	5	9	[Not Available]	Bilateral	Apex|Middle|Base	Male	NO	YES	-22460	No	No	2004	-28	Normal (no evidence of prostate cancer) [cM0]	YES	11	No Evidence of Extraprostatic Extension	NO	[Not Available]	[Not Available]	YES	19	[Not Available]	R0	Dead	[Not Available]	3467	[Not Available]	Medical Record	WITH TUMOR	2891	39.8	YES	NO	Progressive Disease	YES	626	61	M0	[Not Applicable]	T2c	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8500/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3a	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	KK	Prostate	DECEASED	113.9	Recurred/Progressed	60.91
98A9CE0E-4F02-4819-BC0C-C1A8D34E3DB6	TCGA-KK-A8IJ	8/19/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Peripheral Zone	4	3	7	5	Bilateral	Apex|Middle|Base	Male	NO	YES	-21793	No	No	2009	42	Normal (no evidence of prostate cancer) [cM0]	YES	42	No Evidence of Extraprostatic Extension	NO	[Not Available]	[Not Available]	YES	34	1	R0	Alive	1559	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	167	0.1	NO	[Not Available]	[Not Available]	YES	[Not Available]	59	M0	[Not Applicable]	T3a	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N1	T3b	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	KK	Prostate	LIVING	51.22	Recurred/Progressed	10.09
D4F4DDC1-CFD7-4C57-ADE6-4F32CB7FFD85	TCGA-KK-A8IK	8/28/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Peripheral Zone	4	5	9	[Not Available]	Bilateral	Apex|Middle|Base	Male	NO	YES	-20594	No	No	2008	-69	Abnormal (not related to prostate cancer)	YES	-69	No Evidence of Extraprostatic Extension	NO	[Not Available]	[Not Available]	YES	6	[Not Available]	R0	Alive	1563	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	[Not Available]	0	NO	NO	Complete Remission/Response	NO	[Not Available]	56	M0	[Not Applicable]	T1c	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T2c	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	KK	Prostate	LIVING	67.41	DiseaseFree	67.41
2A51E1C2-8A8F-4DF3-BCC6-7DF94A47D94D	TCGA-KK-A8IL	8/19/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Peripheral Zone	4	5	9	[Not Available]	Bilateral	Apex|Middle|Base	Male	NO	YES	-23849	No	No	2009	[Not Available]	[Not Available]	YES	7	No Evidence of Extraprostatic Extension	YES	87	No Evidence of Extraprostatic Extension	YES	8	1	R1	Dead	[Not Available]	628	[Not Available]	Medical Record	[Not Available]	144	0.1	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	65	M0	[Not Applicable]	T1c	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N1	T3b	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	KK	Prostate	DECEASED	20.63	[Not Available]	[Not Available]
4434864A-8A0D-488E-B9A7-6749719663E5	TCGA-KK-A8IM	8/18/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Peripheral Zone	4	3	7	[Not Available]	Bilateral	Apex|Middle|Base	Male	NO	YES	-20425	No	No	2009	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	YES	5	[Not Available]	R0	Alive	1438	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	1438	0.1	NO	NO	Complete Remission/Response	NO	[Not Available]	55	M0	[Not Applicable]	T2a	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T2c	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	KK	Prostate	LIVING	62.91	DiseaseFree	62.91
1583AEA0-5D69-4165-9BEF-D5BFDDDF3A65	TCGA-M7-A71Y	12/10/13	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Overlapping / Multiple Zones	3	4	7	[Not Available]	Bilateral	Apex|Middle|Base	Male	YES	NO	-20357	No	No	2013	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	R0	Alive	158	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	158	[Not Available]	NO	NO	Complete Remission/Response	NO	[Not Available]	55	[Not Available]	[Not Applicable]	T1c	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	[Not Available]	T2c	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	M7	Prostate	LIVING	16.2	DiseaseFree	16.2
4D5D61C4-2E64-422E-ABA6-EC098F40EEEC	TCGA-M7-A71Z	12/10/13	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Overlapping / Multiple Zones	4	3	7	[Not Available]	Right	Apex|Base	Male	YES	NO	-22785	No	No	2013	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	YES	9	0	R0	Alive	209	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	209	[Not Available]	NO	NO	Complete Remission/Response	NO	[Not Available]	62	[Not Available]	[Not Applicable]	T2a	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3a	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	M7	Prostate	LIVING	21.12	DiseaseFree	21.12
444E78F7-1221-4882-ADE2-7E45D828EA2A	TCGA-M7-A720	12/10/13	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Peripheral Zone	3	3	6	[Not Available]	Bilateral	Middle|Base	Male	YES	NO	-19642	No	No	2013	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	R0	Alive	302	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	302	[Not Available]	NO	NO	Complete Remission/Response	NO	[Not Available]	53	[Not Available]	[Not Applicable]	T1c	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	[Not Available]	T2c	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	M7	Prostate	LIVING	12.61	DiseaseFree	12.61
6433F001-DB5C-476B-83C7-23F4C5397AE9	TCGA-M7-A721	12/10/13	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Overlapping / Multiple Zones	3	4	7	[Not Available]	Bilateral	Apex|Middle|Base	Male	YES	NO	-25585	No	No	2012	-8	Normal (no evidence of prostate cancer) [cM0]	NO	[Not Available]	[Not Available]	YES	-8	No Evidence of Extraprostatic Extension	NO	[Not Available]	[Not Available]	R1	Alive	204	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	162	[Not Available]	NO	NO	Complete Remission/Response	NO	[Not Available]	70	M0	[Not Applicable]	T1c	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	[Not Available]	T2c	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	M7	Prostate	LIVING	13.14	DiseaseFree	13.14
3FA3CFFE-40F1-4853-9CBB-54A99FFD6108	TCGA-M7-A722	3/27/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Overlapping / Multiple Zones	4	4	8	3	Bilateral	[Not Available]	Male	YES	NO	-23880	No	No	2011	3	Normal (no evidence of prostate cancer) [cM0]	YES	3	No Evidence of Extraprostatic Extension	NO	[Not Available]	[Not Available]	YES	4	0	R1	Alive	717	[Not Applicable]	[Not Available]	[Not Available]	WITH TUMOR	559	[Not Available]	YES	NO	Partial Remission/Response	YES	559	65	M0	[Not Applicable]	T2a	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3a	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	M7	Prostate	LIVING	34.82	Recurred/Progressed	18.36
E27BC39B-54F1-47B5-AC8F-3245DCE690F4	TCGA-M7-A723	12/10/13	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Overlapping / Multiple Zones	4	3	7	5	Bilateral	Apex|Middle|Base	Male	YES	NO	-20064	No	No	2012	8	Normal (no evidence of prostate cancer) [cM0]	YES	11	No Evidence of Extraprostatic Extension	NO	[Not Available]	[Not Available]	YES	17	1	R1	Alive	62	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	62	0.1	NO	YES	Complete Remission/Response	NO	[Not Available]	54	M0	[Not Applicable]	T1c	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N1	T3b	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	YES	M7	Prostate	LIVING	25.07	DiseaseFree	25.07
F8B98552-AE2A-4609-9929-7864485B3C51	TCGA-M7-A724	12/10/13	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Peripheral Zone	4	4	8	[Not Available]	Right	Apex|Base	Male	YES	NO	-23595	No	No	2012	11	Abnormal (not related to prostate cancer)	YES	35	No Evidence of Extraprostatic Extension	NO	[Not Available]	[Not Available]	YES	7	0	R1	Alive	483	[Not Applicable]	[Not Available]	[Not Available]	WITH TUMOR	483	[Not Available]	NO	NO	Progressive Disease	NO	[Not Available]	64	M0	[Not Applicable]	T1c	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3a	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	M7	Prostate	LIVING	29.2	DiseaseFree	29.2
FCA0331B-8096-40E8-B292-D438370C37C9	TCGA-M7-A725	12/10/13	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Overlapping / Multiple Zones	4	3	7	5	Bilateral	Apex|Base	Male	YES	NO	-20474	No	No	2012	16	Normal (no evidence of prostate cancer) [cM0]	YES	16	No Evidence of Extraprostatic Extension	NO	[Not Available]	[Not Available]	YES	11	0	R1	Alive	96	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	96	[Not Available]	NO	NO	Complete Remission/Response	NO	[Not Available]	56	M0	[Not Applicable]	T3a	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3b	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	M7	Prostate	LIVING	18.82	DiseaseFree	18.82
9C8447AC-5B26-4558-8BFD-F0E7046C1FB9	TCGA-MG-AAMC	7/28/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	4	5	9	3	[Not Available]	[Not Available]	Male	NO	YES	-21846	No	No	2013	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	R0	Alive	173	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	54	0.01	NO	NO	Complete Remission/Response	NO	[Not Available]	59	M0	[Not Applicable]	T1c	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3a	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	MG	Prostate	LIVING	5.68	DiseaseFree	5.68
DFFC3917-BF06-4C3D-B03A-CA54FE5C2E79	TCGA-QU-A6IL	8/21/13	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	3	4	7	[Not Available]	Bilateral	Apex|Middle|Base	Male	NO	YES	-23710	No	No	2002	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	YES	4	0	R0	Alive	97	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	91	0.2	NO	NO	Complete Remission/Response	NO	[Not Available]	64	M0	[Not Applicable]	T2a	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T2c	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	QU	Prostate	LIVING	3.19	DiseaseFree	3.19
D1B31524-8034-4FCE-B14E-1CEF33C26CA5	TCGA-QU-A6IM	8/21/13	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	3	4	7	[Not Available]	Left	Apex|Middle	Male	NO	YES	-21792	Yes, History of Prior Malignancy	No	2003	35	Equivocal	YES	50	Equivocal	YES	35	No Evidence of Extraprostatic Extension	YES	2	0	R0	Alive	1247	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	896	0.1	NO	NO	Complete Remission/Response	NO	[Not Available]	59	M0	[Not Applicable]	T2b	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T2a	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	QU	Prostate	LIVING	40.97	DiseaseFree	40.97
D07D20F4-DD65-4FFC-ADD4-01F350CA7B65	TCGA-QU-A6IN	8/21/13	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	3	4	7	5	Bilateral	Apex|Middle|Base	Male	NO	YES	-22286	No	No	2003	21	Normal (no evidence of prostate cancer) [cM0]	NO	[Not Available]	[Not Available]	YES	43	[Not Available]	YES	15	0	R0	Alive	3487	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	3428	0.1	NO	NO	Complete Remission/Response	NO	[Not Available]	61	M0	[Not Applicable]	T1c	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T2c	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	QU	Prostate	LIVING	140.08	DiseaseFree	140.08
570DDFB3-2721-42B6-9604-2DE6B6090031	TCGA-QU-A6IO	8/21/13	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	3	3	6	[Not Available]	Bilateral	Apex|Middle|Base	Male	NO	YES	-19564	No	No	2003	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	YES	2	0	R1	Alive	1436	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	1436	0.1	NO	NO	Complete Remission/Response	NO	[Not Available]	53	M0	[Not Applicable]	T1c	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T2c	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	QU	Prostate	LIVING	122.08	DiseaseFree	122.08
9A8E27C9-614B-491F-913D-429DFC4E2C4D	TCGA-QU-A6IP	8/21/13	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	3	3	6	[Not Available]	Right	Middle|Base	Male	NO	YES	-24212	No	No	2004	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	YES	2	0	R0	Alive	2620	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	2620	0	NO	NO	Complete Remission/Response	NO	[Not Available]	66	M0	[Not Applicable]	T2a	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T2a	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	QU	Prostate	LIVING	86.07	DiseaseFree	86.07
2648C3C9-9884-4A0C-96AA-61130CD289EA	TCGA-SU-A7E7	1/24/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Peripheral Zone	5	3	8	[Not Available]	Right	Base	Male	YES	NO	-22185	No	No	2013	6	Normal (no evidence of prostate cancer) [cM0]	YES	-10	No Evidence of Extraprostatic Extension	NO	[Not Available]	[Not Available]	YES	9	0	R0	Alive	112	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	426	0.01	NO	NO	Complete Remission/Response	NO	[Not Available]	60	M0	[Not Applicable]	T2b	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T2b	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	SU	Prostate	LIVING	18.1	DiseaseFree	18.1
4FDC9F5A-7BA1-4F80-B3DB-2B7CBE505217	TCGA-TK-A8OK	11/14/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Overlapping / Multiple Zones	3	4	7	[Not Available]	Right	[Not Available]	Male	YES	NO	-26976	No	No	2013	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Alive	27	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	NO	[Not Applicable]	NO	[Not Available]	73	M0	[Not Applicable]	[Not Available]	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	TK	Prostate	LIVING	0.89	DiseaseFree	0.89
A13A7252-DE84-4950-9307-80FC8A6A668D	TCGA-TP-A8TT	3/28/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Peripheral Zone	4	3	7	[Not Available]	Left	Apex|Middle|Base	Male	YES	NO	-23476	No	No	2013	23	Normal (no evidence of prostate cancer) [cM0]	YES	15	No Evidence of Extraprostatic Extension	NO	[Not Available]	[Not Available]	YES	11	0	R0	Alive	362	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	237	0.024	NO	YES	Partial Remission/Response	NO	[Not Available]	64	M0	[Not Applicable]	T1c	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3a	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	TP	Prostate	LIVING	17.28	DiseaseFree	17.28
6F4C1006-519D-4B16-8C96-690C63BEA0B6	TCGA-TP-A8TV	3/28/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Overlapping / Multiple Zones	4	3	7	5	Bilateral	Apex|Middle|Base	Male	YES	NO	-22872	No	No	2013	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	YES	4	0	R1	Alive	249	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	249	0.019	NO	YES	[Not Available]	NO	[Not Available]	62	M0	[Not Applicable]	T1c	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T2c	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	TP	Prostate	LIVING	20.04	DiseaseFree	20.04
56DF9DE6-613D-44CE-8827-9213CC6C8B56	TCGA-V1-A8MF	7/23/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Peripheral Zone	3	3	6	[Not Available]	Bilateral	Apex	Male	NO	YES	-24090	No	No	[Not Available]	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	YES	8	0	R1	Alive	1254	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	1218	0.14	NO	NO	[Not Available]	NO	[Not Available]	65	M0	[Not Applicable]	T2c	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3a	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	V1	Prostate	LIVING	47.6	DiseaseFree	47.6
301C4C32-BC66-4328-8DCF-FE3DD66FBDE2	TCGA-V1-A8MG	7/23/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Peripheral Zone	3	4	7	[Not Available]	Bilateral	Apex	Male	NO	YES	-19710	No	No	[Not Available]	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	R1	Alive	857	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	583	0.03	NO	NO	[Not Available]	NO	[Not Available]	53	M0	[Not Applicable]	T2c	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	[Not Available]	T3b	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	V1	Prostate	LIVING	28.15	DiseaseFree	28.15
F4F81316-C99A-4A88-AA6C-E66FC5D60C53	TCGA-V1-A8MJ	7/15/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Peripheral Zone	3	4	7	[Not Available]	Bilateral	Apex	Male	NO	YES	-21535	No	No	[Not Available]	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	YES	16	1	R0	Alive	1230	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	1230	0.015	NO	NO	[Not Available]	YES	[Not Available]	58	M0	[Not Applicable]	T2a	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N1	T3a	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	V1	Prostate	LIVING	58.84	DiseaseFree	58.84
9938C4AD-748C-4086-9081-FAC0AEFAD440	TCGA-V1-A8MK	7/15/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Peripheral Zone	3	3	6	[Not Available]	Bilateral	Apex	Male	NO	YES	-15330	No	No	[Not Available]	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	R0	Alive	508	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	-1	0.83	YES	NO	[Not Available]	NO	[Not Available]	41	M0	[Not Applicable]	T2a	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T2c	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	V1	Prostate	LIVING	16.69	DiseaseFree	16.69
69174712-AF41-422D-952A-D8D0D16D7182	TCGA-V1-A8ML	7/15/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Peripheral Zone	3	4	7	[Not Available]	Bilateral	Apex	Male	NO	YES	-23360	No	No	[Not Available]	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	YES	12	0	R0	Alive	448	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	448	0.01	NO	NO	[Not Available]	NO	[Not Available]	63	M0	[Not Applicable]	T2b	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T2c	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	V1	Prostate	LIVING	14.72	DiseaseFree	14.72
94D6675E-27AE-4F34-9D53-6E19238EB01D	TCGA-V1-A8MM	7/15/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Peripheral Zone	4	3	7	[Not Available]	Bilateral	Apex	Male	NO	YES	-22265	No	No	[Not Available]	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	YES	10	0	R0	Alive	1019	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	990	0.37	YES	NO	Complete Remission/Response	YES	990	60	M0	[Not Applicable]	T2b	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3a	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	V1	Prostate	LIVING	39.26	Recurred/Progressed	32.52
A76BCD1F-E47F-4DC5-A97A-4C4F00032191	TCGA-V1-A8MU	7/15/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Peripheral Zone	3	4	7	[Not Available]	Bilateral	Apex	Male	NO	YES	-20805	No	No	[Not Available]	[Not Available]	[Not Available]	YES	87	No Evidence of Extraprostatic Extension	NO	[Not Available]	[Not Available]	YES	15	1	R1	Alive	1399	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	1384	0.015	NO	NO	[Not Available]	NO	[Not Available]	56	M0	[Not Applicable]	T2b	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N1	T3a	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	YES	V1	Prostate	LIVING	61.63	DiseaseFree	61.63
F7FC3F2E-C70E-460D-B34D-BB2EA423A0AE	TCGA-V1-A8WL	7/23/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Peripheral Zone	3	4	7	[Not Available]	Bilateral	Apex	Male	NO	YES	-23725	No	No	[Not Available]	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	YES	4	0	R0	Alive	1375	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	1175	0.015	NO	NO	[Not Available]	NO	[Not Available]	64	M0	[Not Applicable]	T1c	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3a	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	V1	Prostate	LIVING	63.99	DiseaseFree	63.99
DC16F348-A49F-4958-A3FF-BC40E18DF2BD	TCGA-V1-A8WN	7/15/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Peripheral Zone	3	3	6	[Not Available]	Bilateral	Apex	Male	NO	YES	-17520	No	No	[Not Available]	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	R0	Alive	476	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	463	0.02	NO	NO	[Not Available]	NO	[Not Available]	47	M0	[Not Applicable]	T2a	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	[Not Available]	T2c	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	V1	Prostate	LIVING	30.35	DiseaseFree	30.35
BEA84D33-3286-44E2-9595-893C34A01F58	TCGA-V1-A8WS	7/23/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Peripheral Zone	3	3	6	[Not Available]	Bilateral	Apex	Male	NO	YES	-20805	No	No	[Not Available]	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	R0	Alive	474	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	474	0.09	NO	NO	[Not Available]	YES	[Not Available]	56	M0	[Not Applicable]	T1c	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	[Not Available]	T3b	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	V1	Prostate	LIVING	15.57	DiseaseFree	15.57
8E5B1D47-7D92-4D28-8186-4176ADA96672	TCGA-V1-A8WV	7/15/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Peripheral Zone	4	5	9	[Not Available]	Bilateral	Middle	Male	NO	YES	-19345	No	No	[Not Available]	[Not Available]	[Not Available]	YES	95	No Evidence of Extraprostatic Extension	NO	[Not Available]	[Not Available]	YES	10	1	R0	Alive	686	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	686	0.01	NO	NO	[Not Available]	NO	[Not Available]	52	M0	[Not Applicable]	T2a	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N1	T3b	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	YES	V1	Prostate	LIVING	22.54	DiseaseFree	22.54
D843996C-0F17-4482-8466-9F6144981B8A	TCGA-V1-A8WW	7/15/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Peripheral Zone	4	5	9	[Not Available]	Bilateral	Apex	Male	NO	YES	-21900	No	No	[Not Available]	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	YES	709	No Evidence of Extraprostatic Extension	YES	20	1	R0	Alive	709	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	695	0.015	NO	NO	Complete Remission/Response	YES	105	59	M0	[Not Applicable]	T2b	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N1	T3b	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	YES	V1	Prostate	LIVING	35.41	DiseaseFree	35.41
86B82965-B19B-4285-B1A5-51A5D5267103	TCGA-V1-A8X3	7/23/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Peripheral Zone	3	4	7	[Not Available]	Bilateral	Apex	Male	NO	YES	-18980	No	No	[Not Available]	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	YES	18	0	R1	Alive	202	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	202	0.03	NO	NO	[Not Available]	NO	[Not Available]	51	M0	[Not Applicable]	T1c	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T2c	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	V1	Prostate	LIVING	6.64	DiseaseFree	6.64
E0DFC37A-4A2E-4353-9673-241B100B3467	TCGA-V1-A9O5	7/23/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Peripheral Zone	5	4	9	[Not Available]	Bilateral	Apex	Male	NO	YES	-23725	No	No	[Not Available]	[Not Available]	[Not Available]	YES	25	No Evidence of Extraprostatic Extension	NO	[Not Available]	[Not Available]	YES	20	6	R1	Alive	1776	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	1776	3.26	YES	YES	Complete Remission/Response	YES	124	64	M0	[Not Applicable]	T2b	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N1	T4	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	YES	V1	Prostate	LIVING	63.47	Recurred/Progressed	4.07
40EBEB10-7390-44FC-9EF2-80D40D251018	TCGA-V1-A9O7	7/23/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Peripheral Zone	5	4	9	[Not Available]	Bilateral	Apex	Male	NO	YES	-22265	No	No	[Not Available]	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	YES	45	[Not Available]	YES	15	0	R1	Alive	2425	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	2425	9.69	YES	YES	Progressive Disease	YES	921	60	M0	[Not Applicable]	T2b	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3a	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	V1	Prostate	LIVING	82.1	Recurred/Progressed	26.91
F6935F67-5C62-4774-8346-711F36F3B547	TCGA-V1-A9O9	7/23/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Peripheral Zone	3	5	8	[Not Available]	Bilateral	Apex	Male	NO	YES	-20805	No	No	[Not Available]	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	YES	12	0	R0	Alive	204	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	-53	5.04	YES	NO	[Not Available]	NO	[Not Available]	56	M0	[Not Applicable]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3b	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	V1	Prostate	LIVING	94.28	DiseaseFree	94.28
A8396F6D-53E2-4664-A3E2-DF061D022108	TCGA-V1-A9OA	7/23/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Peripheral Zone	4	5	9	[Not Available]	Bilateral	Apex	Male	NO	YES	-22630	No	No	[Not Available]	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	YES	27	[Not Available]	YES	8	1	R0	Alive	636	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	510	0.01	NO	YES	[Not Available]	NO	[Not Available]	61	M0	[Not Applicable]	T2c	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N1	T3b	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	V1	Prostate	LIVING	20.89	DiseaseFree	20.89
D4DC7C5C-45B3-4741-B0C1-FEE477DA2EF4	TCGA-V1-A9OF	7/23/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Peripheral Zone	3	3	6	[Not Available]	Bilateral	Apex	Male	NO	YES	-18250	No	No	[Not Available]	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	R1	Alive	1184	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	1184	0.01	NO	NO	[Not Available]	NO	[Not Available]	49	M0	[Not Applicable]	T1c	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	[Not Available]	T2c	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	V1	Prostate	LIVING	38.9	DiseaseFree	38.9
6EF0FC2D-F274-4253-BEC5-6DBD55953D76	TCGA-V1-A9OH	7/23/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Peripheral Zone	4	4	8	[Not Available]	Right	Apex	Male	NO	YES	-23360	No	No	[Not Available]	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	R0	Alive	1253	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	1253	0.01	NO	NO	[Not Available]	NO	[Not Available]	63	M0	[Not Applicable]	T1c	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	[Not Available]	T2b	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	V1	Prostate	LIVING	78.94	DiseaseFree	78.94
FCBD7B29-12DA-44C8-B241-1388D1B15684	TCGA-V1-A9OL	7/11/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Peripheral Zone	5	4	9	[Not Available]	Bilateral	Apex	Male	NO	YES	-24090	No	No	[Not Available]	[Not Available]	[Not Available]	YES	19	No Evidence of Extraprostatic Extension	NO	[Not Available]	[Not Available]	YES	9	0	R0	Alive	589	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	559	0.01	NO	NO	Complete Remission/Response	YES	131	65	M0	[Not Applicable]	T2	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3b	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	V1	Prostate	LIVING	62.84	Recurred/Progressed	3.45
10271D9C-9B9C-4B5F-A845-A0F1BD03AF51	TCGA-V1-A9OQ	7/11/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Peripheral Zone	3	3	6	[Not Available]	Bilateral	Apex	Male	NO	YES	-24820	No	No	[Not Available]	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	NO	0	[Not Available]	R1	Alive	371	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	371	0.01	NO	NO	[Not Available]	NO	[Not Available]	67	M0	[Not Applicable]	T1c	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	[Not Available]	T3a	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	V1	Prostate	LIVING	12.19	DiseaseFree	12.19
18B8AD7F-0F39-4853-AE13-5B13AA5E6F7D	TCGA-V1-A9OT	7/23/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Peripheral Zone	3	3	6	[Not Available]	Bilateral	Middle	Male	NO	YES	-22630	No	No	[Not Available]	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	R1	Alive	476	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	349	0.01	YES	NO	[Not Available]	YES	[Not Available]	61	M0	[Not Applicable]	T1c	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	[Not Available]	T2c	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	V1	Prostate	LIVING	15.64	Recurred/Progressed	9.59
14C2819B-9AFC-4C89-849F-530E289D55BF	TCGA-V1-A9OX	7/23/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Peripheral Zone	3	5	8	[Not Available]	Bilateral	Apex	Male	NO	YES	-20805	No	No	[Not Available]	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	YES	8	0	R0	Alive	256	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	256	0.04	NO	NO	[Not Available]	NO	[Not Available]	56	M0	[Not Applicable]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T2c	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	V1	Prostate	LIVING	37.25	DiseaseFree	37.25
69FC0351-6496-46B5-BE22-25B80C1DC4CC	TCGA-V1-A9OY	7/23/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Peripheral Zone	4	3	7	[Not Available]	Bilateral	Apex	Male	NO	YES	-21170	No	No	[Not Available]	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	YES	13	1	R1	Alive	170	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	170	0.099	NO	NO	[Not Available]	NO	[Not Available]	57	M0	[Not Applicable]	T2	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N1	T3a	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	V1	Prostate	LIVING	35.05	DiseaseFree	35.05
4DB62B98-ABD4-4A7C-9FCE-8BBDA2AEC8A3	TCGA-V1-A9Z7	7/23/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Peripheral Zone	5	4	9	[Not Available]	Bilateral	Apex	Male	NO	YES	-20075	No	No	[Not Available]	[Not Available]	[Not Available]	YES	50	No Evidence of Extraprostatic Extension	NO	[Not Available]	[Not Available]	YES	10	0	R0	Alive	123	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	-75	28.1	YES	NO	[Not Available]	YES	[Not Available]	54	M0	[Not Applicable]	T2	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3b	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	V1	Prostate	LIVING	28.71	DiseaseFree	28.71
9BF4E7BB-6AA9-4BE8-A7C3-E630ECFF4DCE	TCGA-V1-A9Z8	7/23/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Peripheral Zone	5	4	9	[Not Available]	Bilateral	Apex	Male	NO	YES	-21900	No	No	[Not Available]	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	YES	18	0	R1	Alive	187	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	181	0.01	NO	NO	[Not Available]	NO	[Not Available]	59	M0	[Not Applicable]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3b	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	V1	Prostate	LIVING	27.17	DiseaseFree	27.17
0885EB03-DE9F-46BA-9C53-FB69C67AB9F0	TCGA-V1-A9Z9	7/23/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Peripheral Zone	4	5	9	[Not Available]	Bilateral	Apex	Male	NO	YES	-23360	No	No	[Not Available]	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	YES	9	[Not Available]	YES	29	0	R0	Alive	295	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	291	0.015	NO	NO	[Not Available]	NO	[Not Available]	63	M0	[Not Applicable]	T1c	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T2c	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	V1	Prostate	LIVING	17.74	DiseaseFree	17.74
DEC99F86-622B-477F-A26A-98C954FB1F17	TCGA-V1-A9ZG	7/23/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Peripheral Zone	4	5	9	[Not Available]	Bilateral	Apex	Male	NO	YES	-23725	No	No	[Not Available]	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	YES	5	0	R0	Alive	1117	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	893	0.015	NO	NO	[Not Available]	NO	[Not Available]	64	M0	[Not Applicable]	T1c	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T2c	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	V1	Prostate	LIVING	49.84	DiseaseFree	49.84
3D92B872-A76A-49CD-9FD5-7993E78D2FB0	TCGA-V1-A9ZI	7/23/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Peripheral Zone	4	5	9	[Not Available]	Bilateral	Middle	Male	NO	YES	-25185	No	No	[Not Available]	[Not Available]	[Not Available]	YES	40	No Evidence of Extraprostatic Extension	NO	[Not Available]	[Not Available]	YES	10	0	R0	Alive	86	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	86	3.11	YES	NO	Progressive Disease	YES	86	68	M0	[Not Applicable]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3b	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	V1	Prostate	LIVING	53.88	DiseaseFree	53.88
7DC62C0F-B82D-417F-89A7-4CB984A9D304	TCGA-V1-A9ZK	10/23/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Peripheral Zone	4	4	8	[Not Available]	Left	Middle	Male	NO	YES	-25185	No	No	[Not Available]	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	YES	6	0	R0	Alive	1049	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	1049	0.01	NO	NO	[Not Available]	NO	[Not Available]	68	M0	[Not Applicable]	T2a	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	C61	8490/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3b	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	V1	Prostate	LIVING	45.43	DiseaseFree	45.43
338FE754-FC4A-4294-BA15-42D4C7C9AC10	TCGA-V1-A9ZR	7/23/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Peripheral Zone	4	4	8	[Not Available]	Bilateral	Apex	Male	NO	YES	-25185	No	No	[Not Available]	[Not Available]	[Not Available]	YES	78	No Evidence of Extraprostatic Extension	NO	[Not Available]	[Not Available]	YES	7	[Not Available]	R1	Alive	177	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	54	1.44	YES	NO	[Not Available]	YES	[Not Available]	68	M0	[Not Applicable]	T2c	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T4	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	V1	Prostate	LIVING	44.71	DiseaseFree	44.71
C3FD52FE-BDC2-4CCA-91C7-590A192F80ED	TCGA-VN-A88I	1/10/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Overlapping / Multiple Zones	4	4	8	5	Bilateral	Apex|Middle|Base	Male	NO	YES	-21576	No	No	2011	9	Abnormal (not related to prostate cancer)	NO	[Not Available]	[Not Available]	YES	-1	No Evidence of Extraprostatic Extension	YES	11	0	R0	Alive	269	[Not Applicable]	[Not Available]	[Not Available]	WITH TUMOR	269	0.16	NO	[Not Available]	Partial Remission/Response	NO	[Not Available]	59	M0	[Not Applicable]	T1c	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3a	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	VN	Prostate	LIVING	8.84	DiseaseFree	8.84
A186C956-6756-4339-9793-494FE9B80C94	TCGA-VN-A88K	1/10/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Overlapping / Multiple Zones	4	4	8	5	Bilateral	Apex|Middle|Base	Male	NO	YES	-21524	No	No	2011	24	Equivocal	YES	24	No Evidence of Extraprostatic Extension	YES	-48	Extraprostatic Extension Localized (e.g. seminal vesicles)	YES	37	15	R0	Alive	776	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	776	0	NO	NO	Complete Remission/Response	NO	[Not Available]	58	M0	[Not Applicable]	T1c	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N1	T3a	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	YES	VN	Prostate	LIVING	25.49	DiseaseFree	25.49
74602E83-3EE3-4EE7-B05A-135FBDDDCC5C	TCGA-VN-A88L	1/10/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	3	4	7	[Not Available]	Bilateral	Middle|Base	Male	NO	YES	-20026	No	No	2012	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	YES	79	No Evidence of Extraprostatic Extension	YES	18	0	R0	Alive	394	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	394	0	NO	NO	Complete Remission/Response	NO	[Not Available]	54	M0	[Not Applicable]	T1c	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T2c	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	VN	Prostate	LIVING	24.51	DiseaseFree	24.51
35243518-B086-4D76-A336-8C61A14F9DED	TCGA-VN-A88M	1/10/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	3	4	7	[Not Available]	Bilateral	Middle	Male	NO	YES	-20157	No	No	2013	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	YES	128	No Evidence of Extraprostatic Extension	YES	13	0	R0	Alive	183	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	[Not Available]	[Not Available]	[Not Available]	NO	Complete Remission/Response	NO	[Not Available]	55	M0	[Not Applicable]	T1c	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T2c	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	VN	Prostate	LIVING	6.21	DiseaseFree	6.21
E9A4C770-665F-454B-81F7-B8AE3F1E154E	TCGA-VN-A88N	1/10/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Overlapping / Multiple Zones	4	3	7	[Not Available]	Bilateral	Apex|Middle|Base	Male	NO	YES	-22695	No	No	2013	98	Equivocal	YES	98	No Evidence of Extraprostatic Extension	YES	-117	No Evidence of Extraprostatic Extension	YES	50	0	R0	Alive	176	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	176	0	NO	NO	Complete Remission/Response	NO	[Not Available]	62	M0	[Not Applicable]	T1c	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T2c	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	VN	Prostate	LIVING	25.16	DiseaseFree	25.16
EB715348-7C5C-4E95-BAC8-05604BDDA2DA	TCGA-VN-A88O	1/10/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Overlapping / Multiple Zones	3	4	7	4	Bilateral	Apex|Middle|Base	Male	NO	YES	-17945	No	No	2012	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	YES	70	No Evidence of Extraprostatic Extension	YES	34	0	R0	Alive	481	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	376	0	NO	NO	Complete Remission/Response	NO	[Not Available]	49	M0	[Not Applicable]	T1c	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T2c	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	VN	Prostate	LIVING	15.8	DiseaseFree	15.8
74C7DD37-7FF5-47AC-AEB7-14202871B6F1	TCGA-VN-A88P	1/10/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Overlapping / Multiple Zones	3	4	7	[Not Available]	Bilateral	Base	Male	NO	YES	-21916	No	No	2011	839	Abnormal (not related to prostate cancer)	YES	839	No Evidence of Extraprostatic Extension	YES	805	No Evidence of Extraprostatic Extension	YES	65	0	R0	Alive	917	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	917	0	NO	NO	Complete Remission/Response	NO	[Not Available]	60	M0	[Not Applicable]	T1c	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T2c	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	VN	Prostate	LIVING	41.39	DiseaseFree	41.39
AB540819-9531-4E99-868A-751649F25E6A	TCGA-VN-A88Q	1/10/14	Prostate Adenocarcinoma, Other Subtype	Prostatic Adenocarcinoma Acinar Type Mixed with Prostatic Duct Adenocarcinoma	Overlapping / Multiple Zones	4	4	8	[Not Available]	Bilateral	Apex	Male	NO	YES	-22087	No	No	2010	929	Abnormal (not related to prostate cancer)	NO	[Not Available]	[Not Available]	YES	796	No Evidence of Extraprostatic Extension	YES	12	0	R0	Alive	1001	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	1000	0	NO	NO	Complete Remission/Response	NO	[Not Available]	60	M0	[Not Applicable]	T2a	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T2c	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	VN	Prostate	LIVING	44.88	DiseaseFree	44.88
FCF64B55-5C4F-4D82-AC6A-4713D01143CB	TCGA-VN-A88R	1/10/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	4	4	8	[Not Available]	Bilateral	Apex|Middle|Base	Male	NO	YES	-19513	No	No	2012	316	Abnormal (not related to prostate cancer)	YES	316	Equivocal	YES	207	No Evidence of Extraprostatic Extension	YES	34	0	R0	Alive	459	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	459	0.15	NO	NO	[Not Available]	[Not Available]	[Not Available]	53	M0	[Not Applicable]	T1c	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T2c	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	VN	Prostate	LIVING	25.76	Recurred/Progressed	16.82
92F45022-EE76-418D-8F9E-C3509EFDA0C0	TCGA-VN-A943	3/5/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Overlapping / Multiple Zones	4	4	8	[Not Available]	Bilateral	Apex|Middle|Base	Male	NO	YES	-26162	No	No	2013	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	YES	-17	No Evidence of Extraprostatic Extension	YES	10	0	R0	Alive	132	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	132	0.01	NO	NO	Complete Remission/Response	NO	[Not Available]	71	M0	[Not Applicable]	T1c	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T2c	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	VN	Prostate	LIVING	16.29	DiseaseFree	16.29
7FC65E49-0401-4A36-8800-FD87B7927FC1	TCGA-VP-A872	3/26/14	Prostate Adenocarcinoma, Other Subtype	mixed ductal and acinar	Overlapping / Multiple Zones	5	3	8	4	Bilateral	Apex|Base	Male	NO	YES	-22098	No	No	2005	8	Normal (no evidence of prostate cancer) [cM0]	YES	[Not Available]	No Evidence of Extraprostatic Extension	NO	[Not Available]	[Not Available]	YES	12	0	R0	Alive	3253	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	3253	0.01	NO	NO	Complete Remission/Response	NO	[Not Available]	60	M0	[Not Applicable]	T2	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8500/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3a	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	VP	Prostate	LIVING	119.28	DiseaseFree	119.28
E833AD67-2CB3-414C-B15E-28F49479E2EF	TCGA-VP-A875	3/26/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Overlapping / Multiple Zones	3	4	7	[Not Available]	Bilateral	Apex|Base	Male	NO	YES	-24742	No	No	2005	15	Abnormal (not related to prostate cancer)	YES	15	No Evidence of Extraprostatic Extension	NO	[Not Available]	[Not Available]	YES	4	0	R0	Alive	805	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	867	0.01	NO	NO	Complete Remission/Response	NO	[Not Available]	67	M0	[Not Applicable]	T2a	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3a	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	VP	Prostate	LIVING	75.85	DiseaseFree	75.85
75D22D59-DEC8-4F59-86C8-36B5E9F4FB0D	TCGA-VP-A876	3/26/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Overlapping / Multiple Zones	3	5	8	[Not Available]	Bilateral	Apex|Base	Male	NO	YES	-16934	No	No	2005	13	Normal (no evidence of prostate cancer) [cM0]	YES	13	No Evidence of Extraprostatic Extension	NO	[Not Available]	[Not Available]	YES	12	0	R0	Alive	2576	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	2576	0.1	NO	NO	Complete Remission/Response	NO	[Not Available]	46	[Not Available]	[Not Applicable]	T1c	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T2c	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	VP	Prostate	LIVING	109.49	DiseaseFree	109.49
48F36FBE-356A-40AF-B81F-8EA0B1369BAB	TCGA-VP-A878	3/27/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Overlapping / Multiple Zones	4	5	9	[Not Available]	Bilateral	Apex|Base	Male	NO	YES	-21402	No	No	2006	35	Normal (no evidence of prostate cancer) [cM0]	YES	44	Extraprostatic Extension (regional lymphadenopathy)[e.g. cN1]	NO	[Not Available]	[Not Available]	YES	3	1	R1	Alive	2704	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	2704	0.1	NO	NO	[Not Available]	YES	98	58	[Not Available]	[Not Applicable]	T1c	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N1	T2c	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	VP	Prostate	LIVING	102.83	Recurred/Progressed	77.33
11882DAC-3BA3-40FA-8AF4-174CBA77881A	TCGA-VP-A879	4/7/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Overlapping / Multiple Zones	4	5	9	[Not Available]	Right	Apex|Base	Male	NO	YES	-25799	No	No	2006	8	Normal (no evidence of prostate cancer) [cM0]	YES	8	No Evidence of Extraprostatic Extension	NO	[Not Available]	[Not Available]	YES	2	0	R0	Dead	[Not Available]	728	[Not Available]	[Not Available]	[Not Available]	688	0.01	NO	NO	[Not Available]	NO	[Not Available]	70	M0	[Not Applicable]	T1c	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T2b	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	VP	Prostate	DECEASED	23.92	[Not Available]	[Not Available]
17C0CE0F-8227-4119-9B39-EA8DB18F5F4B	TCGA-VP-A87B	3/28/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Overlapping / Multiple Zones	4	4	8	3	Right	Apex|Base	Male	NO	YES	-23271	No	No	2007	[Not Available]	Normal (no evidence of prostate cancer) [cM0]	YES	[Not Available]	No Evidence of Extraprostatic Extension	NO	[Not Available]	[Not Available]	YES	2	0	R0	Alive	2309	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	2309	3.37	NO	NO	Complete Remission/Response	NO	[Not Available]	63	M0	[Not Applicable]	T1c	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T2b	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	VP	Prostate	LIVING	89.42	Recurred/Progressed	81.24
7C398299-D789-4185-ADFA-194817877947	TCGA-VP-A87C	3/28/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Overlapping / Multiple Zones	4	3	7	[Not Available]	Bilateral	Apex|Base	Male	NO	YES	-24608	No	No	2007	14	Normal (no evidence of prostate cancer) [cM0]	YES	14	No Evidence of Extraprostatic Extension	NO	[Not Available]	[Not Available]	YES	12	0	R0	Alive	1690	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	1690	0.5	NO	NO	Complete Remission/Response	NO	[Not Available]	67	M0	[Not Applicable]	T1c	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T2c	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	VP	Prostate	LIVING	55.52	DiseaseFree	55.52
AA405B5F-F75D-486A-96F3-1DF7ADD18193	TCGA-VP-A87D	3/28/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Overlapping / Multiple Zones	4	5	9	[Not Available]	Bilateral	Apex|Base	Male	NO	YES	-19818	No	No	2007	14	Normal (no evidence of prostate cancer) [cM0]	NO	[Not Available]	[Not Available]	YES	12	No Evidence of Extraprostatic Extension	YES	12	3	R0	Alive	1853	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	1853	0.2	YES	NO	Complete Remission/Response	YES	1194	54	M0	[Not Applicable]	T1c	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N1	T3a	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	YES	VP	Prostate	LIVING	60.87	Recurred/Progressed	39.22
DC20ECF0-2807-4675-A7FD-8EAD1CEE7EA0	TCGA-VP-A87E	3/28/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Overlapping / Multiple Zones	3	3	6	[Not Available]	Bilateral	Apex|Base	Male	NO	YES	-21811	No	No	2008	15	Normal (no evidence of prostate cancer) [cM0]	YES	15	No Evidence of Extraprostatic Extension	NO	[Not Available]	[Not Available]	YES	12	0	R0	Alive	2037	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	2037	0.11	NO	NO	Complete Remission/Response	NO	[Not Available]	59	M0	[Not Applicable]	T1c	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T2c	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	VP	Prostate	LIVING	66.92	DiseaseFree	66.92
661DC657-D2B3-44FA-B859-2C4EE42B0046	TCGA-VP-A87H	3/28/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Overlapping / Multiple Zones	4	5	9	[Not Available]	Bilateral	Apex|Base	Male	NO	YES	-28060	No	No	2009	[Not Available]	[Not Available]	YES	24	No Evidence of Extraprostatic Extension	NO	[Not Available]	[Not Available]	YES	16	0	R2	Alive	663	[Not Applicable]	[Not Available]	[Not Available]	WITH TUMOR	663	0.01	NO	NO	Complete Remission/Response	NO	[Not Available]	76	M0	[Not Applicable]	T2	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3b	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	VP	Prostate	LIVING	21.78	DiseaseFree	21.78
486D225F-ECA6-499B-A142-DD86137B22E4	TCGA-VP-A87J	3/31/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Overlapping / Multiple Zones	3	4	7	[Not Available]	Bilateral	Apex|Base	Male	NO	YES	-20792	No	No	2010	11	Normal (no evidence of prostate cancer) [cM0]	YES	13	No Evidence of Extraprostatic Extension	NO	[Not Available]	[Not Available]	YES	11	1	R2	Alive	1296	[Not Applicable]	[Not Available]	[Not Available]	WITH TUMOR	1296	0.13	NO	NO	[Not Available]	NO	[Not Available]	56	M0	[Not Applicable]	T2a	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N1	T3a	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	VP	Prostate	LIVING	58.28	DiseaseFree	58.28
24D7D4D8-F5C1-4D71-80E0-72A429FC9DBD	TCGA-VP-A87K	3/31/14	Prostate Adenocarcinoma, Other Subtype	mixed ductal and acinar type	Overlapping / Multiple Zones	4	4	8	[Not Available]	Bilateral	Apex|Base	Male	NO	YES	-23030	No	No	2010	13	Normal (no evidence of prostate cancer) [cM0]	YES	13	No Evidence of Extraprostatic Extension	NO	[Not Available]	[Not Available]	YES	12	0	R1	Alive	655	[Not Applicable]	[Not Available]	[Not Available]	WITH TUMOR	655	0.3	YES	NO	Complete Remission/Response	YES	473	63	M0	[Not Applicable]	T1c	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8500/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3b	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	VP	Prostate	LIVING	42.9	Recurred/Progressed	22.9
EA953CE5-7082-41FF-8E38-760FE4100414	TCGA-VP-AA1N	3/31/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Overlapping / Multiple Zones	5	4	9	[Not Available]	Bilateral	Apex|Base	Male	NO	YES	-25781	No	No	2008	17	Normal (no evidence of prostate cancer) [cM0]	YES	17	No Evidence of Extraprostatic Extension	NO	[Not Available]	[Not Available]	YES	5	0	R1	Alive	542	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	542	0.01	NO	YES	[Not Available]	NO	[Not Available]	70	M0	[Not Applicable]	T1c	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3a	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	VP	Prostate	LIVING	44.84	DiseaseFree	44.84
ABEB0894-862F-4035-A6D9-FE0BA61630A9	TCGA-WW-A8ZI	3/26/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	4	4	8	[Not Available]	Bilateral	Apex	Male	YES	NO	-25593	No	No	2013	13	Normal (no evidence of prostate cancer) [cM0]	YES	20	No Evidence of Extraprostatic Extension	NO	[Not Available]	[Not Available]	YES	4	0	R0	Alive	176	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	176	0	NO	NO	Complete Remission/Response	NO	[Not Available]	70	M0	[Not Applicable]	T2c	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T2c	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	WW	Prostate	LIVING	14.75	DiseaseFree	14.75
56353D9C-9578-4D62-9DCD-92D800EFDEA0	TCGA-X4-A8KQ	3/7/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Peripheral Zone	4	5	9	[Not Available]	Right	[Not Available]	Male	NO	YES	-23999	No	No	2010	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	YES	3	0	RX	Alive	1131	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	963	0.25	NO	YES	Progressive Disease	NO	[Not Available]	65	M0	[Not Applicable]	T1c	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3b	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	YES	X4	Prostate	LIVING	45.43	DiseaseFree	45.43
56829C8D-7BB7-4AAC-999F-B1353DB4915D	TCGA-X4-A8KS	3/7/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Peripheral Zone	3	4	7	[Not Available]	Bilateral	[Not Available]	Male	NO	YES	-22571	No	No	2011	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	RX	Alive	846	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	797	0.01	NO	NO	Stable Disease	NO	[Not Available]	61	M0	[Not Applicable]	T2c	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	[Not Available]	T2c	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	X4	Prostate	LIVING	32.16	DiseaseFree	32.16
5E15DCC7-932E-4D9A-A765-BD5FF1CD7AEA	TCGA-XA-A8JR	10/9/13	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	4	3	7	5	Bilateral	[Not Available]	Male	YES	NO	-25090	No	No	2013	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	YES	7	0	R2	Alive	119	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	69	0	NO	NO	Complete Remission/Response	NO	[Not Available]	68	M0	[Not Applicable]	[Not Available]	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T2c	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	XA	Prostate	LIVING	12.35	DiseaseFree	12.35
BDD4FEFA-512A-4720-9F9E-11EB3892FE3C	TCGA-XJ-A83F	3/6/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Peripheral Zone	3	4	7	[Not Available]	Right	Middle|Base	Male	NO	YES	[Not Available]	No	No	2011	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	YES	7	0	RX	Alive	762	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	762	0.01	NO	NO	Complete Remission/Response	NO	[Not Available]	67	[Not Available]	[Not Applicable]	[Not Available]	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Transurethral resection (TURBT)	[Not Applicable]	N0	T3a	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	XJ	Prostate	LIVING	37.02	DiseaseFree	37.02
BF428D43-2DA6-43FC-BD62-7CBFF84E95EC	TCGA-XJ-A83G	3/6/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Peripheral Zone	4	3	7	5	Bilateral	Apex|Middle	Male	NO	YES	[Not Available]	No	No	2010	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	YES	4	0	[Not Available]	Alive	1157	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	1126	0.01	NO	NO	Complete Remission/Response	NO	[Not Available]	51	[Not Available]	[Not Applicable]	T1c	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3b	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	XJ	Prostate	LIVING	48	DiseaseFree	48
58C27028-F37C-4CF1-B134-BD9AEC9BF170	TCGA-XJ-A83H	3/6/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Peripheral Zone	3	4	7	[Not Available]	Bilateral	Middle|Base	Male	NO	YES	[Not Available]	No	No	2007	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	R0	Alive	1280	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	1280	0.03	NO	NO	Partial Remission/Response	NO	[Not Available]	57	M0	[Not Applicable]	T2a	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	[Not Available]	T2c	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	XJ	Prostate	LIVING	42.05	DiseaseFree	42.05
39A5AEBE-ACAD-4141-AA5A-66228C4049F8	TCGA-XJ-A9DI	5/21/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Peripheral Zone	5	4	9	[Not Available]	[Not Available]	Base	Male	NO	YES	[Not Available]	No	No	2009	-61	Normal (no evidence of prostate cancer) [cM0]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	YES	5	0	R0	Alive	1461	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	1461	0.1	NO	YES	Complete Remission/Response	NO	[Not Available]	62	M0	[Not Applicable]	T2b	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3b	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	YES	XJ	Prostate	LIVING	48	DiseaseFree	48
5A4D8694-947D-45E9-9A21-6DE0F63837F0	TCGA-XJ-A9DK	5/21/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Peripheral Zone	4	4	8	[Not Available]	Right	Apex	Male	NO	YES	[Not Available]	No	No	2007	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	R0	Alive	275	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	275	0.1	NO	NO	Complete Remission/Response	NO	[Not Available]	63	M0	[Not Applicable]	T1c	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	[Not Available]	T2c	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	XJ	Prostate	LIVING	9.03	DiseaseFree	9.03
5D8C9B90-8D40-4CDD-900D-03681BC2D2A6	TCGA-XJ-A9DQ	5/21/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Peripheral Zone	3	3	6	[Not Available]	Right	Apex|Base	Male	NO	YES	[Not Available]	No	No	2007	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	R0	Alive	91	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	NO	NO	[Not Available]	NO	[Not Available]	48	M0	[Not Applicable]	T1c	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	[Not Available]	T2a	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	XJ	Prostate	LIVING	2.99	DiseaseFree	2.99
84A5D5FC-7350-4846-A1BC-8BFADBCFF8DC	TCGA-XJ-A9DX	5/21/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Peripheral Zone	5	4	9	[Not Available]	Bilateral	Base	Male	NO	YES	[Not Available]	No	No	2012	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	YES	22	2	R1	Alive	790	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	790	0.05	NO	[Not Available]	Partial Remission/Response	NO	[Not Available]	51	M1c	[Not Applicable]	T1c	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N1	T3b	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	XJ	Prostate	LIVING	31.96	DiseaseFree	31.96
12D2B93E-A033-4B36-AE81-C15879EB40BD	TCGA-XK-AAIR	5/8/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	4	4	8	[Not Available]	Bilateral	Apex|Middle	Male	NO	YES	-27703	No	No	2011	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	YES	10	0	R0	Alive	972	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	953	0.09	NO	NO	Complete Remission/Response	NO	[Not Available]	75	M0	[Not Applicable]	T1c	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T2c	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	XK	Prostate	LIVING	31.93	DiseaseFree	31.93
0E747C7E-3621-4D88-847C-86811655D908	TCGA-XK-AAIV	5/8/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	5	5	10	[Not Available]	Bilateral	Apex|Middle|Base	Male	NO	YES	-23325	No	No	2011	16	Normal (no evidence of prostate cancer) [cM0]	YES	20	No Evidence of Extraprostatic Extension	YES	42	Extraprostatic Extension Localized (e.g. seminal vesicles)	YES	18	2	R1	Alive	958	[Not Applicable]	[Not Available]	[Not Available]	WITH TUMOR	85	0.32	NO	YES	Complete Remission/Response	NO	[Not Available]	63	M0	[Not Applicable]	T1c	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N1	T3b	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	YES	XK	Prostate	LIVING	37.22	DiseaseFree	37.22
2270D09E-A8BE-4B7D-9520-A4BB1CD053C0	TCGA-XK-AAIW	5/12/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	5	4	9	[Not Available]	Bilateral	Middle|Base	Male	NO	YES	-28721	No	No	2011	7	Normal (no evidence of prostate cancer) [cM0]	YES	7	No Evidence of Extraprostatic Extension	NO	[Not Available]	[Not Available]	YES	7	0	R1	Alive	972	[Not Applicable]	[Not Available]	[Not Available]	WITH TUMOR	769	0.09	NO	NO	Complete Remission/Response	YES	[Not Available]	78	M0	[Not Applicable]	T2b	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3b	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	XK	Prostate	LIVING	40.01	Recurred/Progressed	14.03
06C9EB11-6018-4015-9FBE-B46886B2C3E0	TCGA-XK-AAJ3	5/12/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	4	4	8	[Not Available]	Bilateral	Apex|Middle|Base	Male	NO	YES	-20604	Yes, History of Prior Malignancy	No	2010	13	Normal (no evidence of prostate cancer) [cM0]	YES	6	No Evidence of Extraprostatic Extension	NO	[Not Available]	[Not Available]	YES	6	0	R0	Alive	868	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	863	0.09	NO	NO	Complete Remission/Response	NO	[Not Available]	56	M0	[Not Applicable]	T1c	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3a	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	XK	Prostate	LIVING	41.46	DiseaseFree	41.46
D17B1955-0565-46C1-A5A7-ECD41AC0286A	TCGA-XK-AAJA	5/12/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	4	3	7	[Not Available]	Bilateral	Apex|Middle|Base	Male	NO	YES	-22771	No	No	2010	15	Normal (no evidence of prostate cancer) [cM0]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	YES	7	0	R0	Alive	930	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	712	0.09	NO	NO	Complete Remission/Response	NO	[Not Available]	62	M0	[Not Applicable]	T2a	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3a	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	XK	Prostate	LIVING	30.55	DiseaseFree	30.55
720D77BC-58E3-42EE-AAE7-5DE586C2AC41	TCGA-XK-AAJP	5/13/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Peripheral Zone	4	3	7	[Not Available]	Left	Middle|Base	Male	NO	YES	-24320	No	No	2011	18	Normal (no evidence of prostate cancer) [cM0]	NO	[Not Available]	[Not Available]	YES	18	No Evidence of Extraprostatic Extension	YES	6	0	R0	Alive	889	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	889	0.09	NO	NO	Complete Remission/Response	NO	[Not Available]	66	M0	[Not Applicable]	T1c	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3a	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	XK	Prostate	LIVING	41.36	DiseaseFree	41.36
A3A4A518-2DAC-4846-9476-1AA7E0C1FB5E	TCGA-XK-AAJR	5/13/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	4	3	7	5	Bilateral	Apex|Middle|Base	Male	NO	YES	-22643	No	No	2011	12	Normal (no evidence of prostate cancer) [cM0]	YES	10	No Evidence of Extraprostatic Extension	NO	[Not Available]	[Not Available]	YES	8	0	R0	Alive	824	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	753	0.09	YES	NO	Complete Remission/Response	YES	131	61	M0	[Not Applicable]	T1c	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3a	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	XK	Prostate	LIVING	36.93	Recurred/Progressed	4.3
5D66AC77-1543-488B-A68F-665811BEC67A	TCGA-XK-AAJT	5/13/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Peripheral Zone	4	3	7	5	Bilateral	Base	Male	NO	YES	-27428	No	No	2010	19	Normal (no evidence of prostate cancer) [cM0]	YES	14	No Evidence of Extraprostatic Extension	NO	[Not Available]	[Not Available]	YES	4	0	R1	Alive	1126	[Not Applicable]	[Not Available]	[Not Available]	WITH TUMOR	566	0.09	NO	NO	Partial Remission/Response	NO	[Not Available]	75	M0	[Not Applicable]	T1c	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3a	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	XK	Prostate	LIVING	47.11	DiseaseFree	47.11
ED7084F8-060C-4780-8B35-A03A5EAB9684	TCGA-XK-AAJU	5/13/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	4	3	7	[Not Available]	Bilateral	Apex|Middle|Base	Male	NO	YES	-23958	No	No	2010	9	Normal (no evidence of prostate cancer) [cM0]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	YES	5	0	R0	Alive	1206	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	1206	0.09	NO	NO	Complete Remission/Response	NO	[Not Available]	65	M0	[Not Applicable]	T1c	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T2c	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	XK	Prostate	LIVING	51.77	DiseaseFree	51.77
1BC21D56-299D-40BC-B9C8-C74DB990611E	TCGA-XK-AAK1	5/15/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	[Not Available]	4	3	7	[Not Available]	Bilateral	Apex|Middle|Base	Male	NO	YES	-22965	Yes, History of Prior Malignancy	No	2012	-2	Normal (no evidence of prostate cancer) [cM0]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	YES	6	0	R0	Alive	614	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	614	0.09	NO	NO	Complete Remission/Response	NO	[Not Available]	62	M0	[Not Applicable]	T1c	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T2c	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	XK	Prostate	LIVING	32.16	DiseaseFree	32.16
B47791BA-85FD-41D0-AC1F-B6FA06F18E96	TCGA-XQ-A8TA	1/26/15	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Peripheral Zone	5	5	10	[Not Available]	Bilateral	[Not Available]	Male	[Not Available]	[Not Available]	-21889	No	Yes, Pharmaceutical Treatment Prior to Resection	2012	[Not Available]	Prostate Cancer Metastases Present [cM1b]	YES	[Not Available]	Distant Metastasis [e.g. cM1]	YES	-10	Distant Metastasis [e.g. cM1]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Dead	[Not Available]	146	Prostate Cancer	Medical Record	WITH TUMOR	62	323	YES	NO	Progressive Disease	NO	[Not Available]	59	M1b	[Not Applicable]	T3a	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Transurethral resection (TURBT)	[Not Applicable]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	YES	XQ	Prostate	DECEASED	4.8	[Not Available]	[Not Available]
5277F041-F9FB-47C2-83F3-65AD230DD40A	TCGA-XQ-A8TB	1/26/15	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Peripheral Zone	4	5	9	[Not Available]	Bilateral	Apex|Middle|Base	Male	[Not Available]	[Not Available]	-24623	No	No	2012	-24	Abnormal (not related to prostate cancer)	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	YES	4	0	R1	Alive	770	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	674	0	NO	YES	Complete Remission/Response	NO	[Not Available]	67	M0	[Not Applicable]	T2a	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3b	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	XQ	Prostate	LIVING	25.3	DiseaseFree	25.3
A7045324-CB44-4B37-BBAF-641642C1D903	TCGA-Y6-A8TL	4/17/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Peripheral Zone	3	3	6	[Not Available]	Right	Apex	Male	NO	YES	-23776	No	No	2012	[Not Available]	[Not Available]	YES	328	No Evidence of Extraprostatic Extension	NO	[Not Available]	[Not Available]	YES	5	0	R0	Alive	775	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	775	0	NO	NO	[Not Available]	NO	[Not Available]	65	[Not Available]	[Not Applicable]	T2a	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3a	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	Y6	Prostate	LIVING	32.59	DiseaseFree	32.59
C4EBB2EB-E1F0-4490-80F3-5CF0C40A3091	TCGA-Y6-A9XI	11/13/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Peripheral Zone	4	4	8	[Not Available]	Bilateral	Apex	Male	NO	YES	-26471	No	No	2012	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	YES	4	0	R1	Alive	526	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	519	0.06	NO	NO	[Not Available]	NO	[Not Available]	72	[Not Available]	[Not Applicable]	[Not Available]	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	[Discrepancy]	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	Y6	Prostate	LIVING	17.28	DiseaseFree	17.28
74DE01BD-30D9-45FC-841D-ED1C0D7446BA	TCGA-YJ-A8SW	5/13/14	Prostate Adenocarcinoma, Other Subtype	adenocarcinoma with focal mucinous features	[Not Available]	5	4	9	[Not Available]	Right	[Not Available]	Male	NO	YES	[Not Available]	No	No	2008	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	YES	2	0	R1	Alive	148	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	148	0.38	YES	[Not Available]	[Not Available]	[Not Available]	148	67	[Not Available]	[Not Applicable]	T1c	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61.9	8480/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3b	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	YJ	Prostate	LIVING	4.86	DiseaseFree	4.86
666D8B0C-593F-4EC3-B16A-2DADBEAD8C32	TCGA-YL-A8HJ	3/13/14	Prostate Adenocarcinoma, Other Subtype	25-30% ductal component	Overlapping / Multiple Zones	4	5	9	3	Bilateral	Apex|Middle|Base	Male	NO	YES	-21416	No	No	2009	54	Normal (no evidence of prostate cancer) [cM0]	YES	-34	No Evidence of Extraprostatic Extension	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	R0	Alive	1611	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	1589	0.03	NO	YES	Complete Remission/Response	NO	[Not Available]	58	M0	[Not Applicable]	[Not Available]	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	[Not Available]	T3b	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	YES	YL	Prostate	LIVING	52.92	DiseaseFree	52.92
351239DB-52D3-4AB5-BD4F-8FEAA6701BA1	TCGA-YL-A8HK	3/13/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Overlapping / Multiple Zones	4	5	9	[Not Available]	Bilateral	Apex|Middle|Base	Male	NO	YES	-21850	No	No	2009	27	Normal (no evidence of prostate cancer) [cM0]	YES	195	No Evidence of Extraprostatic Extension	NO	[Not Available]	[Not Available]	YES	1	0	R1	Alive	1491	[Not Applicable]	[Not Available]	[Not Available]	WITH TUMOR	1491	1	YES	YES	Complete Remission/Response	YES	1376	59	M0	[Not Applicable]	[Not Available]	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3b	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	YES	YL	Prostate	LIVING	48.98	Recurred/Progressed	45.2
FF52FA2F-BD12-4DE0-9F5C-CD330FFB5FB3	TCGA-YL-A8HL	3/13/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Overlapping / Multiple Zones	4	5	9	[Not Available]	Bilateral	Apex|Middle|Base	Male	NO	YES	-21249	No	No	2010	25	Normal (no evidence of prostate cancer) [cM0]	YES	27	No Evidence of Extraprostatic Extension	NO	[Not Available]	[Not Available]	YES	8	2	R1	Alive	1173	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	1173	0.03	NO	YES	Stable Disease	NO	[Not Available]	58	M0	[Not Applicable]	[Not Available]	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N1	T3b	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	YES	YL	Prostate	LIVING	51.41	DiseaseFree	51.41
EFF14FED-8A21-41C5-8ED3-75346A06E44E	TCGA-YL-A8HM	3/13/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Overlapping / Multiple Zones	4	5	9	[Not Available]	Bilateral	Apex|Middle|Base	Male	NO	YES	-24121	No	No	2010	26	Normal (no evidence of prostate cancer) [cM0]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	YES	10	0	R0	Alive	1124	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	1124	0.03	NO	YES	Complete Remission/Response	NO	[Not Available]	66	M0	[Not Applicable]	[Not Available]	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3b	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	YES	YL	Prostate	LIVING	48.69	Recurred/Progressed	48.39
B7C8CA4C-8D9C-4C5B-99EE-2FCEBE4F70E6	TCGA-YL-A8HO	3/14/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Overlapping / Multiple Zones	4	3	7	5	Bilateral	Middle|Base	Male	NO	YES	-24509	No	No	2008	62	Abnormal (not related to prostate cancer)	YES	117	No Evidence of Extraprostatic Extension	NO	[Not Available]	[Not Available]	YES	18	0	R1	Alive	2183	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	2168	0.01	NO	NO	Stable Disease	YES	1068	67	M0	[Not Applicable]	[Not Available]	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3a	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	YL	Prostate	LIVING	75.69	Recurred/Progressed	35.09
494A8495-8D10-4A8F-8664-F68AC339C889	TCGA-YL-A8S8	4/25/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Overlapping / Multiple Zones	4	5	9	[Not Available]	Bilateral	Apex|Middle|Base	Male	NO	YES	-25119	No	No	2008	18	Normal (no evidence of prostate cancer) [cM0]	YES	28	No Evidence of Extraprostatic Extension	NO	[Not Available]	[Not Available]	YES	10	0	R1	Alive	1890	[Not Applicable]	[Not Available]	[Not Available]	WITH TUMOR	1890	1.36	YES	NO	Stable Disease	YES	679	68	M0	[Not Applicable]	[Not Available]	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3a	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	YL	Prostate	LIVING	62.09	Recurred/Progressed	22.31
B0669EEC-6A1A-4618-AE23-AE0F9E9C266C	TCGA-YL-A8S9	4/25/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Overlapping / Multiple Zones	4	5	9	3	Bilateral	Apex|Middle	Male	NO	YES	-23204	No	No	2008	20	Normal (no evidence of prostate cancer) [cM0]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	YES	5	0	R1	Alive	1842	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	1839	0.03	NO	NO	Stable Disease	YES	[Not Available]	63	M0	[Not Applicable]	[Not Available]	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3a	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	YL	Prostate	LIVING	60.51	Recurred/Progressed	33.05
2919AFA2-3FEE-43BD-AE68-E70718E73608	TCGA-YL-A8SA	4/25/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Overlapping / Multiple Zones	4	4	8	5	Bilateral	Apex|Middle|Base	Male	NO	YES	-25340	No	No	2009	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	YES	9	0	R1	Alive	512	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	467	0.06	NO	YES	Stable Disease	NO	[Not Available]	69	M0	[Not Applicable]	T2b	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3b	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	YL	Prostate	LIVING	16.82	DiseaseFree	16.82
21A29827-7896-436D-AB52-E7EDFC91E7D0	TCGA-YL-A8SB	4/25/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Overlapping / Multiple Zones	4	5	9	[Not Available]	Bilateral	Apex|Middle|Base	Male	NO	YES	-22991	No	No	2010	27	Normal (no evidence of prostate cancer) [cM0]	YES	52	No Evidence of Extraprostatic Extension	NO	[Not Available]	[Not Available]	YES	3	0	R1	Alive	1384	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	1384	0.23	NO	YES	Stable Disease	NO	[Not Available]	62	M0	[Not Applicable]	[Not Available]	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3a	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	YES	YL	Prostate	LIVING	56.47	Recurred/Progressed	45.47
42FA9774-9471-4707-8F6F-8041B34C49E4	TCGA-YL-A8SC	4/27/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Overlapping / Multiple Zones	4	5	9	[Not Available]	Bilateral	Apex|Middle|Base	Male	NO	YES	-24206	No	No	2010	40	Normal (no evidence of prostate cancer) [cM0]	YES	47	No Evidence of Extraprostatic Extension	NO	[Not Available]	[Not Available]	YES	6	0	R1	Alive	1261	[Not Applicable]	[Not Available]	[Not Available]	WITH TUMOR	1261	0.65	NO	NO	Partial Remission/Response	NO	[Not Available]	66	M0	[Not Applicable]	[Not Available]	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3a	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	YES	YL	Prostate	LIVING	41.43	Recurred/Progressed	4.99
FE7B283C-9CF4-4BE2-8A3A-251A81A8D78F	TCGA-YL-A8SF	4/25/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Overlapping / Multiple Zones	4	4	8	5	Bilateral	Apex|Middle|Base	Male	NO	YES	-22844	No	No	2010	29	Normal (no evidence of prostate cancer) [cM0]	YES	22	No Evidence of Extraprostatic Extension	NO	[Not Available]	[Not Available]	YES	2	0	R1	Alive	1373	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	1247	0.01	NO	NO	Stable Disease	NO	[Not Available]	62	M0	[Not Applicable]	[Not Available]	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3b	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	YL	Prostate	LIVING	45.11	DiseaseFree	45.11
BFB973EB-D42D-4900-A606-A381D2317555	TCGA-YL-A8SH	4/25/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Overlapping / Multiple Zones	4	3	7	[Not Available]	Bilateral	Apex|Middle|Base	Male	NO	YES	-25395	No	No	2009	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	YES	21	0	R0	Dead	[Not Available]	875	Other, non-malignant disease	Death Certificate	TUMOR FREE	617	0.06	NO	NO	Complete Remission/Response	NO	[Not Available]	69	M0	[Not Applicable]	[Not Available]	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3a	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	YL	Prostate	DECEASED	28.75	[Not Available]	[Not Available]
C5F8C89C-EF69-42F4-9B37-5B552FCCDF4B	TCGA-YL-A8SI	4/25/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Overlapping / Multiple Zones	4	5	9	[Not Available]	Bilateral	Apex|Middle|Base	Male	NO	YES	-25292	No	No	2010	47	Normal (no evidence of prostate cancer) [cM0]	YES	62	No Evidence of Extraprostatic Extension	NO	[Not Available]	[Not Available]	YES	15	0	R0	Alive	1441	[Not Applicable]	[Not Available]	[Not Available]	WITH TUMOR	1441	0.48	NO	NO	Complete Remission/Response	YES	1423	69	M0	[Not Applicable]	[Not Available]	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3a	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	YL	Prostate	LIVING	53.02	Recurred/Progressed	46.75
F3EC5BF3-97AE-4033-91A6-084A1AA152A4	TCGA-YL-A8SJ	4/25/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Overlapping / Multiple Zones	4	5	9	[Not Available]	Bilateral	Middle|Base	Male	NO	YES	-21916	No	No	2010	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	YES	29	0	R0	Alive	1395	[Not Applicable]	[Not Available]	[Not Available]	WITH TUMOR	1426	0.24	YES	NO	Complete Remission/Response	YES	752	60	M0	[Not Applicable]	[Not Available]	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3b	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	YL	Prostate	LIVING	45.83	Recurred/Progressed	24.7
159B47B2-DC7D-4856-9A00-454E27301E23	TCGA-YL-A8SK	4/25/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Overlapping / Multiple Zones	4	5	9	[Not Available]	Bilateral	Apex|Middle|Base	Male	NO	YES	-24759	No	No	2010	38	Normal (no evidence of prostate cancer) [cM0]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	YES	20	4	R1	Alive	1155	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	924	0.03	NO	YES	Stable Disease	NO	[Not Available]	67	M0	[Not Applicable]	[Not Available]	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N1	T3b	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	YES	YL	Prostate	LIVING	46.25	DiseaseFree	46.25
23EBC73D-BE3B-42F8-9390-BF18A21AFC5C	TCGA-YL-A8SL	4/25/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Overlapping / Multiple Zones	4	4	8	3	Bilateral	Apex|Middle|Base	Male	NO	YES	-27033	No	No	2011	41	Normal (no evidence of prostate cancer) [cM0]	YES	43	Extraprostatic Extension (regional lymphadenopathy)[e.g. cN1]	NO	[Not Available]	[Not Available]	YES	19	3	R0	Alive	798	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	623	0	NO	NO	Complete Remission/Response	NO	[Not Available]	74	M0	[Not Applicable]	[Not Available]	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N1	T3b	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	YES	YL	Prostate	LIVING	32.42	DiseaseFree	32.42
5E3D0E50-AFB4-4D2D-B4D9-5F320C573BA3	TCGA-YL-A8SO	4/27/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Overlapping / Multiple Zones	4	5	9	[Not Available]	Bilateral	Apex|Middle	Male	NO	YES	-23584	No	No	2004	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	R1	Alive	3247	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	3247	0	NO	NO	Stable Disease	NO	[Not Available]	64	M0	[Not Applicable]	T1a	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Transurethral resection (TURBT)	[Not Applicable]	[Not Available]	T3a	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	YES	YL	Prostate	LIVING	114.29	DiseaseFree	114.29
C506FAE4-7C0A-4705-8E80-5BCC122A8A32	TCGA-YL-A8SP	4/30/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Overlapping / Multiple Zones	4	5	9	3	Bilateral	Apex|Middle|Base	Male	NO	YES	-21455	No	No	2008	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	R1	Alive	2170	[Not Applicable]	[Not Available]	[Not Available]	WITH TUMOR	2155	0.38	NO	NO	Stable Disease	NO	[Not Available]	58	M0	[Not Applicable]	T2a	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	[Not Available]	T3b	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	YES	YL	Prostate	LIVING	77.73	Recurred/Progressed	66.89
24E5D323-F3D4-4ADD-9A29-79E77CED357C	TCGA-YL-A8SQ	4/30/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Overlapping / Multiple Zones	4	5	9	3	Bilateral	Apex|Middle|Base	Male	NO	YES	-22482	No	No	2008	19	Normal (no evidence of prostate cancer) [cM0]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	YES	5	0	R1	Alive	1943	[Not Applicable]	[Not Available]	[Not Available]	WITH TUMOR	1943	1.1	YES	NO	Stable Disease	YES	329	61	M0	[Not Applicable]	[Not Available]	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3b	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	YL	Prostate	LIVING	68.43	Recurred/Progressed	10.81
CCCDD4A2-EBF0-482D-B71C-9FE44414EEC6	TCGA-YL-A8SR	4/25/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Overlapping / Multiple Zones	4	5	9	3	Bilateral	Apex|Middle|Base	Male	NO	YES	-23488	No	No	2011	-1060	Normal (no evidence of prostate cancer) [cM0]	YES	-1062	No Evidence of Extraprostatic Extension	NO	[Not Available]	[Not Available]	YES	6	0	R1	Alive	213	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	222	0.06	NO	NO	Stable Disease	NO	[Not Available]	64	M0	[Not Applicable]	T1c	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3a	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	YL	Prostate	LIVING	8.97	DiseaseFree	8.97
1BCB1132-A9FC-4F03-BBED-ABAF80C7A24A	TCGA-YL-A9WH	4/10/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Overlapping / Multiple Zones	4	5	9	[Not Available]	Bilateral	Apex|Middle|Base	Male	NO	YES	-24755	No	No	2011	55	Normal (no evidence of prostate cancer) [cM0]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	YES	2	1	R1	Alive	427	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	349	0.03	NO	YES	Stable Disease	NO	[Not Available]	67	M0	[Not Applicable]	[Not Available]	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N1	T3b	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	YES	YL	Prostate	LIVING	14.03	DiseaseFree	14.03
2D70EACC-D0C3-4121-BD1A-A47D68ECEDE5	TCGA-YL-A9WI	4/10/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Overlapping / Multiple Zones	4	5	9	[Not Available]	Bilateral	Apex|Middle|Base	Male	NO	YES	-23184	No	No	2010	93	Normal (no evidence of prostate cancer) [cM0]	YES	99	No Evidence of Extraprostatic Extension	NO	[Not Available]	[Not Available]	YES	15	1	R0	Alive	1259	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	1259	0.03	NO	NO	Stable Disease	NO	[Not Available]	63	M0	[Not Applicable]	[Not Available]	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N1	T3a	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	YL	Prostate	LIVING	53.32	DiseaseFree	53.32
0B5ED938-6AB8-4E76-8558-1D86F3A90DFA	TCGA-YL-A9WJ	4/14/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Overlapping / Multiple Zones	4	4	8	3	Bilateral	Apex|Middle	Male	NO	YES	-17322	No	No	2008	19	Normal (no evidence of prostate cancer) [cM0]	YES	21	No Evidence of Extraprostatic Extension	YES	51	Extraprostatic Extension Localized (e.g. seminal vesicles)	YES	10	1	R1	Dead	[Not Available]	1855	Prostate Cancer	Medical Record	WITH TUMOR	838	3.1	YES	YES	Progressive Disease	YES	76	47	M0	[Not Applicable]	T4	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N1	T3b	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	YL	Prostate	DECEASED	60.94	Recurred/Progressed	48.49
B2BCC97F-03A6-409A-8B91-78221CB10D7F	TCGA-YL-A9WK	4/13/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Overlapping / Multiple Zones	4	5	9	[Not Available]	Bilateral	Middle	Male	NO	YES	-23272	No	No	2008	329	Normal (no evidence of prostate cancer) [cM0]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	YES	1	0	R1	Alive	1897	[Not Applicable]	[Not Available]	[Not Available]	WITH TUMOR	1871	15.6	YES	NO	Stable Disease	YES	1009	63	M0	[Not Applicable]	T2b	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3b	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	YES	YL	Prostate	LIVING	70.17	Recurred/Progressed	33.15
CFCF057A-00FE-4603-A720-586712B75803	TCGA-YL-A9WL	4/12/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Overlapping / Multiple Zones	4	5	9	3	Bilateral	Apex|Middle|Base	Male	NO	YES	-21626	No	No	2011	28	Normal (no evidence of prostate cancer) [cM0]	YES	39	No Evidence of Extraprostatic Extension	NO	[Not Available]	[Not Available]	YES	15	0	R0	Alive	740	[Not Applicable]	[Not Available]	[Not Available]	WITH TUMOR	740	6.4	YES	YES	Complete Remission/Response	YES	740	59	M0	[Not Applicable]	T2a	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3a	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	YES	YL	Prostate	LIVING	24.31	Recurred/Progressed	24.31
A468353E-0A96-4A4D-8AEF-5140BF1BF952	TCGA-YL-A9WX	4/12/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Overlapping / Multiple Zones	4	5	9	3	Bilateral	Middle	Male	NO	YES	-25008	No	No	2009	34	Abnormal (not related to prostate cancer)	YES	37	No Evidence of Extraprostatic Extension	YES	41	Extraprostatic Extension Localized (e.g. seminal vesicles)	YES	11	1	R1	Alive	1518	[Not Applicable]	[Not Available]	[Not Available]	WITH TUMOR	1610	0.76	YES	NO	Stable Disease	YES	1506	68	M0	[Not Applicable]	T3a	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N1	T3b	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	YL	Prostate	LIVING	49.87	Recurred/Progressed	49.47
D7E22AF5-88AA-4A83-985C-1D346DFF652D	TCGA-YL-A9WY	4/13/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Overlapping / Multiple Zones	5	4	9	[Not Available]	Bilateral	Apex|Middle|Base	Male	NO	YES	-21164	No	No	2011	50	Normal (no evidence of prostate cancer) [cM0]	NO	[Not Available]	[Not Available]	YES	62	Extraprostatic Extension Localized (e.g. seminal vesicles)|Extraprostatic Extension (regional lymphadenopathy) [e.g. cN1]	YES	19	11	R1	Alive	846	[Not Applicable]	[Not Available]	[Not Available]	WITH TUMOR	765	1.8	YES	NO	[Not Applicable]	YES	765	57	M0	[Not Applicable]	T3a	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N1	T3b	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	YES	YL	Prostate	LIVING	36.07	Recurred/Progressed	32.03
F06C1EF4-BEDD-4025-ABF8-06F5E9C0821A	TCGA-ZG-A8QW	5/21/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Overlapping / Multiple Zones	4	5	9	[Not Available]	Bilateral	Middle	Male	NO	YES	-26632	No	No	2013	8	Normal (no evidence of prostate cancer) [cM0]	NO	[Not Available]	[Not Available]	YES	43	Extraprostatic Extension Localized (e.g. seminal vesicles)	YES	13	1	R0	Alive	50	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	72	M0	[Not Applicable]	T3a	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N1	T3b	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	ZG	Prostate	LIVING	3.09	DiseaseFree	3.09
AE739A4A-E319-4D87-8330-14F2FBC8839D	TCGA-ZG-A8QX	5/21/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Overlapping / Multiple Zones	3	3	6	[Not Available]	Bilateral	Middle	Male	NO	YES	-20683	No	No	2013	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	YES	18	0	R0	Alive	150	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	56	M0	[Not Applicable]	T1c	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T2c	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	ZG	Prostate	LIVING	14.52	DiseaseFree	14.52
A6D467CF-6783-4885-8DE5-95D32E922500	TCGA-ZG-A8QY	5/21/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Overlapping / Multiple Zones	5	4	9	3	Bilateral	Base	Male	NO	YES	-24731	No	No	2013	5	Normal (no evidence of prostate cancer) [cM0]	NO	[Not Available]	[Not Available]	YES	5	No Evidence of Extraprostatic Extension	YES	14	1	RX	Alive	34	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	67	M0	[Not Applicable]	T2c	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N1	T3b	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	ZG	Prostate	LIVING	13.27	DiseaseFree	13.27
DAA9292E-8012-4AA2-8221-AD65FB1C7B78	TCGA-ZG-A8QZ	5/21/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Overlapping / Multiple Zones	4	5	9	3	Bilateral	Middle	Male	NO	YES	-23980	No	No	2013	12	Normal (no evidence of prostate cancer) [cM0]	YES	42	No Evidence of Extraprostatic Extension	NO	[Not Available]	[Not Available]	YES	8	1	R1	Alive	308	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	239	0.01	NO	YES	[Not Available]	NO	[Not Available]	65	M0	[Not Applicable]	T2a	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N1	T3b	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	YES	ZG	Prostate	LIVING	10.12	DiseaseFree	10.12
ADBF5BDA-E2DC-4B25-8FB9-96D89093F77D	TCGA-ZG-A9KY	7/17/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Overlapping / Multiple Zones	5	4	9	[Not Available]	Bilateral	Apex|Middle|Base	Male	NO	YES	-27000	No	No	2013	14	Normal (no evidence of prostate cancer) [cM0]	YES	14	No Evidence of Extraprostatic Extension	NO	[Not Available]	[Not Available]	YES	16	2	R1	Alive	34	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	73	M0	[Not Applicable]	T1c	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N1	T4	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	ZG	Prostate	LIVING	4.27	DiseaseFree	4.27
355E84E7-0D50-4BC2-A481-DFECE2F8C687	TCGA-ZG-A9L0	7/17/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Overlapping / Multiple Zones	5	4	9	3	Bilateral	Apex|Middle|Base	Male	NO	YES	-26055	No	No	2013	-16	Normal (no evidence of prostate cancer) [cM0]	YES	-119	No Evidence of Extraprostatic Extension	NO	[Not Available]	[Not Available]	YES	20	7	R1	Alive	68	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	71	M0	[Not Applicable]	[Not Available]	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N1	T3b	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	ZG	Prostate	LIVING	11.66	DiseaseFree	11.66
083CC988-19A5-49B4-97C0-4E7BCC5D5C08	TCGA-ZG-A9L1	7/17/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Peripheral Zone	4	5	9	[Not Available]	Bilateral	Apex|Middle|Base	Male	NO	YES	-24214	No	No	2010	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	YES	7	1	R1	Alive	1147	[Not Applicable]	[Not Available]	[Not Available]	WITH TUMOR	1147	0.07	NO	YES	Partial Remission/Response	NO	[Not Available]	66	M0	[Not Applicable]	T1c	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N1	T3b	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	ZG	Prostate	LIVING	42.77	DiseaseFree	42.77
5E7A7629-800A-45C4-B4CB-314A853A1BEC	TCGA-ZG-A9L2	7/17/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Peripheral Zone	4	5	9	3	[Not Available]	[Not Available]	Male	NO	YES	-25573	No	No	2011	6	Normal (no evidence of prostate cancer) [cM0]	NO	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	YES	14	0	R1	Alive	986	[Not Applicable]	[Not Available]	[Not Available]	WITH TUMOR	1137	0.01	YES	NO	Stable Disease	YES	180	70	M0	[Not Applicable]	T3a	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3b	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	ZG	Prostate	LIVING	37.91	Recurred/Progressed	5.91
C75BEE57-D6DA-4083-9BE8-17C970B77FC7	TCGA-ZG-A9L4	7/17/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Overlapping / Multiple Zones	5	4	9	3	Bilateral	Apex|Middle|Base	Male	NO	YES	-22388	No	No	2011	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	YES	10	0	R1	Alive	1108	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	1108	0.03	NO	NO	Stable Disease	NO	[Not Available]	61	M0	[Not Applicable]	T1c	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3b	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	ZG	Prostate	LIVING	36.4	DiseaseFree	36.4
E8F39C9E-0F1A-401C-9055-762B52BC77C7	TCGA-ZG-A9L5	7/17/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Overlapping / Multiple Zones	5	4	9	3	Bilateral	Apex|Middle|Base	Male	NO	YES	-21293	No	No	2011	[Not Available]	[Not Available]	YES	11	Extraprostatic Extension (regional lymphadenopathy)[e.g. cN1]	NO	[Not Available]	[Not Available]	YES	3	1	R1	Alive	854	[Not Applicable]	[Not Available]	[Not Available]	WITH TUMOR	[Not Available]	[Not Available]	NO	[Not Available]	Progressive Disease	[Not Available]	[Not Available]	58	M0	[Not Applicable]	T2a	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N1	T4	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	YES	ZG	Prostate	LIVING	29.83	DiseaseFree	29.83
93CF60A7-1D61-4C1C-8DCE-221289800B0C	TCGA-ZG-A9L6	7/17/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Overlapping / Multiple Zones	5	4	9	3	Bilateral	Apex|Middle|Base	Male	NO	YES	-23681	No	No	2011	13	Normal (no evidence of prostate cancer) [cM0]	YES	13	No Evidence of Extraprostatic Extension	NO	[Not Available]	[Not Available]	YES	25	0	R1	Alive	664	[Not Applicable]	[Not Available]	[Not Available]	WITH TUMOR	664	0.36	YES	[Not Available]	Partial Remission/Response	YES	664	64	M0	[Not Applicable]	T1c	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3b	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	ZG	Prostate	LIVING	22.57	Recurred/Progressed	21.81
C7912CA7-11E1-4CB8-902A-9D6CB23FD344	TCGA-ZG-A9L9	7/17/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Overlapping / Multiple Zones	4	5	9	[Not Available]	Bilateral	Apex|Middle|Base	Male	NO	YES	-22108	No	No	2012	-4	Normal (no evidence of prostate cancer) [cM0]	NO	[Not Available]	[Not Available]	YES	0	Extraprostatic Extension Localized (e.g. seminal vesicles)	YES	15	3	R1	Alive	602	[Not Applicable]	[Not Available]	[Not Available]	WITH TUMOR	[Not Available]	[Not Available]	NO	YES	Progressive Disease	YES	51	60	M0	[Not Applicable]	T2b	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N1	T3b	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	ZG	Prostate	LIVING	20.27	Recurred/Progressed	1.68
EF974C39-8BAC-486B-A395-9D1283E08028	TCGA-ZG-A9LB	7/17/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Overlapping / Multiple Zones	5	4	9	[Not Available]	Right	Apex|Middle|Base	Male	NO	YES	-26447	No	No	2012	21	Normal (no evidence of prostate cancer) [cM0]	YES	31	No Evidence of Extraprostatic Extension	NO	[Not Available]	[Not Available]	YES	9	0	R1	Alive	485	[Not Applicable]	[Not Available]	[Not Available]	WITH TUMOR	485	0.02	NO	NO	Partial Remission/Response	[Not Available]	[Not Available]	72	M0	[Not Applicable]	T2a	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3b	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	ZG	Prostate	LIVING	19.15	DiseaseFree	19.15
9357E8EB-1CE5-4C0F-A668-E5E7F3031D6C	TCGA-ZG-A9LM	7/18/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Peripheral Zone	4	5	9	3	Right	Middle|Base	Male	NO	YES	-26377	No	No	2013	[Not Available]	[Not Available]	YES	14	No Evidence of Extraprostatic Extension	NO	[Not Available]	[Not Available]	YES	11	2	R0	Alive	121	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	121	0	NO	[Not Available]	Complete Remission/Response	NO	[Not Available]	72	M0	[Not Applicable]	T2b	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N1	T3a	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	ZG	Prostate	LIVING	12.42	DiseaseFree	12.42
1D2C5F72-CDCA-4CC8-8A96-2ABE10207356	TCGA-ZG-A9LN	7/18/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Overlapping / Multiple Zones	5	4	9	[Not Available]	Bilateral	Apex|Middle|Base	Male	NO	YES	-21050	No	No	2013	3	Normal (no evidence of prostate cancer) [cM0]	YES	9	No Evidence of Extraprostatic Extension	YES	7	No Evidence of Extraprostatic Extension	YES	10	6	R1	Alive	115	[Not Applicable]	[Not Available]	[Not Available]	WITH TUMOR	90	7.42	NO	NO	Partial Remission/Response	NO	[Not Available]	57	M0	[Not Applicable]	T1c	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N1	T3b	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	YES	ZG	Prostate	LIVING	3.78	DiseaseFree	3.78
AFA7D9A2-3998-4182-BF63-54895ED2DE37	TCGA-ZG-A9LS	7/18/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Central Zone	5	4	9	[Not Available]	Bilateral	Apex|Middle|Base	Male	NO	YES	-23540	No	No	2013	16	Normal (no evidence of prostate cancer) [cM0]	YES	16	No Evidence of Extraprostatic Extension	NO	[Not Available]	[Not Available]	YES	47	3	R1	Alive	211	[Not Applicable]	[Not Available]	[Not Available]	WITH TUMOR	147	0.03	NO	YES	Complete Remission/Response	[Not Available]	[Not Available]	64	M0	[Not Applicable]	T2a	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N1	T3b	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	ZG	Prostate	LIVING	16.95	DiseaseFree	16.95
610603D0-43FB-4A4E-B368-D143E6C61802	TCGA-ZG-A9LU	7/18/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Overlapping / Multiple Zones	5	4	9	[Not Available]	Bilateral	Apex|Middle|Base	Male	NO	YES	-24742	No	No	2012	37	Normal (no evidence of prostate cancer) [cM0]	NO	[Not Available]	[Not Available]	YES	40	No Evidence of Extraprostatic Extension	YES	7	0	R1	Alive	549	[Not Applicable]	[Not Available]	[Not Available]	WITH TUMOR	549	0.7	NO	YES	Partial Remission/Response	NO	[Not Available]	67	M0	[Not Applicable]	T2b	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3a	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	ZG	Prostate	LIVING	19.02	DiseaseFree	19.02
3DE1A86B-AAEB-4F0D-9F32-1FDA924198D7	TCGA-ZG-A9LY	7/18/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Overlapping / Multiple Zones	4	5	9	3	Bilateral	Apex|Middle|Base	Male	NO	YES	-21942	No	No	2012	20	Normal (no evidence of prostate cancer) [cM0]	YES	12	No Evidence of Extraprostatic Extension	NO	[Not Available]	[Not Available]	YES	11	1	R1	Alive	287	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	288	0.01	NO	YES	Complete Remission/Response	NO	[Not Available]	60	M0	[Not Applicable]	T2b	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N1	T3b	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	ZG	Prostate	LIVING	12.16	DiseaseFree	12.16
CA076CFD-C628-4AF2-837C-37617429ADB9	TCGA-ZG-A9LZ	7/18/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Overlapping / Multiple Zones	4	5	9	3	Bilateral	Apex|Middle|Base	Male	NO	YES	-24132	No	No	2011	-15	Normal (no evidence of prostate cancer) [cM0]	YES	-9	No Evidence of Extraprostatic Extension	NO	[Not Available]	[Not Available]	YES	5	0	R1	Alive	692	[Not Applicable]	[Not Available]	[Not Available]	WITH TUMOR	692	2.19	YES	YES	Partial Remission/Response	YES	310	66	M0	[Not Applicable]	T3a	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3b	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	ZG	Prostate	LIVING	22.73	DiseaseFree	22.73
9B5D36B2-8B46-48A4-AFA7-0E1936F2D315	TCGA-ZG-A9M4	7/18/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Overlapping / Multiple Zones	5	4	9	[Not Available]	Bilateral	Apex|Middle|Base	Male	NO	YES	-24030	No	No	2012	21	Normal (no evidence of prostate cancer) [cM0]	YES	22	Extraprostatic Extension (regional lymphadenopathy)[e.g. cN1]	NO	[Not Available]	[Not Available]	YES	18	1	R1	Alive	223	[Not Applicable]	[Not Available]	[Not Available]	WITH TUMOR	218	0.95	NO	NO	Partial Remission/Response	NO	[Not Available]	65	M0	[Not Applicable]	T2a	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N1	T3b	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	ZG	Prostate	LIVING	17.97	DiseaseFree	17.97
7EFC26B2-EFF9-4F1E-9F4B-F26AF072C84A	TCGA-ZG-A9MC	7/18/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Peripheral Zone	5	4	9	3	Bilateral	Apex|Middle|Base	Male	NO	YES	-25477	No	No	2012	3	Normal (no evidence of prostate cancer) [cM0]	NO	[Not Available]	[Not Available]	YES	0	Extraprostatic Extension Localized (e.g. seminal vesicles)	YES	14	2	R1	Alive	428	[Not Applicable]	[Not Available]	[Not Available]	WITH TUMOR	427	31.85	NO	YES	Partial Remission/Response	NO	[Not Available]	69	M0	[Not Applicable]	T2a	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N1	T3b	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	ZG	Prostate	LIVING	14.95	DiseaseFree	14.95
305B0B57-5952-43C7-9063-7BCD954EB44D	TCGA-ZG-A9N3	7/18/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Overlapping / Multiple Zones	5	4	9	3	Bilateral	Apex|Middle|Base	Male	NO	YES	-26902	No	No	2013	7	Normal (no evidence of prostate cancer) [cM0]	NO	[Not Available]	[Not Available]	YES	7	Extraprostatic Extension Localized (e.g. seminal vesicles)	YES	30	1	R1	Alive	244	[Not Applicable]	[Not Available]	[Not Available]	WITH TUMOR	244	0.1	NO	NO	Partial Remission/Response	NO	[Not Available]	73	M0	[Not Applicable]	T1c	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N1	T3b	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	YES	ZG	Prostate	LIVING	11.47	DiseaseFree	11.47
348C2BF3-2146-4990-9ADF-FA6968B4F072	TCGA-ZG-A9ND	7/18/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Overlapping / Multiple Zones	5	4	9	3	Bilateral	Apex|Middle	Male	NO	YES	-20428	No	No	2013	7	Normal (no evidence of prostate cancer) [cM0]	YES	10	No Evidence of Extraprostatic Extension	NO	[Not Available]	[Not Available]	YES	8	0	R0	Alive	261	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	184	0.08	NO	NO	Complete Remission/Response	NO	[Not Available]	55	M0	[Not Applicable]	T1c	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3a	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	ZG	Prostate	LIVING	13.47	DiseaseFree	13.47
03C15D06-B81E-433C-9DE4-906CBA91539F	TCGA-ZG-A9NI	7/18/14	Prostate Adenocarcinoma Acinar Type	[Not Applicable]	Overlapping / Multiple Zones	5	4	9	3	Bilateral	Apex|Middle|Base	Male	NO	YES	-26697	No	No	2013	22	Normal (no evidence of prostate cancer) [cM0]	YES	22	No Evidence of Extraprostatic Extension	NO	[Not Available]	[Not Available]	YES	21	0	R1	Alive	132	[Not Applicable]	[Not Available]	[Not Available]	TUMOR FREE	99	0.03	NO	NO	Complete Remission/Response	NO	[Not Available]	73	M0	[Not Applicable]	T2a	[Not Applicable]	0	[Not Available]	[Not Available]	[Not Applicable]	C61	8140/3	C61.9	YES	Core needle biopsy	[Not Applicable]	N0	T3b	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	ZG	Prostate	LIVING	4.34	DiseaseFree	4.34